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Hydrometalation of α,β-unsaturated carbonyl compounds provides access to reactive 
metal enolates, which can then be trapped by a suitable electrophile. The copper-
catalysed reductive aldol reaction involves hydrometalation of an α,β-unsaturated 
carbonyl compound, followed by an inter- or intramolecular aldol reaction. While 
there have been numerous examples of copper-catalysed reductive aldol reactions 
reported in the literature, the corresponding reductive Michael reaction has been 
relatively understudied. 
Herein, the copper-catalysed reductive Michael cyclisation of substrates containing 
two α,β-unsaturated carbonyl moieties is described. A range of structurally and 
electronically diverse substrates were prepared by various different methods. Both 
α,β-unsaturated ketones and esters underwent cyclisation, in the presence of a copper 
catalyst, a bisphosphine ligand, and a stoichiometric reductant, to afford 5- and 6- 
membered carbocyclic and heterocyclic products, with good-to-excellent levels of 
diastereo- and enantiocontrol. Furthermore, the diastereochemical outcome of these 
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Copper-Mediated Conjugate Reduction 1 
1 Copper-Mediated Conjugate Reduction 
1.1 Introduction 
The addition of a metal hydride across an unsaturated bond is commonly referred to 
as hydrometalation. Although many metals have been used to accomplish this 
transformation, the use of copper complexes to effect the reduction of activated 
alkenes is a comparatively recent development.1 In the past decade, copper hydride 
chemistry has emerged as a powerful tool for effecting reductions of various α,β-
unsaturated compounds, ranging from α,β-unsaturated ketones, esters, and 
aldehydes, to other Michael acceptors, such as α,β-unsaturated nitroalkenes, 
sulfones, and nitriles.2 Moreover, the development of new biaryl and ferrocenyl 
chiral ligands has led to asymmetric variants of such reactions, providing easy access 
to synthetically useful chiral building blocks.  
 
Hydrometalation of α,β-unsaturated carbonyl compounds is known to proceed via 
metal enolates, and the inter- or intramolecular trapping of these intermediates by 
electrophiles can result in highly stereoselective carbon−carbon bond-forming 
reactions.3 Thus, domino modifications have also been achieved, including reductive 
aldol, Michael and Henry reactions, among others, providing rapid increases in 
molecular complexity with often extremely high stereocontrol. 
 
Herein, the conjugate reduction of a range of electron−deficient alkenes will be 
discussed, including the development of highly enantioselective modifications. 
Domino processes will also be introduced, providing insight into the broad range of 
complex transformations achievable through copper hydride chemistry. 
 
1.2 Stryker’s Reagent 
The phosphine−stabilised hexameric copper hydride species, [CuH(PPh3)]6 was 
discovered by Osborn and co-workers in 1972.4 However, it was not until 1988, 
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when Stryker discovered that [CuH(PPh3)]6, now commonly referred to as Stryker’s 
reagent, could be used to effect the conjugate reduction of various α,β-unsaturated 
carbonyl compounds, that modern usage of copper hydride in synthesis began to 
develop.5 In this seminal publication, Stryker described the stereoselective conjugate 
reduction of a range of α,β-unsaturated carbonyl compounds, including ketones, 





Reduction of β,β'-disubstituted enone 1 was found to be highly stereoselective, 
affording saturated cyclohexanone cis-2 as the major product, resulting from hydride 
delivery to the least hindered face of the substrate. Importantly, 1,2-reduction was 
not observed, nor was the reduction of isolated double bonds. Furthermore, the 
reaction was found to be stable to water under an inert atmosphere and tolerant of a 
range of functionalities, including unprotected hydroxyl groups. Shortly after his 
initial publication, Stryker described a simple, one-pot procedure for the synthesis of 
[CuH(PPh3)]6, and the reagent quickly became commercially available.6 
 
Stryker recognised the potential for the reaction to be made catalytic and 
subsequently described a method for the reduction of α,β-unsaturated ketones in the 
presence of a substoichiometric amount of [CuH(PPh3)]6 under a hydrogen 




















The reaction is thought to proceed via copper enolate 4 (Scheme 1.3). This enolate 
must be capable of activating hydrogen gas heterolytically, to effect both protonation 
of the enolate, and regeneration of the catalyst. Although this intermediate has not 
been isolated, there is considerable evidence supporting its formation, including 
NMR signals indicative of a copper-oxygen-bonded enolate, which can be detected 





Unfortunately, Stryker’s catalytic variant required the undesirable use of high 
pressures of hydrogen gas and suffered from slow catalytic turnover, leaving room 
for improvement. 
 
In 1990, Stryker and co-workers reported the conjugate reduction of a range of α,β-




[CuH(PPh3)]6 (2.7 mol %)
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variety of different functional groups, including γ-sulfur, and oxygen-containing 





Thiophenoxy-substituted enone 6 was found to undergo reduction in the presence of 
a stoichiometric amount of Stryker’s reagent to afford saturated ketone 7 in excellent 
yield. Substrate 8, which is substituted at the γ-position with an acetate group, was 
also found to undergo reduction, without loss of acetate. The authors also note that a 
decrease in reaction rate is observed upon addition of excess PPh3 or when the 
reaction is performed in a coordinating solvent, such as THF, suggesting 
coordination of the copper(I) to the substrate prior to conjugate reduction. 
 
1.3 Copper-Catalysed Hydrosilylation 
Despite the initial success of Stryker’s reagent, a reliable catalytic variant was still 
sought. Furthermore, a more convenient reagent would also be beneficial, since 
Stryker’s reagent is moderately air sensitive. In 1984, Burnner and Miehling reported 
the copper-catalysed reduction of acetophenone using diphenylsilane as the 





























[CuH(PPh3)]6 (0.24 equiv., 1.4 hydride equiv.)
 




However, it was not until 1997 that Hosomi and co-workers established that hydride 
transfer from a silane to a copper(I) salt was possible in a polar, aprotic solvent, such 





Addition of dimethylphenylsilane to a suspension of copper(I) chloride resulted in 
complete consumption of the silane, along with formation of dimethylphenyl 
chlorosilane, a result indicative of transmetalation of the hydrosilane to copper(I) to 
generate a copper hydride species. Preliminary investigations revealed that solvent 
plays an important role in this reaction, and the use of less polar solvents such as 
THF or CH2Cl2, resulted in no reaction. 
 
Conjugate reduction of a range of α,β-unsaturated carbonyl compounds was then 
carried out (Scheme 1.7). In agreement with Stryker’s work,5 the reduction of enone 
1 was highly stereoselective, and proceeded to give mainly cis-2. However, 
replacement of the δ-proton by a methyl group, as in enone 12, resulted in a 
significant decrease in the yield. The reaction was found to be tolerant of isolated 
olefinic double bonds, exemplified by the conjugate reduction of substrate 16, which 
proceeded to give cyclohexanone 17 in 83% yield. The authors also investigated the 

















(!)-L18 (0.3 mol %)
PhMe2SiH + CuCl PhMe2SiCl + "Cu!H"
DMI, rt
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CuCl were used, 86% of ester 15 was obtained, however, decreasing the amount to 
0.1 equivalents resulted in no reaction. Nevertheless, this result proves that it is 





Around the same time, Mori and co-workers published an analogous procedure for 
the 1,4-reduction of α,β-unsaturated ketones (Scheme 1.8).11 Using stoichiometric 
CuF(PPh3)3·2EtOH in combination with dimethylphenylsilane, the reaction was 
found to be highly selective for 1,4-addition. However, if diphenylsilane was used as 
the reductant, a significant amount of allylic alcohol 20, arising from 1,2-addition, 
was also observed. It was also noted that increased steric bulk at either the α-, or 
β-position inhibited reduction; for example, β,β-disubstituted enone 21 did not 
undergo reduction. 
 
R = H, 1
R = Me, 12











































Shortly after the pioneering work of Hosomi10 and Mori,11 Lipshutz successfully 
developed the first method for conjugate reduction of α,β-unsaturated carbonyl 
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Lipshutz and co-workers reported that catalyst loadings as low as 0.5 mol % were 
tolerated, resulting in yields of up to 99%. Of particular interest, is the reduction of 
β-ionone 24, which proceeds regioselectively to afford only the product arising from 
1,4-reduction, with no concomitant 1,6-reduction. Inexplicably, α-ionone 26 did not 
undergo reduction. It is also noteworthy that no competing 1,2-reduction was 
observed, even in the case of enal 27, which underwent reduction to give aldehyde 
28 in 80% yield.  
 
Lipshutz’s work was quickly superceded by the first asymmetric copper-catalysed 
conjugate reduction, published by Buchwald in 1999.13 Following this seminal 
publication, a plethora of reports emerged, describing 1,4-reduction of various types 
of α,β-unsaturated carbonyl compounds and other Michael acceptors. Due to the 
abundance of literature on copper-catalysed conjugate reductions, the remainder of 
this section will concentrate specifically on asymmetric conjugate reductions of 
various Michael acceptors. 
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1.4 Copper-Catalysed Asymmetric 1,4-Reduction Reactions 
1.4.1 Introduction 
Asymmetric conjugate reduction of α,β-unsaturated carbonyl compounds and similar 
Michael acceptors allows control of absolute stereochemistry at a site β to an 
electrophilic centre. Although there are numerous methods for asymmetric conjugate 
addition of nucleophiles to various Michael acceptors,14 the area of asymmetric 
conjugate reduction remains relatively understudied, and would provide a 





1.4.2 Copper-Catalysed Asymmetric 1,4-Reductions of α,β-
Unsaturated Esters, Ketones and Aldehydes 
In 1999, Buchwald and co-workers began to investigate the use of copper hydride, 
along with chiral bisphosphine ligands to effect the asymmetric conjugate reduction 
of α,β-unsaturated esters.13 An efficient catalyst was generated in situ from a 
combination of CuCl, NaOtBu and (S)-p-tol-Binap, followed by addition of four 
equivalents of polymethylhydrosiloxane (PMHS), and was subsequently used in the 





















The reduced products were obtained in high yields and good enantioselectivities. 
Buchwald also noted that when the conjugate reductions of (E)- and (Z)-isomers of 
the same substrate were examined, they reacted to give products of comparable 
enantiomeric excess, but opposite enantiomers were obtained.  
 
The proposed catalytic cycle involves the formation of (p-tol-Binap)CuOtBu from 
CuCl, NaOtBu, and p-tol-Binap (Scheme 1.12). Upon addition of PMHS, (p-tol-
Binap)CuOtBu then undergoes σ-bond metathesis to give (p-tol-Binap)CuH. 
Conjugate reduction then occurs, to give a copper enolate intermediate 35, which 
then undergoes σ-bond metathesis, giving rise to silyl ketene acetal 36 along with 
regeneration of the copper catalyst. Cleavage of the silyl group provides saturated 











CuCl (5 mol %), NaOtBu (5 mol %) 



























98% yield, 91% ee
98% yield, 83% ee
90% yield, 85% ee
89% yield, 92% ee
P(p-C6H4CH3)2
P(p-C6H4CH3)2
(S)-p-tol-Binap (L1) (10 mol %)
 




Shortly afterwards, Buchwald and co-workers reported the use of the same catalyst 
system to effect the reduction of β-substituted cyclic enones (Scheme 1.13).15 In this 
case, however, the authors noted that it was important to limit the amount of PMHS 
to one equivalent, to avoid over reduction to the saturated alcohol. Furthermore, 
reduction of the catalyst loading to 1 mol % was found to have no effect on the 

































Examination of the substrate scope revealed that the catalyst is tolerant of 
cyclopentenones substituted at the β-position with a simple alkyl chain, or substrates 
containing ether or ester functionalities. However, cyclopentenones with vinyl or 
alkynyl substitution at the β-position, gave mixtures of products resulting from both 
1,4- and 1,6-reduction.  
 
In a remarkable extension of this work, Buchwald and co-workers carried out 
dynamic kinetic resolution of 3,5-dialkyl cyclopentenones, allowing simultaneous 




CuCl (5 mol %), NaOtBu (5 mol %) 
PMHS (1.05 equiv.), toluene, rt, 24 h
O
R
R = nBu, 37a
R = CH2CH2CO2Me, 37b
R = (CH2)3OBn, 37c
38a, 84% yield, 98% ee
38b, 86% yield, 92% ee





CuCl (5 mol %), NaOtBu (5 mol %) 
PMHS (1.05 equiv.), toluene, rt, 48 h
40
82% yield, 87% ee
O
Ph
CuCl (5 mol %), NaOtBu (5 mol %) 
(S)-p-tol-Binap (L1) (5 mol %)




82% yield, 96% ee
PPh2
PPh2










(S)-p-tol-Binap (L1) (10 mol %)
 




By carrying out the conjugate reduction in the presence of a base, racemisation of the 
starting material was rapid (Scheme 1.15). As the more reactive enantiomer 43 
underwent reduction to give the silyl enol ether 49 − which is protected from 
epimerization − it was replenished by the less reactive enantiomer ent-43. Low 
temperatures were necessary in order to increase the selectivity; however, under such 
conditions, racemisation of the starting material was too slow, relative to conjugate 
reduction. To resolve this issue, tBuOH was added in order to increase the rate of 
racemisation by acting as a proton source. As a result, the cyclopentanone products 




CuCl (10 mol %), NaOtBu (1.7 equiv.), tBuOH (5  equiv.)















46a, 89% yield, dr 91:9, 91% ee






CuCl (10 mol %), (S)-p-tol-Binap (10 mol %) 
NaOtBu (2.4 equiv.), tBuOH (5  equiv.)
PMHS (3.1 equiv.), toluene, 48 h, -50 oC then TBAF
racemic-47 48







(S)-p-tol-Binap (L1) (10 mol %)
 




In 2005, Buchwald applied this methodology to the total synthesis of eupomatilone-
3, a target that became of great interest due to the cis-orientation of the substituents 
at C3 and C4 positions of the lactone ring.17 Hence, the key step in this synthesis was 
the dynamic kinetic resolution of unsaturated lactone 50, to give saturated lactone 51, 
which was subsequently converted into the natural product by stereoselective 
alkylation at C5 (Scheme 1.16). In this case, MeO-Biphep was used, as opposed to p-
tol-Binap, which was found to give slightly inferior results, and lactone 51 was 
isolated as a single diastereomer in 85% yield, and 93% ee. Enolisation of lactone 51 
with NaHMDS, followed by alkylation with methyl iodide provided eupomatilone-3 










































Following the success of their copper-catalysed asymmetric reduction of both α,β-
unsaturated esters13 and ketones,15 Buchwald and co-workers devised a convenient 
one-pot asymmetric reduction/alkylation protocol for the synthesis of 2,3-
disubstituted cyclopentanones (Scheme 1.17).18 Conjugate reduction, using 
Buchwald’s previously described conditions, afforded silyl enol ether 53a or 53b. 
Addition of an alkyl halide and TBAT (tetrabutylammonium 
triphenyldifluorosilicate), gave the α-alkylated species as the trans-diastereomer in 
all cases. In general, the alkylated products were obtained in moderate yields and 
good diastereoselectivites, although equilibration of the product in the presence of 










Me CuCl2·H2O (5 mol %), NaO
tBu (1.2 equiv.)






























85% yield, 93% ee
 




Buchwald extended this methodology to include palladium-catalysed α-arylations of 
cyclopentenones.19 Similarly, the first step involves asymmetric conjugate reduction 
of the enone, to form a silyl enol ether. Subsequent activation of the silyl enol ether 
by fluoride increases the nucleophilicity of the enolate, and palladium-catalysed 
arylation proceeds diastereoselectively to afford arylated products 61-65 in good 
yields. Interestingly, when screening ligands for the arylation reaction, the authors 
noted that (S)-p-tol-Binap inhibited the reaction, which they attributed to its higher 
binding affinity for palladium, relative to L19. Thus, in the one-pot reaction, it was 




CuCl (5 mol %), NaOtBu (5 mol %)










R = Me, 52a








































(S)-p-tol-Binap (L1) (5 mol %)
TBAT (1.2 equiv.), R!Br (2 equiv.) 
CH2Cl2, rt
 




In 2003, Buchwald and co-workers discovered that the rate of conjugate reduction 
reactions could be dramatically accelerated upon addition of alcohols (Table 1.1).20 
Furthermore, it was found that the addition of excess alcohol could also lead to an 
increase in the yield of the reaction. This was realised when poor yields were 







CuCl (1 mol %), NaOtBu (1 mol %)










n = 1, R = Me, 59a
n = 2, R = CH2CH2Ph, 59b
n = 2, R = Me, 59c





























(S)-p-tol-Binap (L1) (1 mol %)
Pd(OAc)2 (5 mol %), CsF (1.1 equiv.) 
Ar!Br (1.5 equiv.), THF, rt
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Upon closer examination of the reaction mechanism (Scheme 1.19), it was postulated 
that the poor mass balance was conceivably due to unwanted side reactions of either 
the silyl ketene acetal 69, or the copper enolate 68; addition of an alcohol would 
inhibit these side reactions by protonation of the copper enolate, providing saturated 






Following extensive investigation, Buchwald and co-workers concluded that in the 
absence of any alcohol, the rate-limiting step is silylation of copper enolate 68. In 
contrast, silylation of copper alkoxide 70 is much faster, owing to the rapid rate 
acceleration observed upon addition of alcohol. The authors attribute the slow σ-
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Shortly afterwards, Lipshutz published the first example of 1,4-reduction of acyclic 
α,β-unsaturated ketones, using CuCl and NaOtBu as the precatalyst, and PMHS as 
the stoichiometric reductant.21 After screening various ligands, it was found that 
Josiphos ligand L30, and Walphos ligand L23 (Scheme 1.20) gave superior results. 
A range of enones underwent conjugate reduction, including sterically hindered tert-





The authors noted that steric factors do not appear to play a major role in determining 
enantioselectivity, exemplified by the reaction of tert-butyl substrate 75, which 
underwent reduction to afford ketone 76 in excellent yield and enantiomeric excess. 
In contrast, however, a slight decrease in enantioselection was observed upon 
changing the R substituent from alkyl (74), to benzyl (72b), to aryl (72a), suggesting 
that stereoelectronics might be of some importance. An alternative explanation is that 
arene-arene interactions or arene-copper interactions are taking place, resulting in 










CuCl (2 mol %), NaOtBu (2 mol %) 
PMHS, toluene, -78 oC
R = Ph, 71a
R = CH2Ph, 71b
72a, 96% yield, 87% ee (R)






















CuCl (2 mol %), NaOtBu (2 mo l%) 
PMHS, toluene, -78 oC
76








(R,S)-L30 (1 mol %)
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undergo reduction under the same reaction conditions to give the opposite 
enantiomer to that of the corresponding alkyl ketones. 
 
In 2004, the Lipshutz group furthered this research by carrying out the conjugate 
reduction of cyclic α,β-unsaturated enones in the presence of DTBM-Segphos, using 
extremely low catalyst loadings.22 Of particular note is the example given below 
(Scheme 1.21), which was conducted using 65 g of 12, and only 2 mg of ligand, 
equivalent to a substrate-to-ligand rato of 275,000:1. The product was isolated in 
good yield and extremely high enantioselectivity, illustrating the effectiveness of this 
particular catalyst system. Interestingly, the authors also noted that increasing the 





Later that year, Lipshutz and co-workers reported the highly enantioselective 
reduction of α,β-unsaturated esters, using a substoichiometric amount of Stryker’s 
reagent, and either Segphos, or Josiphos ligands.23 Building on the initial work by 
Buchwald,13,20 Lipshutz was able to carry out the highly enantioselective reduction of 
challenging substrate 77, in which the substituents on the β-carbon are Me, and nBu, 
illustrating the remarkably high degrees of facial selectivity obtained using this 





CuCl (1 mol %), NaOtBu (1 mol %)





























Encouraged by these results, the authors also examined the impact of an existing 
stereocentre at the γ-carbon, postulating that energetically dissimilar conformations 
of the substrate might lead to a “matched/mismatched” situation, in which amplified 
diastereoselectivity is obtained using one enantiomer of the ligand (matched), and 
reduced diastereoselectivity is obtained using the opposite enantiomer (mismatched) 
(Scheme 1.23). In the event, this was found to be the case, and enoate 79 was 
reduced to saturated product 80 with 99:1 dr in the presence of (R,S)-L32, by attack 
on 79 from the si-face. In contrast, a significantly lower 2:1 dr was obtained when 









[CuH(PPh3)]6 (0.5 mol %)


























[CuH(PPh3)]6 (0.5 mol %), PMHS (2 equiv.)
tBuOH (1.1 equiv.), toluene, 0 oC
80a














[CuH(PPh3)]6 (0.5 mol %), PMHS (2 equiv.)
tBuOH (1.1 equiv.), toluene, 0 oC
80b













(S,R)-L31 (0.2 mol %)
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Up to this point, all examples of conjugate reduction have been limited to α,β-
unsaturated carbonyl compounds substituted at the β-position with either carbon or 
hydrogen. However, there have been no examples of the conjugate reduction of 
substrates containing β-heteroatoms. One possible explanation for this is the 
interaction between the lone pair of electrons on the heteroatom and the π-system of 
the α,β-unsaturated carbonyl component. In 2004, Buchwald addressed this issue by 
carrying out the asymmetric conjugate reduction of a range of β-azoheterocyclic acid 
derivatives, which were chosen specifically to minimise such interactions.24 Both N-
vinyl pyrroles and indoles were effectively reduced, as well as both β- and δ-lactam 





The authors noted that exposure of the reaction mixture to air increased the rate, 
relative to reactions carried out in an inert atmosphere. As a consequence, however, 





Cu(OAc)2·H2O, PMHS (10 equiv.)





R = Ph, n = 0, 81a
R = Me, n = 1, 81b
82a, 96% yield, 99% ee (5 mol % Cu/ligand)
82b, 90% yield, 82% ee (10 mol % Cu/ligand)
CO2Et
R N
Cu(OAc)2.H2O (5 mol %)
(S)-Binap (5 mol %)




R = Ph, R' = H, 83a
R = Me, R' = Me, 83b
84a, 87% yield, 86% ee







Cu(OAc)2·H2O (10 mol %)
(S)-Binap (10 mol %)
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moisture in the atmosphere. It was also noted that substrates containing a lactam at 
the β-position typically required longer reaction times than those containing a β-
indole or pyrrole substituent. The proposed explanation is that the carbonyl group of 
the lactam moiety coordinates to the catalyst in a non-productive way, inhibiting the 
reaction somewhat.  
 
Nevertheless, Buchwald and co-workers have developed a robust method for the 
highly enantioselective conjugate reduction of a range α,β-unsaturated esters 
containing β-heteroatoms, providing access to biologically interesting β-amino acids, 
and their derivatives. In 2005, Movassaghi and Ondrus utilised this methodology in 
the total synthesis of various tricyclic myrmicarin alkaloids.25 One of the key 
transformations in this synthesis is the copper-catalysed enantioselective conjugate 
reduction of β-pyrroyl ester 87 (Scheme 1.25). In the presence of (S)-Binap and 
copper acetate, using PMHS as the stoichiometric reductant, the reaction proceeded 
efficiently to give β-amino ester 88 in 89% yield and 85% ee. Intermediate 88 was 



















Cu(OAc)2·H2O (20 mol %)
PMHS (6.5 equiv.)
























(S)-Binap (L3) (20 mol %)
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A minor drawback of the methods for asymmetric conjugate reduction discussed so 
far is that the catalyst systems must be generated in situ. Lipshutz addressed this 
issue by preparing a stable “copper hydride in a bottle” for use in asymmetric 
conjugate reductions.26 The catalyst is synthesised from Cu(OAc)2·H2O, NaOtBu, 
and (R)-DTBM-Segphos, in the presence of PMHS, and while one might expect 
copper hydrides to be unstable, it can be stored under an inert atmosphere and kept 





Shortly after this discovery, Lipshutz reported the conjugate reduction of a range of 
β-silyl-α,β-unsaturated esters, furnishing enantioenriched organosilanes, which are 
useful intermediates in organic synthesis.27 Despite recent success with their 
CuH(DTBM-Segphos) system, Lipshutz and co-workers found that this catalytic 
system was not particularly discriminating in this case, and far superior results were 










t0 = 86% yield, 98% ee







































The authors found that carrying the reactions out at low temperatures provided 
products with higher enantioselectivites. Unfortunately, the use of such low 
temperatures resulted in a considerable decrease in reaction rate, and tBuOH was 
required to drive the reactions to completion within a reasonable time period. 
However, in the case of electron-rich substrate 96, higher temperatures were 
required, resulting in slightly inferior enantioselectivity. Both E and Z-enoates were 
found to undergo reduction to furnish products with similar enantioselectivites, but 
with opposite configurations. Furthermore, the availability of enantiomeric (S,R)-L31 
provides access to either stereochemistry of the resulting chiral silanes.  
 
More recently, Zheng reported the enantioselective synthesis of a range of β-aryl-
substituted γ-amino acid derivatives by copper-catalysed conjugate reduction of γ-
phthalimido-substituted α,β-unsaturated esters (Scheme 1.28).28 Following brief 
optimisation, Cu(OAc)2·H2O, (S)-Binap and PMHS emerged as the best reactions 
conditions and the authors noted that the use of other silanes, such as TMDS 
PhMe2Si
CO2Et
R CuCl (1 mol %), NaO
tBu (1 mol %)
PMHS, tBuOH (1.1 equiv.), toluene, -30 oC PhMe2Si
CO2Et
R
R = Me, 94a
R = Ph, 94b
95a, 96% yield, 95% ee (S)
95b, 89% yield, 91% ee (R)
PhMe2Si
Me CuCl (1 mol %), NaO
tBu (1 mol %)
PMHS, tBuOH (1.1 equiv.), toluene, -78 oC PhMe2Si
CO2Et
Me
ent-95a, 98% yield, >95% ee (R)
95a, 85% yield, >95% ee (S)
CO2Et
using (R,S)-L32 (1 mol %)






















(R,S)-L32 (1 mol %)
CuCl (1 mol %), NaOtBu (1 mol %)
PMHS, (R,S)-L32 (1 mol %)





(S,R)-L31 (1 mol %)
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(1,1,3,3-tetramethyldisiloxane), diphenylsilane or phenylsilane had a profoundly 





It is also evident that the electronic properties of the substituent on the phenyl ring 
had a negligible effect on the enantioselectivity, and enantiomeric excess ranged 
from 91-96% in all cases. Furthermore, due to the high crystallinity of the 
phthalimido group, the enantiomeric excess could be increased further by 
recrystallisation.  
 
The authors applied this method to the synthesis of (R)-Baclofen, a chiral 
pharmaceutical reagent primarily used to treat disorders of the central nervous 
system (Scheme 1.29). (R)-Balcofen was obtained from para-chlorophenyl 







Cu(OAc)2·H2O (5 mol %), PMHS (4 equiv.)







Ar = 4-MeO-C6H4, 98a
Ar = 4-F3C-C6H4, 98b
Ar = 2-thiophenyl, 98c
Ar = 2-naphthyl, 98d
99a, 77% yield, 95% ee
99b, 94% yield, 94% ee
99c, 92% yield, 91% ee
99c, 88% yield, 95% ee
PPh2
PPh2
(S)-Binap (L3) (5 mol %)
 




1.4.3 Copper-Catalysed Asymmetric 1,4-Reductions of α,β-
Unsaturated Nitroalkenes 
Although nitro compounds have historically found great use in the dye industry, in 
recent years they have been employed as reactive intermediates in organic synthesis, 
becoming increasingly important in the synthesis of complex natural products.29 
Despite their synthetic utility and facile transformation into a variety of diverse 
functionalities, there are very few methods for the preparation of optically active 
nitroalkanes. 
 
While numerous methods exist for the asymmetric conjugate addition of various 
nucleophiles to α,β-unsaturated nitroalkenes,30 the corresponding conjugate 
reduction reaction remained unreported until 2003, when Carreira and co-workers 
successfully reported the asymmetric reduction of β,β'-disubstituted nitroalkenes.31 A 
range of substrates underwent reduction, including 105, which has an unprotected 















Cu(OAc)2·H2O (5 mol %)
PMHS (4 equiv.), tBuOH (4 equiv.)






(R)-102, 94% yield, 94% ee





(S)-Binap (L3) (5 mol %)
100
 




Interestingly, the authors noted that if the catalyst was prepared from CuCl and 
NaOtBu, the rate of reaction was significantly lower than if CuOtBu was employed 
directly. Subsequent investigations led to the conclusion that the presence of NaCl or 
any other inorganic salts resulted in diminished reaction rates. Inexplicably, further 
rate acceleration was observed using a substoichiometric amount of PMHS, along 
with a stoichiometric amount of phenylsilane as the reductant. However, under these 
conditions the nitro group was susceptible to over-reduction, and water was required 
to prevent formation of the oxime. 
 
Although this proved a reliable method for the reduction of a range of substituted 
nitroalkenes, CuOtBu is highly air- and moisture-sensitive and Carreira and co-
workers sought to find a more practical catalyst system. In 2004, they reported a 
more convenient method using CuF2 as the precatalyst in the reduction of β,β’-





CuOtBu (1 mol %), PMHS (0.1 equiv.)
 PhSiH3 (1.2 equiv.), toluene




R = OMe, 103a
R = Cl, 103b
104a, 94% yield, 90% ee








NO2 CuOtBu (1 mol %), (S,R)-L31 (1.1 mol %)
PMHS (0.1 equiv.), PhSiH3 (1.2 equiv.)
toluene, H2O (1.2 equiv.), rt, 12 h
Me
NO2
X = O, 107a
X = S, 107b
108a, 72% yield, 90% ee
108b, 75% yield, 84% ee
105 106, 66% yield, 90% ee
X X
CuOtBu (0.3 mol %), (S,R)-L31 (0.33 mol %)
PMHS (0.1 equiv.), PhSiH3 (1.2 equiv.)








(S,R)-L31 (1.1 mol %)
 




Contrary to their previous theory regarding the suppression of the catalyst by halides, 
Carreira and co-workers found that the reaction was tolerant of CuF2, and proposed 
that the CuF2 is sequestered from the reaction mixture by formation of strong Si−F 
bonds. In spite of this theory, additional phenylsilane was required, and added 
batchwise in order to ensure complete conversion. 
 
It is also noteworthy that under these conditions, electron-rich substrates such as p-
methoxyphenyl, or furanyl substrates 103a and 107a, failed to undergo reduction. It 
was previously hypothesised that the silane is responsible for the generation of the 
catalytic Cu(I) species from the Cu(II) precatalyst; however, in this case the authors 
considered the possibility that the nitroalkene could effect this transformation. This 
would involve tautomerisation of the nitro group to a nitronate, followed by 
oxidative dimerisation. Hence, in the case of more electron rich substrates this 
transformation would be less facile, owing to the decreased acidity of the 
nitroalkenes, and the active catalyst would not be generated. In the event, 10 mol % 
of nitromethane was required to catalyse the reaction (Scheme 1.32). 
R
NO2
CuF2·H2O (1 mol %)
PhSiH3 (1.5 equiv.), PMHS (0.1 equiv.)
toluene, H2O (1 equiv.), rt
R
NO2
R = Me, 109a
R = CH2OH, 109b
110a, 76% yield, 90% ee






























1.4.4 Copper-Catalysed Asymmetric 1,4-Reductions of α,β-
Unsaturated Nitriles 
α,β-Unsaturated nitriles are valuable and easily accessible building blocks in organic 
chemistry, and are common motifs in many natural products.33 However, due to their 
poor coordination to transition metals, the metal-catalysed asymmetric conjugate 
reduction of α,β-unsaturated nitriles poses some difficulties. Owing to their 
electronic structure, nitriles prefer end-on coordination to metal ions; thus, the 
linearity of the nitrile group does not provide the optimum environment for catalyst 
coordination, and many examples have required substrates bearing additional 





In 2005, Xu and co-workers reported the enantioselective conjugate reduction of 
α,β-unsaturated dinitriles, catalysed by Cu(OAc)2·H2O and (S)-Binap, using 
phenylsilane as the stoichiometric reductant (Scheme 1.33).35 In correlation with 
Carreira’s findings,31 the authors noted a significant decrease in yield when the 
Me
NO2
MeO CuF2 (1 mol %), (R,S)-L32 (1.1 mol %)












86% yield, 88% ee
ent-104a
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catalyst was prepared from CuCl and NaOtBu, and attributed this to the concomitant 





In general, yields and enantioselectivites were high, with the notable exception of 
β,β-dialkyl substituted malononitrile 113, which underwent reduction to give the 
product 114 in only 22% enantiomeric excess. It is probable that higher selectivities 
are only obtained when there is a greater steric difference between the two β-
substituents. The electronic properties of the aryl substituent were found to have a 
considerable affect on the enantiomeric excess, for example, product 118, which 
contains an electron-rich methoxynaphthyl group was obtained in 91% ee, whereas 








Cu(OAc)2·H2O (5 mol %)
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87% yield, 22% ee
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72% yield, 68% ee
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Following this initial publication, Yun and co-workers reported the highly 
enantioselective conjugate reduction of β,β’-disubstituted nitriles of type 119, where 
R is aromatic and R’ is aliphatic, catalysed by Cu(OAc)2·H2O and Josiphos ligand 





A range of α,β-unsaturated nitriles were found to undergo reduction, including those 
with electron-withdrawing, or electron-donating substituents on the aromatic ring, 
such as 120b an 120a, respectively. Bulky alkyl substituents, such as Et or iPr were 
also well tolerated, providing reduced products with up to 99% enantiomeric excess. 
 
Yun and co-workers also employed the same reaction conditions to effect the 




CN Cu(OAc)2·H2O (3 mol %), PMHS (4 equiv.)





















91% yield, 95% ee
120b
92% yield, 97% ee
120c
96% yield, 65% ee
120d
81% yield, 99% ee
120e
98% yield, 98% ee
119a-e 120a-e










It is noteworthy that the position of the nitrogen atom on the pyridyl ring has no 
affect on the enantioselectivity, exemplified by substrates 122a-c. This indicates that 
additional coordination between the pyridyl ring and the catalyst is not necessary to 
obtain high enantiomeric excess.  
 
Interestingly, in the case of substrates 123 and 125 (Scheme 1.36), which contain 
halogen substituents on the aromatic ring, the enantioselectivity was found to 
increase upon increasing the temperature from 0 oC to room temperature, displaying 
an unprecedented inverse temperature dependence. Upon increasing the temperature 
further to 40 oC, the enantioselectivity decreased to below 90%, in both cases, 




CN Cu(OAc)2·H2O (2 mol %), PMHS (4 equiv.)
 tBuOH (4 equiv.), toluene, rt Ar Ar'
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93% yield, 95% ee
122b
92% yield, 96% ee
122c
87% yield, 92% ee
122d
94% yield, 94% ee
122e

















In 2009, Yun applied this methodology to the total synthesis of (R)-tolterodine, a 





The authors found that protection of the hydroxyl group of 127 was not necessary, 




Cu(OAc)2·H2O (2 mol %)








Cu(OAc)2·H2O (2 mol %), (S,R)-L28 (2 mol %)







At 0 oC: 87% yield, 84% ee
At 22 oC: 95% yield, 91% ee
At 40 oC: 90% yield, 84% ee
126
124
At 0 oC: 91% yield, 79% ee
At 22 oC: 89% yield, 93% ee
At 40 oC: 92% yield, 89% ee
(1)
(2)
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86% yield, 96% ee
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The synthesis of (R)-tolterodine was completed by reduction of nitrile 128 to lactol 
129, followed by reductive amination with diisopropylamine. 
 
1.4.5 Copper-Catalysed Asymmetric 1,4-Reductions of α ,β-
Unsaturated Sulfones  
In recent years, the synthetic utility of the sulfone group in organic chemistry has 
increased dramatically. In particular, it has proved to be of great importance in the 
synthesis of biologically active compounds and natural product synthesis.39 
Subsequent manipulation of the sulfone functionality can be accomplished via 
numerous methods, including alkylation, oxidation, and Julia-Kocienski olefination, 
among others. 
 
Optically active sulfones are of particular importance; recent advances in the 
asymmetric conjugate reduction of β,β'-disubstituted vinyl sulfones have resulted in 
moderate success, although enantioselectivities are modest at best, leaving room for 
improvement. In 2007, Carretero and co-workers published the asymmetric reduction 
of a range of structurally diverse α,β-unsaturated vinyl 2-pyridylsulfones to alkyl 2-
pyridylsulfones in excellent yields and enantioselectivities (Scheme 1.38).40 
 
 




Previous investigations by the Carretero group into rhodium−catalysed conjugate 
addition of boronic acids to α,β-unsaturated 2-pyridylsulfones suggest that the 
mechanism involves coordination of the nitrogen atom to the metal catalyst. Thus, 
the 2-pyridyl group is thought to be essential to effect this transformation, and 
replacement by a phenyl group results in no reaction. Furthermore, in correlation 
with Buchwald’s previous findings,13 the E− and Z− isomers of the THP-protected 
substrate 130 led to opposite enantiomers of the reduced product 131. 
 
Carretero and co-workers illustrated the diverse range of chiral compounds 
accessible via optically active sulfones, by either functionalisation α− to the sulfonyl 
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91% yield, 91% ee
133
93% yield, 91% ee
135
93% yield, 90% ee
131
89% yield, 91% ee
PPh2
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Almost simultaneously, Descosiers and Charette reported the enantioselective 
conjugate reduction of vinyl phenyl sulfones, despite Carretero’s hypothesis that the 
2-pyridyl group is a vital component in this reaction.41 Using the hemilabile bidentate 
ligand Me-DuPhos monoxide (L14), and CuF2·H2O as the copper source, a range of 
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R = Me, Me-DuPhos(O), (R,R)-L14




CuF2·H2O (5 mol %)
(R,R)-L14 (5.5 mol %), PhSiH3 (1.5 equiv.)











85% yield, 98% ee
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90% yield, 99% ee
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with (R,R)-L14: 89% yield, 77% ee
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In general, excellent yields and enantioselectivities were obtained, with the notable 
exception of substrate 144, which resulted in only moderate enantioselectivity in the 
presence of Me-DuPhos(O). However, it was found that changing the ligand to the 
slightly bulkier Et-DuPhos(O) afforded alkyl sulfone 145 in 90% ee. 
 
1.4.6 Copper-Catalysed Asymmetric Reduction of Other 
Electron−Deficient Alkenes 
Thus far, the conjugate reduction of a wide range of electron−deficient alkenes, 
including α,β-unsaturated nitroalkenes, nitriles, sulfones, and carbonyl compounds, 
has been discussed. Although these examples represent the most common functional 
groups used to activate alkenes, our group recently discovered that nitrogen-
containing aromatic heterocycles also provide sufficient activation of an adjacent 
alkene towards reduction.42 A range of β,β’-disubstituted 2-alkenylheteroarenes 
underwent reduction in the presence of Cu(OAc)2·H2O and Josiphos ligand L29 to 








Cu(OAc)2·H2O (5 mol %)
PhSiH3 (1.5 equiv.), 
tBuOH (2 equiv.)





(R,S)-L29 (5 mol %)
R = CH2CH2OBn, 146a
R = CH2CH2OTBS, 146b
R = Ph, 146c
147a, 88% yield, 95% ee
147b, 67% yield, 94% ee
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The reaction proved tolerant of various different heterocycles, including 
benzoxazoles, such as 146a-c, benzothiazole 148, and pyridine 150. A range of 
functionalities were also tolerated at the β-position, including both aliphatic and 
aromatic groups, and various oxygen-containing groups. The reactivity of 3- and 4-
alkenylpyridines 161 and 163 was also examined (Scheme 1.42). Interestingly, 4-
alkenylpyridine 161 underwent reduction to afford 162 in 60% yield, and 94% ee 
after 4 days, suggesting that reduction is possible without the assistance of the 
directing effect from the nitrogen, although the reaction is significantly slower. In 
contrast, 3-alkenylpyridine 163 did not undergo reduction, suggesting that the alkene 






Copper hydride chemistry has advanced considerably during the past decade, and is 
currently considered to be a fundamental component of organic synthesis, providing 
a technique complementary to asymmetric conjugate addition reactions and 
hydrogenations. Typically, conjugate reduction reactions exhibit remarkable 
functional group diversity, and have proven tolerant to a range of different 
conditions, including even air and water. 
By employing commercially available, easy to handle copper sources, and readily 
available chiral ligands, the asymmetric conjugate reduction of a range of different 
α,β-unsaturated Michael acceptors has been achieved. Furthermore, recent advances 
in ligand development have resulted in remarkable levels of enantiocontrol, with 
Me
161 162





Cu(OAc)2·H2O (5 mol %)
PhSiH3 (1.5 equiv.), 
tBuOH (2 equiv.)
toluene, 0 oC to rt
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substrate-to-ligand ratios of up to 275,000:1 resulting in enantiomeric excesses of 
more than 98%. It is therefore not surprising that these reactions have found use in 
the synthesis of a variety of biologically active molecules, and pharmaceuticals. 
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1.5 Reductive Aldol Reactions and Related Modifications 
1.5.1 Introduction 
Thus far, most of the transformations described involve formation of a new C-H 
bond. As discussed previously, hydrometalation of α,β-unsaturated carbonyl 
compounds is known to proceed via metal enolates and inter- or intramolecular 
trapping of these intermediates by electrophiles can result in carbon-carbon bond-
forming reactions.3 Many research groups have exploited this by developing 
“domino” processes. Although the majority of this research has focussed on 
reductive aldol reactions, analogous reactions involving α,β-unsaturated nitroalkenes 
(reductive Henry reactions) and nitriles have also been reported, as well as reductive 





In order to place this work into context, it is important to define the term “domino”: 
“Domino reactions are described as processes of two or more 
bond-forming reactions under identical conditions, in which 
the subsequent transformation takes place at the 
functionalities obtained in the former transformation”.  
- Tietze, 1993.43 
 
Thus, to be considered a “domino” reaction, reduction and alkylation must occur 
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Although not regarded as a domino process, Lipshutz and co-workers devised a one-
pot conjugate reduction/Mukaiyama aldol reaction in which a range of enones 
underwent reduction in the presence of Stryker’s reagent, followed by 
transmetalation with a silane, to afford the corresponding silyl enol ether.44 
Subsequent addition of the desired aldehyde and Lewis acid triggered the 






The authors noted that addition of the aldehyde at the start of the reaction resulted in 
competitive reduction of the aldehyde by Stryker’s reagent, promoted by the Lewis 
acid. Furthermore, in all cases, two diastereomers were obtained, although 
diastereomeric ratios were not determined. In a subsequent communication, Lipshutz 
reported the use of diethylborane, in place of a silane, to effect a regio- and 
stereoselective reduction/aldol reaction via formation of a boron enolate (Scheme 
1.45).45 As anticipated, reduction of acyclic enones led to the regioselective 
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regioselective formation of (E)-enolates took place. When the aldehyde was 
introduced into the reaction mixture, aldol reaction occurred to afford the 





The first truly domino reductive alkylation process was reported by Stryker and co-
workers in 1990. In the presence of stoichiometric [CuH(PPh3)]6, it was discovered 
that enone 177 underwent reductive followed by intramolecular alkylation to give 
cis-decalone 178 in 29% yield, along with ketone 179 in 34% yield (Scheme 1.46).8 






Despite this initial discovery, subsequent reports of domino processes were not 
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of the intermediate copper enolate could be harnessed, giving rise to rapid increases 
in molecular complexity, in a single transformation.46 
 
1.5.2 Stoichiometric Reductive Aldol Reactions 
During the course of their studies towards the synthesis of pseudolaric acid A, Chiu 
and co-workers reported the intramolecular aldol reaction of enone 180, in the 
presence of stoichiometric [CuH(PPh3)]6 (Scheme 1.47).46 Although the reaction was 
carried out at -23 oC to increase the selectivity, two diastereomers were obtained, cis-
181 and trans-181, both arising from conjugate reduction, followed by aldol addition 
onto the tethered ketone moiety. However, only trans-181 possessed the trans-ring 





Chiu and co-workers investigated the scope of this reaction, and found that a range of 
α,β-unsaturated carbonyl compounds underwent reductive cyclisation, including 
α,β-unsaturated nitrile 188 (Scheme 1.48).47 Interestingly, both (enolendo)-exo-trig 
substrates (eq. 1) and (enolexo)-exo-trig substrates (eq. 2-4), could be used. In most 
cases, the cyclised products were isolated in good yields, with the notable exception 
of sterically hindered β,β'-disubstituted cyclic enone 184, which only provided β-
hydroxy ketone 185 in 19% yield, along with 69% recovered starting material. 
Futhermore, substrates bearing trans-double bonds, such as trans-enoate (E)-186 
underwent reaction much faster than their corresponding cis-isomeric counterparts; 
even after 18 h, a significant amount of (Z)-186 was recovered from the reaction 




























The reactions were carried out at low temperatures to avoid dehydration of the 
products, with loss of the two newly formed stereocentres. Furthermore, it was found 
that, in the case of substrate 190 (Scheme 1.49), increasing the temperature led to a 
decrease in selectivity, giving rise to stereoisomer trans-191, in greater quantities 
relative to cis-191. Thus, the product formed at low temperatures, bearing the cis-
ring junction, was deemed to be the kinetic product, and the product formed at higher 






toluene, -40 oC, 1 h
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41% yield from Z-186
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Shortly after their initial publication, Chiu and co-workers reported the synthesis of 
lucinone, an antispasmodic drug, in which the key transformation is a highly 
diastereoselective reductive aldol cyclisation.48 The cyclisation of enantiopure enone 
192 was carried out in the presence of Stryker’s reagent to give 193 in 99% yield, 





1.5.3 Catalytic Reductive Aldol Reactions 
During this time, the first reports of copper-catalysed conjugate reductions had begun 
to emerge, providing precedent for a catalytic reductive aldol reaction. This was first 
realised by Chiu and co-workers in 2004.49 Alkynones were found to undergo 
reductive aldol cyclisation in the presence of a substoichiometric amount of Stryker’s 
reagent and PMHS, giving rise to cis-fused β-hydroxyenones, in yields comparable 
to those obtained using stoichiometric Stryker’s reagent (Scheme 1.51). Although the 
reactions were highly diastereoselective, minor products were obtained in most 






























In 2005, our research group achieved the next major development in this field, 
reporting the first copper-catalysed asymmetric reductive aldol reaction (Scheme 
1.52).50 In the presence of substoichiometric Cu(OAc)2·H2O, a chiral bisphosphine 
ligand, and TMDS, a range of α,β-unsaturated esters were found to undergo 
intramolecular reductive aldol reaction with tethered ketones. The β-hydroxylactone 




































































catalytic using PMHS (2 equiv.)
200
stoichiometric
catalytic using PMHS (2 equiv.)
 




The reaction was found to be tolerant to aromatic, heteroaromatic, and aliphatic α,β-
unsaturated ester substituents. Although a range of chiral ligands were screened in 
this reaction, (R)-3,5-xyl-MeO-Biphep was found to give marginally superior results, 
providing β-hydroxy lactone 208 in 83% ee. The proposed catalytic cycle involves 
formation of a copper(I)-bisphosphine hydride complex 209, which then undergoes 
hydrometalation with the substrate 210 to give copper enolate 211 (Scheme 1.53). 
Addition of the copper enolate to the tethered ketone affords copper aldolate 212, 
which then undergoes σ-bond metathesis with the siloxane, liberating the silylated 










Cu(OAc)2·H2O (5 mol %)
























dppf (5 mol %)
PPh2
PPh2
Cu(OAc)2·H2O (5 mol %)





(R)-3,5-xyl-MeO-Biphep (L8) (5 mol %)
205 206
62% yield
n = 2, R = H, 203a
n = 2, R = Ph, 203b














In an extension of this work, our group used this methodology to synthesise a range 
of substituted piperidinones (Scheme 1.54).51 Using the conditions developed for the 
corresponding ester substrates, a range of α,β-unsaturated amide substrates 
underwent reductive aldol cyclisation to afford the corresponding 4-
hydroxypiperidin-2-one products in good yields and excellent syn-selectivities. 
Variation of the ketone substituent was well tolerated; however, the reaction was less 
tolerant of substitution at the α,β-unsaturated amide component, with acryloyl and 











































The effect of pre-existing stereocentres was also examined, exemplified by 
enantioenriched substrate 218, which underwent cyclisation to give the highly 
substituted piperidinone 219, containing four contiguous stereocentres with excellent 
levels of internal induction. The piperidinone products can easily be converted into 






In 2005, Shibasaki and Kanai reported the enantioselective intermolecular reductive 
aldol reaction of various α,β-unsaturated esters to ketones.52 Although the reaction 
was tolerant of a range of β-substituents on the α,β-unsaturated ester component, it 






R = Me, 214a







Cu(OAc)2·H2O (5 mol %)
TMDS (1 equiv.), THF, rt
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R = 4-MeC6H4, 216a
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enantioselectivities. Allenic esters could also be used, although the reaction was 
complicated by the formation of both α- and γ-aldol products, and thereafter by 






In a later communication, the authors resolved this issue by modifying the reaction 
conditions such that the α- vs. γ-selectivity could be tuned to produce the desired 
product − with high degrees of specificity − by the addition of extra phosphine 
ligand.53 The reaction of allenic ester 227 with a range of unsymmetrical ketones was 
carried out in the presence of Cu(OAc)2·H2O and (R)-DTBM-Segphos, using 
pinacolborane as the stoichiometric reductant (Scheme 1.57). The addition of PCy3 
was imperative in order to obtain high γ-cis-selectivities and high yields. Both 
aromatic and aliphatic ketones underwent reduction to afford γ-cis-products in 







1. CuF(PPh3)3·2EtOH (2.5 mol %)









R = Me, 224a
R = Et, 224b
R = Ph, 224c
225a, 93% yield, 71% ee
225b, 96% yield, 76% ee




1. CuF(PPh3)3·2EtOH (2.5 mol %)
    (R)-p-tol-Binap (5 mol %)
    




































Changing the copper source to CuF(PPh3)3·2EtOH, and the ligand to Taniaphos 
ligand L25 resulted in a switch in regioselectivity, to give exclusively α-adduct 
products. Once more, a range of ketones underwent reductive aldol reaction to afford 
β-hydroxy ester products in comparable yields to that of the γ-selective reaction, 
though enantioselectivities were somewhat lower. 
 
Around the same time as Shibasaki’s initial publication,52 Riant and co-workers 
reported the highly diastereo- and enantioselective copper-catalysed intermolecular 
reductive aldol reaction of methyl acrylate to a range of unsymmetrical ketones 
(Scheme 1.58).54 The reaction proved tolerant of a variety of aromatic and 
heteroaromatic ketones, providing β-hydroxy ester products in generally high yields 
and enantioselectivities, with moderate anti-selectivities. The authors noted that the 




Cu(OAc)2·H2O (2.5 mol %)
PCy3 (5 mol %)








R = Ph, 10a
R = iPr, 10b
R = homoallyl, 10c
230a, 96% yield, 99% ee




CuF(PPh3)3·2EtOH (2.5 mol %)




R = Ph, 10a
R = cinnamyl, 10d
R = 2-naphthyl, 10e
232a, 90% yield, 84% ee, dr 10:1
232d, 87% yield, 67% ee, dr 9:1


























230b, 80% yield, 98% ee
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diastereoselectivity and enantioselectivity, whereas the presence of an electron 





Following their initial publication, Riant and co-workers reported an analogous 
reaction, this time using aldehydes as the electrophilic component, allowing the 
formation of small propionate-type compounds (Scheme 1.59).55 This reaction 
provides a significant challenge, owing to the facile reduction of the aldehyde 
starting material; indeed, in most cases, ca. 5% alcohol was produced, alongside the 
desired β-hydroxy ester products. However, in the case of trifluoromethyl substituted 










CuF(PPh3)3·2MeOH (1 mol %)






Ar = Ph, 10a
Ar = 4-MeOC6H4, 10f
Ar = 4-CF3C6H4, 10g
233 234a, 98% yield, 95% ee, dr 92:8
234f, 31% yield, 90% ee, dr 92:8
























CuF(PPh3)3·2MeOH (1 mol %)






R = iPr, 237a
R = 4-MeOC6H4, 237b
R = 4-CF3C6H4, 237c
233 238a, 73% (26%) ee, dr 2:1
238b, 68% (72%) ee, dr 1:1
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Interestingly, while isopropylaldehyde 237a provided the product in 73% ee, no 
enantioselectivity was observed in the case of tert-butylaldehyde. Furthermore, the 
reaction was more efficient when aromatic or heteroaromatic, rather than aliphatic, 
aldehydes were employed. 
 
Both Buchwald56 and Yun57 have investigated the use of N-heterocyclic carbene 
copper complexes as catalysts in conjugate reduction reactions and in 2006, Riant 
and Nolan extended this methodology to include intermolecular reductive aldol 
reactions.58 Using 1 mol % of N-heterocyclic carbene copper(I) complex, 
IMesCuDBM, various α,β-unsaturated carbonyl compounds underwent reaction, to 
afford the corresponding silylated products (Scheme 1.60). The reaction was 
predominantly anti-selective and proved tolerant of a range of aldehydes, including 
aliphatic, aromatic and heteroaromatic aldehydes. α,β-Unsaturated nitriles also 

















R = Cy, 243a
R = tBu, 243b
R = Ph, 243c
233 244a, 70% yield, dr 2:1
244b, 80% yield, dr 2:1





















245 R = H, 248a
R = Me, 248b
249a, 73% yield, dr 7:1
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Thus far, all examples of asymmetric reductive aldol reactions have involved non-
asymmetric conjugate reduction to afford a chiral copper enolate, which then 
controls the stereochemistry in the subsequent aldol reaction. However, in 2008 
Lipshutz and co-workers reported the asymmetric intramolecular reductive aldol 
reaction of β,β’-disubstituted α,β-unsaturated ketones with pendant ketones (Scheme 
1.61).59 In this case, the reaction proceeds via asymmetric conjugate reduction, 
followed by asymmetric reductive aldol cyclisation, allowing the formation of three 
contiguous stereocentres. Both aromatic, and aliphatic enones underwent reduction to 
provide highly functionalised 5, and 6-membered rings with good-to-high 
enantioselectivity. The authors noted that both E- and Z-enones underwent reaction 
to give enantiomeric products, for example E-250b provided cyclised product 251b 





The cycloreduction of enone E-254 was carried out in the presence of heterogeneous 
Cu/C (Scheme 1.62), conditions previously used by Lipshutz to effect the 








(S,R)-L31 (5 mol %)
Cu(OAc)2·H2O (5 mol %)




















R1 = Ph, R2 = Me, 250a
R1 = Me, R2 = Ph, E-250b
251a, 98% yield, 85% ee
251b, 77% yield, 97% ee
ent-251b
75% yield, 97% ee
252 253
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was obtained in 84% yield, with 98% ee. In addition, the cycloreduction of Z-254 
was found to proceed smoothly using Cu(OAc)2·H2O in water and non-ionic 
surfactant PTS, despite the inherent insolubility of Z-254 in water (Scheme 1.62). In 
both cases, yields and enantioselectivities obtained were comparable to those 





Recently, Riant and co-workers reported the highly diastereo- and enantioselective 
construction of polycyclic compounds by reductive aldol cyclisations.61 Using 
CuF(PPh3)3·2MeOH and Taniaphos ligand L22, a range of α,β-unsaturated esters 
tethered to cyclic ketones underwent reductive aldol cyclisation to afford bicyclic 
derivatives 257a-d (Scheme 1.63). Predominantly cis-fused ring junctions were 
formed, and the authors noted that, in general, 6-membered rings were produced with 
















(S,R)-31 (1 mol %)
Cu(OAc)2·H2O (5 mol %)







84% yield, 98% ee
ent-255


















PTS (n = ca. 13)










The authors extended this strategy to the synthesis of tricyclic compound 261 by 
cross metathesis of allyl-substituted derivative 259 with tert-butyl acrylate in the 
presence of Hoveyda’s catalyst to give tert-butyl ester 260 (Scheme 1.64). A second 
reductive aldol cyclisation afforded tricyclic product 261, containing five contiguous 




CuF(PPh3)3·2MeOH (1 mol %)









































97% (72%) ee, dr 8:1
257c
85% yield
66% ee, dr >19:1
257d
85% yield





(R,R)-L22 (1 mol %)
Ar = 3,5-Me,4-MeOC6H2
CuF(PPh3)3·2MeOH (1 mol %)
















Hoveyda's Catalyst (2 mol %)
tert-butyl acrylate (10 equiv.)
CH2Cl2, 40 
oC
CuF(PPh3)3·2MeOH (2 mol %)
(R,R)-L22 (2 mol %)

















(R,R)-L22 (1 mol %)
Ar = 3,5-Me,4-MeOC6H2
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1.5.4 Reductive Henry Reactions 
Despite numerous examples of reductive aldol reactions in the literature, the 
corresponding reductive Henry reaction, involving conjugate reduction of an α,β-
unsaturated nitroalkene, followed by reaction with a ketone or aldehyde, has been 
relatively understudied. In 2005, Chiu reported the first example of a copper-
catalysed reductive Henry reaction.62 In parallel with traditional base-induced Henry 
reactions, which are typically less selective than aldol reactions, the intramolecular 
reductive Henry reactions of nitroalkenes, such as 262 (Scheme 1.65) were found to 
be less diastereoselective than previously reported reductive aldol reactions.47 The 
authors attribute this low selectivity to the reversibility of the reaction, which gives 
rise to reduced diastereomer ratios after prolonged reaction time, and the acidity of 
the α-proton, which gives rise to mixtures of epimers. They also noted that, Stryker’s 
reagent, while thought to be relatively non-basic, was able to induce the Henry 
reaction of saturated precursor 268 at room temperature to afford cis-269 and trans-
269 in a 1:1 ratio. 
 
 




1.5.5 Reductive Mannich Reactions 
In 2008, Shibasaki and co-workers reported a highly diastereo- and enantioselective 
copper-catalysed reductive Mannich reaction between unactivated ketimines and 
α,β-unsaturated esters.63 This reaction overcomes the inherent low reactivity of 
ketimines, relative to aldehydes or ketones, and provides access to synthetically 
useful chiral β,β’-disubstituted amino acids. Initially, the authors investigated the use 
of pinacolborane as the stoichiometric reductant, in combination with CuOAc and 
PPh3. A range of ketimines underwent reaction with ethyl acrylate to provide 
products 270a-c in good yield, and diastereoselectivity (Scheme 1.66). Interestingly, 
when fumarate 273 was used as the pro-nucleophile, the highly substituted γ-lactam 
































2:1 mixture of epimers
267
74% yield


























Unfortunately, all attempts to render the reaction enantioselective using 
pinacolborane proved unsuccessful. However, when (EtO)3SiH was used as the 
reductant, along with CuOAc and (R)-difluorophos (L17), the corresponding chiral 













CuOAc (5 mol %)










R = (CH2)4CH3, 270a
R = Ph, 270b
R = 3-thienyl, 270c
271 272a, 77% yield, dr 2:1
272b, 89% yield, dr 18:1



































CuOAc (10 mol %)
(EtO)3SiH (2.8 equiv.)
THF, -30 to -50 oC
R = 1-cyclohexenyl, 270e
































274e, 47% yield, dr 30:1, 93% ee












(R)-L17 (10 mol %)
as above
R = 2-naphthyl, 270f
R = 4-ClC6H4, 270d
R = 1-cyclohexenyl, 270e
271
272d, 90% yield, dr 6:1, 91% ee
272f, 88% yield, dr 3:1, 86% ee
272e, 90% yield, dr 9:1, 91% ee
(2)
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1.5.6 Conclusion 
Conjugate reduction of α,β-unsaturated carbonyl compounds allows regioselective 
enolate formation in compounds bearing multiple carbonyl groups, which is 
generally difficult to achieve using traditional base-induced aldol reaction conditions. 
Subsequent electrophilic trapping of these enolates results in the highly 
diastereoselective, and in some cases, enantioselective, synthesis of complex 
molecules. Furthermore, the use of prochiral electrophiles leads to the formation of 
multiple contiguous stereocentres, with extremely high levels of stereocontrol. 
Moreover, in contrast to asymmetric conjugate reduction reactions, most of the 
reported tandem modifications do not install a stereogenic centre at the reduction 
stage, but in the subsequent bond-forming step, providing further evidence for the 
formation of a chiral copper enolate, rather than a silyl enol ether. 
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1.6 Conclusion 
Modern usage of copper hydride chemistry in organic synthesis is often attributed to 
the popularisation of [CuH(PPh3)]6 by Stryker 1988.5 Despite these early advances, 
the full potential of this chemistry was not realised until the discovery that mildly 
hydridic silanes could be used as stoichiometric reductants to effect the copper-
catalysed conjugate reduction of α,β-unsaturated carbonyl compounds.10,11 Since 
then, this process has proved to be an effective method for the conjugate reduction of 
a range of Michael acceptors, including α,β-unsaturated sulfones, nitriles and 
nitroalkenes. 
Furthermore, considerable effort has been devoted to the development of efficient 
stereoselective methods; the introduction of new chiral ligands, including ferrocenyl 
ligands, and axially chiral Segphos and Biphep ligands, has led to asymmetric 
conjugate reduction reactions exhibiting remarkably high levels of enantiocontrol. 
Over the past 10 years, copper hydride chemistry has emerged as a powerful carbon-
carbon bond forming process; conjugate reduction, followed by trapping with an 
electrophile has proved to be an extremely reliable method for the construction of 
multiple stereogenic centres. Both inter- and intramolecular reductive aldol reactions 
have been reported, in addition to the analogous reductive Henry reaction, and the 
reductive Mannich reaction. 
In the constantly evolving field of organic synthesis, copper hydride chemistry has 
proved to be a valuable and broadly applicable C-H bond forming process, providing 
access to structurally diverse chiral building blocks for potential use in the synthesis 
of biologically active natural products. 
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2 Enantioselective Copper-Catalysed Reductive Michael 
Cyclisations 
2.1 Introduction 
Despite numerous examples of catalytic reductive aldol reactions in the literature, the 
analogous reductive Michael reaction has been comparatively understudied. Indeed, 
only five examples of reductive Michael reactions have been reported in the 
literature. Furthermore, prior to the publication of the work described within this 
chapter, the only example of an asymmetric reductive Michael reaction employed a 
chiral secondary amine as the catalyst. 
 
As with reductive aldol reactions, metal-catalysed reductive Michael reactions 
involve conjugate reduction of an α,β-unsaturated carbonyl moiety to give a metal 
enolate (Scheme 2.1). This enolate then undergoes reaction with a second α,β-





In order to be considered efficient, reductive Michael reactions must be both chemo- 
and diastereoselective. In the case of intermolecular reductive Michael reactions, if 
each α,β-unsaturated carbonyl compound is different (R ≠ R2 and/or R1 ≠ R3), 
reactions can be complicated by problems with chemoselectivity, giving rise to 
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2.1.1 Metal-Mediated Reductive Michael Reactions 
Krische reported the first reductive Michael reaction in 2001 (Scheme 2.2).64 In the 
presence of a substoichiometric amount of a cobalt(II) catalyst, using phenylsilane as 
the stoichiometric reductant, a range of bis-enones underwent reductive Michael 
cyclisation to afford both 5- and 6-membered ring products. In all cases, the anti-
diastereomer was obtained. Unsymmetrical enone 277 was also found to undergo 
reduction to afford both 278 and 279, resulting from hydrometalation of the phenyl-
substituted enone, and the methyl-substituted enone, respectively. However, a much 
lower level of chemoselectivity was obtained with substrate 280, which underwent 
cyclisation to afford a 1:1 mixture of 281 and 282. This poor selectivity is attributed 





The authors propose that exposure of Co(dpm)2 to phenylsilane results in cobalt 
hydrido species 283, which undergoes hydrometalation with the enone to generate 
cobalt enolate 285 (Scheme 2.3). Conjugate addition of the enolate to the tethered 
Co(dpm)2 (5 mol %)






Co(dpm)2 (5 mol %)






T = C, n = 0, 275a
T = C, n = 1, 275b
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enone affords a second cobalt enolate 286, which undergoes σ-bond metathesis to 





Following this initial publication by Krische, Overman and co-workers reported an 
intramolecular reductive Michael reaction mediated by Stryker’s Reagent (Scheme 
2.4).65 A range of 7-oxo-2,8-alkadienoic ester and nitrile substrates underwent 
cyclisation in good yield, with varying degrees of cis-selectivity. In general, 
substitution at the 4-position, for example in substrates 292a and 292b, was well 
tolerated, however, substitution at either the α- or β- position of the unsaturated ester 































The authors noted that the diastereoselectivity was dependent on various factors, 
including (1) solvent polarity – the stereoselectivity decreased with increasing 
solvent polarity, (2) the purity of the reductant – the stereoselectivity decreased with 
increasing amounts of PPh3 contaminant and (3) the geometry of the α,β-unsaturated 
nitrile/ester component – (E)-alkenes resulted in higher selectivites than (Z)-alkenes. 
It was suggested that the cis-selectivity arises from formation of a (Z)-copper enolate 
intermediate, which then chelates with the appended α,β-unsaturated ester, 





More recently, Jang and co-workers reported the platinum-catalysed reductive 
Michael cyclisation of a range of bis-enones, mediated by molecular hydrogen 
(Scheme 2.5).66,67 Initial ligand screening revealed that electron-poor phosphine 










R = OMOM, 292a
R = Me, 292b
293a, 75% yield, dr >19:1











































Enantioselective Copper-Catalysed Reductive Michael Cyclisations 67 
rich ligands. Furthermore, increasing the amount of ligand relative to PtCl2 resulted 





The authors proposed that SnCl2 acts as a co-catalyst, activating PtCl2 to afford the 
active catalytic species LnPtH(SnCl3) (279) upon reaction with hydrogen gas 
(Scheme 2.6). The active catalytic species then undergoes hydrometalation with the 
substrate to afford intermediate 298. Intramolecular Michael addition provides 
platinum enolate 299; the low diastereoselectivity is attributed to poor coordination 
between the platinum ion and the oxygen in intermediate 298. This enolate then 
undergoes oxidative addition with molecular hydrogen, followed by reductive 




R = Me, 295a
R = Ph, 275b
R = 4-MeOC6H4, 295b
296a, 59% yield, dr 1:1
296b, 91% yield, dr 1:3.5
276b, 98% yield, dr 1:2
PtCl2 (5 mol %)
P(4-CF3C6H4)3 (5 mol %)














275a 276a, 71% yield, dr 1:1









2.1.2 Organocatalysed Reductive Michael Reactions 
List and co-workers reported the first asymmetric reductive Michael cyclisation in 
2005, using a chiral secondary amine as the catalyst, and the Hanzsch ester as the 
reductant (Scheme 2.7).68 A range of substrates underwent reductive Michael 
cyclisation to afford the product as the anti-diastereomer in high yield and 
enantioselectivity. The reaction was found to be tolerant of many functional groups 
including − at the β-position of the enone – aromatic, heteroaromatic, and aliphatic 





















The authors proposed that the mechanism proceeds via non-asymmetric imine-
catalysed conjugate reduction, followed by asymmetric enamine-catalysed conjugate 
addition (Scheme 2.8). The enal is activated with MacMillan imidazolidinium salt 
308 to form imine 310. Hydride transfer from Hantzsch ester 303 provides enamine 
intermediate 312, which subsequently undergoes conjugate addition to afford imine 


















R = Me, 300a







301a, 91% yield, dr >50:1, 91% ee
301b, 98% yield, dr 15:1, 96% ee






















In a notable extension of this work, List and co-workers applied this methodology to 
the synthesis of the natural product (+)-ricciocarpin A (Scheme 2.9).69 The 
cyclisation precursor 315 was subjected to the standard reaction conditions, and 
underwent cyclisation to provide the undesired cis-isomer cis-316, with excellent 
enantioselectivity. Fortunately, the rate of epimerisation of cis-316 is rapidly 
increased in the presence of Sm(OiPr)3, resulting in the formation of the more 
thermodynamically stable trans-316. This event is followed by a highly 
diastereoselective Tishchenko reaction to afford the desired natural product, (+)-

















































The authors explored the generality of this novel cascade reaction by preparing a 
range of different cyclisation precursors, which underwent reaction to provide 



















































dr 2:1, 99% ee
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2.2 Results and Discussion 
As discussed previously, hydrometalation of α,β-unsaturated carbonyl compounds 
provides access to reactive chiral metal enolates, which can be trapped by a suitable 
electrophile to afford enantiomerically enriched products. In view of the considerable 
success realised with asymmetric copper-catalysed reductive aldol reactions, we 
envisioned an asymmetric copper-catalysed reductive Michael cyclisation reaction, 
which represents an appropriate extension to the asymmetric reductive aldol 
cyclisations previously described within our group.50,51 
 
2.2.1 Nitrogen-Tethered Substrates 
2.2.1.1 Preparation of Cyclisation Precursors 
Initially, we thought it would be of interest to investigate the reductive Michael 
cyclisation of nitrogen-tethered bis-enoates, such as 323. Cyclisation of such 
substrates would provide access to potentially useful chiral piperidine derivatives 





A range of cyclisation precursors were prepared by variation of both the nitrogen 
protecting group and the ester substituent, providing a range of structurally and 
electronically diverse bis-enoates. In the presence of excess base, various primary 
amines underwent alkylation with the appropriate alkyl-4-bromocrotonate to afford 


















Unsymmetrical cyclisation precursor 331, containing a β,β'-disubstituted enoate was 
also prepared (Scheme 2.12). In general, mono-alkylation of amines represents a 
problem, given the tendency of amines to undergo poly-alkylation. However, it was 
found that in the presence of triethylamine at room temperature, alkylation of 4-
anisidine proceeded to afford the mono-alkylation product, 330 selectively. 
Subsequent alkylation of 330 with tosylate 332, provided unsymmetrical cyclisation 
precursor 331. Tosylate 332 was prepared by Luche reduction70 of commercially 
available aldehyde 333 using CeCl3 and NaBH4, followed by tosylation under 








R1 NH2 Br CO2R
2+
conditions A or Ba



































































2.2.1.2 Ligand Optimisation 
Initially, it was decided to use the conditions previously developed within the group 
to effect reductive aldol cyclisations. Thus, in the presence of a substoichiometric 
amount of copper acetate, and rac-Binap, using TMDS as the stoichiometric 











































Subesquent derivitisation of a related compound, 335b revealed the major 
diastereomer to be the syn-product (see Section 2.2.1.3). The stereochemistry of 335a 
was assigned by direct comparison of 1H NMR data obtained from both compounds. 
  
Following this, a range of chiral ligands were screened (Table 2.2) and the resulting 
enantiomeric excess was determined by chiral HPLC analysis of the crude reaction 
mixture using either an AD-H or an OD-H column. In general, Binap, Biphep and 
Segphos ligands performed with similar efficacy, providing cyclised product 335a, 
with high enantioselectivity, albeit with low diastereoselectivity (dr ~ 2:1 in most 








Cu(OAc)2·H2O (5 mol %)
rac-Binap (5 mol %)





22% yield (major diastereomer)
dr 2:1
 




2.2.1.3 Substrate Scope 
The reductive Michael cyclisations of substrates 327a-e were then carried out, both 
racemically, using rac-Binap or dppf, and in the presence of a chiral ligand (Table 
2.3). The cyclisation of para-methoxyphenyl-protected enoate 327a proceeded 
smoothly to provide substituted piperidine 335a as 2:1 mixture of diastereomers, 
with 93% ee and 92% ee, for the major and minor diastereomers respectively (Entry 
1). The analogous ethyl-ester substrate 327b also underwent cyclisation to afford 
335b as a 4:1 mixture of diastereomers, in 91% ee (major diastereomer) (Entry 2). 
Although para-methoxybenzyl-protected enoate 327c did undergo cyclisation when 
conducted with rac-Binap, the product was isolated as a 2:1 mixture of inseparable 






Cu(OAc)2·H2O (5 mol %)
chiral ligand (5 mol %)a



















































a Determined by 1H NMR analysis of the unpurified reaction mixture. b Enantiomeric excess was determined by chiral 

























Entry Ligand ee (major diastereomer) (%)b
1 L6 80 (+)
2 L7 91 (+)
3 L4 91 (+)
4 L14
5 L9 90 (!)
6 L10 91 (!)
7 L11 86 (!)
8 L16 no reaction
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(Entry 3). Disappointingly, tosyl-protected substrate 327d did not undergo 
cyclisation, even following prolonged heating (Entry 4). Interestingly, although 
benzyl-protected enoate 327e did undergo cyclisation, no enantiomeric excess was 
obtained when the reaction was conducted with (R)-MeO-Biphep (Entry 5). Further 





In order to determine the relative stereochemistry of para-methoxyphenyl-protected 
piperidine derivative 335b, racemic product (±)-335b was reduced with DIBAL to 
provide diol 337, which was then acylated with para-chlorobenzoyl chloride to 
afford (±)-338 (Scheme 2.15). Fortunately, recrystallisation of (±)-338 gave crystals 








Cu(OAc)2·H2O (5 mol %)
ligand (5 mol %)









a Determined by 1H NMR analysis of the unpurified reaction mixture. b Determined by chiral HPLC analysis of the unpurified
reaction mixture. Enantiomeric excess of major (minor). Absolute configuration not assigned. c Reaction conducted with (R)-
MeO-Biphep. d Reaction conducted with rac-Binap. e Reaction conducted with (S)-DM-Segphos. f Yield of major diastereomer 


















































































4h 3:1 36f -
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stereochemistry of (±)-338, and thus (±)-335b to be syn. The relative stereochemistry 
of compounds 335a and 335e was determined by analogy with 335b based on 





Unsymmetrical cyclisation precursor 331 was subjected to the same reaction 
conditions (Scheme 2.16). However, only reduced product 336 was isolated, 
resulting from conjugate reduction at the least sterically hindered site followed by 
protonation, rather than conjugate addition to the tethered β,β’-disubstituted enoate 
moiety. The propensity of the enolate to undergo protonation as opposed to conjugate 






Cu(OAc)2·H2O (5 mol %)
(rac)-Binap (5 mol %)
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The proposed transition state for the reaction is shown in Figure 2.2. The chiral 







The reductive Michael cyclisations of a range of nitrogen-tethered α,β-unsaturated 
esters were carried out, providing the corresponding piperidine derivatives in 
moderate yields. In general, para-methoxyphenyl-protected substrates 327a and 
327b gave superior results, affording the cis-isomeric products with up to 93% ee. 
Conversely, the cyclisation of benzyl-protected derivative 327e resulted in no 
enantioselection. It is possible that the lone pair of electrons on the nitrogen atom is 
coordinating to the catalyst in an unproductive manner, reducing the enantiocontrol. 
This effect would be particularly prevalent in benzyl-derivative 327e, in which the 
nitrogen lone pair is significantly more basic than in the corresponding para-
methoxyphenyl-derivatives. Thus, we turned our attention towards substrates that do 









P = protecting group
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2.2.2 Carbon- and Oxygen-Tethered α,β-Unsaturated Ester 
Substrates 
2.2.2.1 Preparation of Cyclisation Precursors 
Carbon-tethered cyclisation precursors were prepared according to several different 
methods (Scheme 2.17). Taking advantage of commercially available building blocks 
339 and 345, aromatic-tethered cyclisation precursors were synthesised by either 
Wittig reaction (Eqn. 1), or Heck reaction (Eqn. 3). Carbon-tethered bis-benzyl 
enoate 344 was also prepared by a Wittig reaction using commercially available 
glutaric dialdehyde (342) (Eqn. 2). Finally, cyclisation precursor 350 was prepared in 





2.2.2.2 Ligand Optimisation 
Initially, the reaction of bis-enoate 341a was carried out in the presence of copper 
acetate, rac-Binap and TMDS (Scheme 2.18). Gratifyingly, complete consumption of 
the starting material was observed at 50 oC, and the product was isolated in 57% 
yield as an 8:1 mixture of inseparable diastereomers. 
 
345 R = Et, 346a













339 R = Et, 340a






































The relative stereochemistry of compound 351a was proposed to be syn by direct 
comparison of the 1H NMR data of compound 351a and an analogous compound, 
cis-375, whose stereochemistry was determined to be syn based on nOe experiments 
(see Section 2.2.3.2). 
 
We then turned our attention towards the use of chiral bisphosphine ligands (Table 
2.4). The enantiomeric excess of compound 351a was determined by HPLC analysis 
of the crude reaction mixture using either an AD-H or an OD-H column. The 
cyclisation of bis-enoate 341a proceeded smoothly in the presence of all of the biaryl 
ligands to afford indane derivative 351a in good conversion (>85% in all cases). In 
parallel with results obtained with using the nitrogen-tethered substrates, Biphep 
(Entry 2), Binap (Entry 3), and Segphos (Entry 4) ligands generally provided 
comparable levels of diastereo- and enantioselection. However, results obtained 
using (S)-Segphos were marginally superior. 
 
341a
Cu(OAc)2·H2O (5 mol %)
(rac)-Binap (5 mol %)













2.2.2.3 Substrate Scope 
With optimised conditions in hand, the reductive Michael cyclisations of a range of 
precursors were carried out (Table 2.5). The yield and diastereomer ratio of the 
corresponding racemic reactions, conducted with rac-Binap are displayed in 
parentheses in Table 2.5. Using (S)-Segphos, cyclisation of bis-ethyl ester 341a 
provided indane derivative 351a as a 12:1 mixture of diastereomers, with 91% ee for 
the major diastereomer (Entry 1). The corresponding methyl ester also underwent 
cyclisation to provide 351b with slightly lower diastereoselectivity, but with 
similarly high enantioselectivity (Entry 2). Unfortunately, bis-benzyl ester substrate 
344 did not undergo cyclisation, instead a complex mixture of unidentified products 
was obtained (Entry 3). The effect of substitution on the aromatic ring was 
341a
Cu(OAc)2·H2O (5 mol %)
chiral ligand (5 mol %)




















a Determined by 1H NMR analysis of the unpurified reaction mixture.
b Determined by chiral HPLC analysis of the unpurified reaction mixture.
Enantiomeric excess of major diastereomer. The absolute stereochemistry of






















Entry Ligand dra ee (%)b
CO2Et
CO2Et
1 L6 5:1 84 (+)
2 L7 6:1 92 (+)
3 L4 6:1 87 (+)
4 L9 10:1 94 (!)
5 L10 9:1 84 (!)
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investigated; gratifyingly, cyclisation of bis-ethyl ester derivative 347a proceed 





Increasing the steric bulk of the ester substituent was also tolerated, exemplified by 
bis-tert-butyl ester substrate 347b, which underwent cyclisation using (R)-Binap to 
afford the corresponding indane derivative in 54% yield, with 90% ee (Entry 5). 
Unfortunately, malonate-derived cyclisation precursor 350 did not undergo 
cyclisation, even after prolonged heating (Entry 6). The reduced reactivity of 
precursor 350 could be a result of unproductive 2-point binding of the catalyst to the 
dibenzylmalonate moiety. 
 
a Yield of pure major diastereomer unless otherwise specified. The yield of the racemic reaction, conducted with 
(rac)-Binap is provided in parentheses. b Determined by 1H NMR analysis of the unpurified reaction mixture.
The diastereomer ratio of the racemic reaction is provided in parentheses. c Enantiomeric excess of major
diastereomer as determined by chiral HPLC analysis. Absolute stereochemistry not determined. d Yield of an
inseparable mixture of diastereomers. e Reaction conducted with (R)-Binap. f Enantiomeric excess determined
by conversion to compound 355 (vide infra).

















Cu(OAc)2·H2O (5 mol %)
(S)-Segphos (5 mol %)















R = Et, 341a









































53 (48) 7:1 (7:1) 92
no reaction- -
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It should be noted that the enantiomeric excess of tert-butyl ester 353b could not be 
determined by HPLC analysis due to unresolved enantiomer peaks. Thus, it was 
necessary to convert this product into methyl ester analogue 355 by hydrolysis, 
followed by methylation of the bis-acid with trimethylsilyldiazomethane to afford 





The relative stereochemistry of compounds 351a, 351b, 353a and 353b was 
proposed to be syn based on nOe experiments carried out on a related compound 
(compound cis-375, see Section 2.2.3.2). Unfortunately, the absolute configurations 
of these products could not be determined by X-ray crystallography. 
 
Thus far, reductive Michael cyclisations carried out in the presence of copper acetate, 
a bisphosphine ligand, and TMDS, have generally resulted in diastereoselective and 
highly enantioselective formation of 5- and 6-membered rings. Unfortunately, 
however, the yields of the cyclised products have been moderate, despite high 
conversions and high mass recovery following reaction work-up with a mild acid. 
Various attempts to increase the yield, including the addition of tBuOH to the 
reaction mixture, or quenching the reaction with strong acid or a fluoride source such 
as TBAF, had a negligible effect. Furthermore, quenching the reaction with TBAF, 
as opposed to mild acid, resulted in a significantly lower mass recovery; however, 
following column chromatography, the yield of the reaction was comparable with 
those obtained from reactions which had been quenched with mild acid. This 
conundrum prompted us to reassess our reaction conditions, and revisit the literature 















353b 355, 52% yield, 90% ee
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Thus, a range of different copper sources, ligands and reductants were screened for 
activity. In general, it was found that the selectivity (both diastereo- and enantio-) 
could not compete with that obtained using our previous reaction conditions. 
Significantly, in the presence of CuF(PPh3)3·2MeOH, and josiphos ligand L29, bis-
enoate 341a underwent reduction to provide cyclised product 351a as a racemic 2:1 
mixture of diastereomers (Scheme 2.20, Eqn 1). However, it is particularly 
noteworthy that the product was isolated in 84% yield, which is much higher than the 
yield obtained using our previous conditions (Scheme 2.20, Eqn 1). Subsequent 
investigations revealed that the high yield is most likely a result of using 
phenylsilane as the reductant, instead of TMDS. Unfortunately, the use of 
phenylsilane with copper acetate and (S)-Segphos resulted in a complex mixture of 
unidentified products. Thus, taking into consideration the diastereo- and 
enantioselectivity of these reactions, our previously reported reaction conditions gave 





2.2.2.4 Mixed α,β-Unsaturated Ketone and Ester substrates 
Unsymmetrical substrates, bearing an α,β-unsaturated methyl ketone tethered to an 
α,β-unsaturated ester were synthesised in two steps from commercially available 
starting materials (Scheme 2.21 − Scheme 2.23). Cyclisation precursor 358 was 
synthesised from 2-bromobenzaldehyde (356) by a Heck reaction, followed by a 
341a
Cu(OAc)2·H2O (5 mol %)
(S)-Segphos (5 mol %)
TMDS (1.0 equiv.), THF, rt
351a
57% yield






CuF(PPh3)3·2MeOH (5 mol %)
 

















(R,S)-L29 (5 mol %)
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Wittig reaction of intermediate 357 with methyl ketone ylide 359 (Scheme 2.21). In 
an effort to synthesise a symmetrical bis-tert-butyl ester substrate, it was discovered 
that the reaction of phthaldialdehyde (339) with tert-butyl ester ylide 360 provided 
mono-adduct 361, selectively, despite using 2 equivalents of ylide (Scheme 2.22). 
Subsequent Wittig reaction provided cyclisation precursor 362 in 52% yield. 
Oxygen-tethered substrate 365 was synthesised from salicaldehyde (363) by simple 
alkylation, followed by a Wittig reaction (Scheme 2.23). Successful cyclisation of 











It was anticipated that the electronic difference between an enone and an enoate 
would be sufficient enough to result in chemoselective cyclisation by conjugate 
reduction of the more electrophilic α,β-unsaturated ketone component, followed by 
cyclisation onto the α,β-unsaturated ester. However, in the event, reaction of 358 
resulted in an inseparable mixture of products, most likely consisting of mixtures of 
diastereo- and regioisomers of cyclised products, and reduced substrate that did not 
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tert-butyl ester analogue 362 resulted in a complex mixture of unidentified products 
(Eqn 2). Finally, oxygen-tethered substrate 365 underwent reduction at the α,β-


















Cu(OAc)2·H2O (5 mol %)
(rac)-Binap (5 mol %)
TMDS (1.0 equiv.), THF, rt
Cu(OAc)2·H2O (5 mol %)
(rac)-Binap (5 mol %)
TMDS (1.0 equiv.), THF, rt
Cu(OAc)2·H2O (5 mol %)
(rac)-Binap (5 mol %)
TMDS (1.0 equiv.), THF, rt
mixture unidentified products
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2.2.3 Carbon- and Oxygen-Tethered α,β-Unsaturated Ketone 
Substrates 
2.2.3.1 Preparation of Cyclisation Precursors 
In addition to the α,β-unsaturated ester substrates, a range of α,β-unsaturated ketone 
cyclisation precursors was also prepared (Scheme 2.25). Bis-methyl ketone substrate 
367, and aromatic ketone cyclisation precursors 369a and 369b were prepared by 
Wittig reaction of phthaldialdehyde (339) and the appropriate ylide under the same 
conditions used to prepare the corresponding bis-ester precursors. Mixed ketone 
substrate 371 was prepared in a one-pot procedure, by sequential addition of methyl 





Oxygen-tethered cyclisation precursor 374 was also prepared in a one-pot procedure 
starting with oxidative cleavage of commercially available cis-diol 372 using silica 
gel-supported NaIO4,71 followed by addition of phenyl ketone ylide 368a, to provide 













339 Ar = Ph, 368a






































372 373 374, 63% yield
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2.2.3.2 Optimisation and Scope 
Initially, the bis-enone substrates were subjected to the conditions that had proved 
most successful in effecting the cyclisation of the bis-enoate substrates (see Section 
2.2.2.3). As anticipated, methyl ketone substrate 367 underwent cyclisation to 
provide syn-indane derivative cis-375 as the major diastereomer, in 49% yield and 
trans-375 as the minor diastereomer in 10% yield (Scheme 2.27). Interestingly, a 
small amount of compound 376, resulting from direct reduction of the ketone 





When the reaction was conducted in the presence of (S)-Segphos, as opposed to rac-
Binap, no 1,2-reduction product was observed and cis-375 was isolated in 41% yield, 





The relative stereochemistry of indane cis-375 was determined by nOe experiments 
conducted on both diastereomers of 375, which displayed the diagnostic 
enhancements shown in Figure 2.3. The relative stereochemistries of indanes 351a, 




Cu(OAc)2·H2O (5 mol %)
rac-Binap (5 mol %)


















Cu(OAc)2·H2O (5 mol %)
(S)-Segphos (5 mol %)





dr 6:1, 97% ee
367
 




Unfortunately, efforts to apply our standard reaction conditions to substrates 369a, 
369b and 371, which contain aromatic ketones, were unsuccessful, resulting in 
complex mixtures of unidentified products. Thus, investigations were undertaken to 
find workable conditions for these substrates. Following extensive experimentation, 
it was found that bis-enone 369a underwent cyclisation in the presence of 
CuF(PPh3)3·2MeOH and dppf using PMHS (polymethylhydrosiloxane) as the 
stoichiometric reductant, to afford trans-377a in 32% yield and cis-377a in 3% yield 





Encouraged by this result, we attempted to render the reaction enantioselective using 
Josiphos ligand (R,S)-L27 (Scheme 2.30). Although this lead to an increase in 

















CuF(PPh3)3·2MeOH (5 mol %)
dppf (5 mol %)
















Following this result, we began screening various Josiphos, Mandyphos and 
Taniaphos ligands, and found that Taniaphos ligand (R,R)-L21 gave superior levels 








CuF(PPh3)3·2MeOH (5 mol %)










(R,S)-L27 (5 mol %)
Ar = 3,5-MeC6H3
a Determined by chiral HPLC analysis of the unpurified reaction mixture.
Enantiomeric excess of major diastereomer. Diastereomeric ratio > 10:1 in all
cases. The absolute stereochemistry of 377a was not determined. The sign of 






CuF(PPh3)3.2MeOH (5 mol %)
chiral ligand (5 mol %)





























Ar = 3,5-CF3C6H3, (R,S)-L23 (R,R)-L21 (R,R)-L20
Ar = 3,5-CF3C6H3, (R,S)-L29 (R,S)-L32 (R,S)-L26
Entry Ligand ee (%)a
1 L29 10 (+)
2 L32 6 (!)
3 L26 32 (+)
4 L23 6 (!)
5 L21 44 (!)
6 L20 0
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With the ligand in hand, the effect of different solvents and solvent mixtures on the 
enantioselectivity was investigated (Table 2.7). Conducting the reaction in toluene at 
-25 oC afforded the highest enantiomeric excess (Entry 1). However, in this case, 
conversion was only 40%, possibly owing to the low solubility of 369a in toluene. 
Although carrying out the reaction in mixtures of THF and toluene increased 
conversion, a significant decrease in enantioselectivity was observed (Entries 2 and 
3). The use of acetonitrile appeared to inhibit the reaction (Entry 4), whereas the use 
of dichloromethane led to a complete loss in enantiocontrol (Entry 5). Ultimately, it 
was discovered that conducting the reaction in toluene at 0 oC provided a reasonable 





With the optimised conditions in hand, the reductive Michael cyclisations of 
aromatic ketones 369a, 369b and 374 were carried out. The racemic cyclisations of 
substrates 369b and 374 proceeded smoothly at room temperature to provide the 
corresponding products in good yield, with excellent diastereoselectivity (Scheme 
2.31). To ensure high conversions, reactions were carried out using 5 mol % catalyst 
and ligand, with 1 equivalent of PMHS, and then stirred overnight, followed by 
addition of a further 5 mol % catalyst and ligand, and 1 equivalent of PMHS, and 




CuF(PPh3)3·2MeOH (5 mol %)










a Determined by 1H NMR anaylsis of the unpurified reaction mixture. b Determined by 
chiral HPLC analysis of the unpurified reaction mixture.
Entry Solvent ee (%)b
1 toluene 90
2 toluene/THF (1:1) 60
3 toluene/THF (1:2) 60
4 -














6 toluene 0 70 77
 




The corresponding enantioselective cyclisations were carried out using (R,R)-L21, at 
reduced temperature in order to ensure high enantioselectivity (Scheme 2.32). Bis-
phenyl ketone 369a underwent cyclisation to afford indane derivative trans-377a as 
the anti-diastereomer in 46% yield and 93% ee. Substrate 369b, containing para-
chlorophenyl ketones, was found to be more soluble in toluene than 369a, allowing 
the reaction to be conducted at a lower temperature, and giving rise to increased 
enantiocontrol. Thus, the cyclised product was isolated in 41% yield and 90% ee. 
Finally, oxygen-tethered cyclisation precursor 374 also underwent reaction to 


























(rac)-Binap (5 mol % x 2)
CuF(PPh3)3·2MeOH (5 mol % x 2)








The relative and absolute stereochemistry of indane 377b was determined by X-ray 
crystallography (Figure 2.4) and the absolute stereochemistry of 377a was assigned 
by analogy. The relative stereochemistry of tetrahydropyran 374 was assigned on the 





The chemoselectivity of this reaction was also evaluated, with the cyclisation of 
unsymmetrical ketone precursor 371. In the event, 371 underwent cyclisation to 
afford two diastereomeric products, trans-379 and cis-379, in 80% ee and 67% ee, 











CuF(PPh3)3·2MeOH (5 mol % x 2)









Ar = 4-ClC6H4, 369b











dr 10:1, 52% ee
(2)
Fe
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and through the use of various 2D NMR techniques (HMBC, HSQC, COSY) it was 
revealed that the major regioisomer arises from conjugate addition to the phenyl-
substituted enone, followed by cyclisation onto the methyl-substituted enone. 
Furthermore, this substrate did not require batchwise addition of catalyst, ligand and 
PMHS, as the reaction was found to be complete after stirring overnight with 5 mol 





The relative stereochemistries of indanes cis-379 and trans-379 were assigned on the 
basis of nOe experiments, which displayed the diagnostic enhancements shown in 
Figure 2.5. The absolute stereochemistry of trans-379 was assigned by analogy to 






Interestingly, the diastereochemical outcome of these reactions is opposite to that 
obtained upon cyclisation of α,β-unsaturated ester substrates, and bis-methyl ketone 
substrate 367, in the presence of Cu(OAc)2·H2O, (S)-Segphos, and TMDS. Thus, it 




CuF(PPh3)3·2MeOH (5 mol %)
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CuF(PPh3)3·2MeOH, a Josiphos ligand and PMHS in order to establish whether the 
diastereochemical outcome is dependent on the substrate, or the reaction conditions 
(Scheme 2.34). In the event, bis-methyl ketone 367 underwent cyclisation to afford 
indane 375 as a 1:1 mixture of diastereomers and bis-ethyl ester 341a provided syn-
indane 351a. However, the diastereoselectivity was significantly lower than that 





On the basis of these results, it is possible that in each case, the reaction proceeds via 
two different transition states, giving rise to either syn- or anti-diastereoselectivity, 
depending on which substrate and/or conditions are used. Although one might 
assume that the reaction proceeds via the Z-enolate, the possibility that the reaction 
proceeds via an E-enolate cannot be ruled out. Furthermore, the nature of the copper 
enolate gives rise to further ambiguity; it is not known whether the reaction proceeds 
via an oxygen- (380) or carbon-bound copper enolate (381), or an intermediate oxo-







CuF(PPh3)3·2MeOH (5 mol %)
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In addition, the tendency for aromatic ketones to react differently to aliphatic ketones 
and esters suggests that π-π stacking interactions might also be significant. Thus, 
further investigation is required before it will be possible to determine the exact 
mechanism of this reaction. Nevertheless, it is possible to identify four possible 
transition states, A-D (Figure 2.7) in which the copper is within close proximity of 
both carbonyl groups to allow 2-point binding to occur. These transition states could 
potentially give rise to either syn or anti-products, depending on (1) the conformation 
of the α,β-unsaturated carbonyl component (s-cis vs. s-trans) and (2) the 
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2.3 Conclusions and Future Work 
Herein, enantioselective copper-catalysed reductive Michael cyclisations of a range 
of different cyclisation precursors has been reported. To our knowledge, this 
represents the first example of an asymmetric metal-catalysed reductive Michael 
reaction. A range of structurally and electronically diverse cyclisation precursors 
were prepared by various different methods. Substrates containing both α,β-
unsaturated ketones and esters underwent cyclisation, to afford 5- and 6- membered 
ring carbocyclic and heterocyclic products, with good-to-excellent levels of 
diastereo- and enantiocontrol (Scheme 2.35). Substrates containing α,β-unsaturated 
esters and non-aromatic ketones underwent cyclisation to provide enantiomerically 
enriched syn-indane derivatives. In contrast, cyclisation precursors containing 
aromatic ketones provided anti-indane derivatives. Furthermore, heteroatom-tethered 
precursors 327b and 374 underwent cyclisation to afford synthetically useful 

























































dr 7:1, 92% ee
353b
54% yield
dr 8:1, 90% ee
351b
41% yield
dr 6:1, 93% ee
351a
57% yield
dr 12:1, 91% ee
375
41% yield
dr 6:1, 97% ee
335b
41% yield
dr 4:1, 91% ee
335a
49% yield
dr 2:1, 93% ee
377a
46% yield
dr >19:1, 83% ee
377b
41% yield
dr >19:1, 90% ee
379
42% yield
dr 3:1, 80% ee
378
54% yield
dr 10:1, 52% ee
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A possible extension of this work could include a cascade reaction, in which a bis-
α,β-unsaturated carbonyl compound 383 undergoes intramolecular Michael reaction, 
to provide copper enolate 384. In the presence of a suitable electrophile, enolate 384 
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2.4 Experimental 
2.4.1 General Information 
All non-aqueous reactions were carried out under a nitrogen atmosphere in oven-
dried apparatus. Toluene and THF were dried and purified by passage through 
activated alumina columns using a solvent purification system from 
http://www.glasscontoursolventsystems.com. All commercially available reagents 
were used as received. Thin layer chromatography (TLC) was performed on Merck 
DF-Alufoilien 60F254 0.2 mm precoated plates. Product spots were visualized by UV 
light at 254 nm, and subsequently developed using potassium permanganate or ceric 
ammonium molybdate solution as appropriate. Flash column chromatography was 
carried out using silica gel (Fisher Scientific 60Å particle size 35-70 micron) 
employing the method of Still and co-workers.72 Melting points were recorded on a 
Gallenkamp melting point apparatus and are uncorrected. Infra-red spectra were 
recorded on a Jasco FT/IR-460 Plus instrument as a thin film on sodium chloride 
plates or as a dilute solution in CHCl3. 1H NMR spectra were recorded on a Burker 
AVA600 (600 MHz) spectrometer, a Bruker DMX500 (500 MHz) spectrometer, a 
Bruker DPX360 (360 MHz) spectrometer or a Bruker ARX250 (250 MHz) 
spectrometer. Chemical shifts (δ) are quoted in parts per million (ppm) downfield of 
tetramethylsilane, using residual protonated solvent as internal standard (CDCl3 at 
7.27 ppm). Abbreviations used in the description of resonances are: s (singlet), d 
(doublet), t (triplet), q, (quartet), app (apparent), br (broad). Coupling constants (J) 
are quoted to the nearest 0.1 Hz. Proton-decoupled 13C NMR spectra were recorded 
on a Bruker AVA600 (600 MHz, 150.9) spectrometer, a Bruker DPX360 (90.6 MHz) 
spectrometer or a Bruker ARX250 (62.9 MHz) spectrometer. Chemical shifts (δ) are 
quoted in parts per million (ppm) downfield of tetramethylsilane, using deuterated 
solvent as internal standard (CDCl3 at 77.0 ppm). Assignments were made using the 
DEPT sequence with secondary pulses at 90° and 135°. High resolution mass spectra 
were recorded on a Finnigan MAT 900 XLT spectrometer or a Finnigan MAT 95XP 
spectrometer at the EPSRC National Mass Spectrometry Service Centre, University 
of Wales, Swansea, or on a Finnigan MAT 900 XLT spectrometer or a Kratos 
MS50TC spectrometer at the School of Chemistry, University of Edinburgh. Chiral 
HPLC analysis was performed on an Agilent 1100 instrument. Optical rotations were 
performed on an Optical Activity POLAAR 20 polarimeter. 
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2.4.2 Preparation of Cyclisation Precursors 
 
General Procedure A: Synthesis of Nitrogen-Tethered Cyclisation Precursors 
 
To a solution of K2CO3 (6.91 g, 50.0 mmol) and the appropriate amine (10.0 mmol, 1 
equiv.) in CH3CN (30 mL) at reflux was added the appropriate alkyl-4-
bromocrotonate (22.0 mmol, 2.2 equiv.). The reaction mixture was stirred at reflux 
for 20 h before it was quenched with saturated aqueous NH4Cl (30 mL) and extracted 
with Et2O (2 x 30 mL). The combined organic layers were washed with brine (2 x 30 
mL), dried (MgSO4) and concentrated in vacuo. Purification of the residue by 
column chromatography gave the cyclisation precursor. 
 
General Procedure B: Synthesis of Nitrogen-Tethered Cyclisation Precursors 
  
To a solution of the appropriate amine (5.0 mmol, 1 equiv.) in CH2Cl2 (20 mL) was 
added pyridine (0.80 mL, 10.0 mmol), followed by ethyl 4-bromocrotonate (2.02 
mL, 11.0 mmol). The reaction mixture was stirred for 16 h at room temperature 
before it was quenched with saturated aqueous NH4Cl (30 mL) and extracted with 
CH2Cl2 (2 x 30 mL). The combined organic layers were washed with brine (2 x 30 
mL), dried (MgSO4), and concentrated in vacuo. Purification of the residue by 




The title compound was prepared according to General Procedure A from 4-anisidine 
(1.23 g, 10.0 mmol) and methyl 4-bromocrotonate (2.59 mL, 22.0 mmol), and 
purified by column chromatography (10% EtOAc/hexane→30% EtOAc/hexane) to 
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m.p. 66-68 °C. IR (CHCl3) 2950, 2834, 1723 (C=O), 1654, 1513, 1436, 1275, 1241, 
1168, 1035 cm-1; 1H NMR (360 MHz, CDCl3) δ 6.96 (2H, dt, J = 15.7, 4.6 Hz, 2 x 
CH=CHC=O), 6.80 (2H, d, J = 9.1 Hz, ArH), 6.60 (2H, d, J = 9.1 Hz, ArH), 5.95 
(2H, dt, J = 15.7, 1.9 Hz, 2 x CHC=O), 4.01 (4H, dd, J = 4.6, 1.9 Hz, 2 x NCH2), 
3.75 (3H, s, OCH3), 3.72 (6H, s, 2 x CO2CH3); 13C NMR (62.9 MHz, CDCl3) δ 
166.4 (2 x C), 152.3 (C), 144.6 (2 x CH), 141.9 (C), 121.8 (2 x CH), 114.8 (2 x CH), 
114.4 (2 x CH), 55.6 (CH3), 52.3 (2 x CH2), 51.5 (2 x CH3); HRMS (EI) Exact mass 
calcd for C17H21NO5 [M]+: 319.1414, found: 319.1414. 
 
(2E,2'E)-Diethyl 4,4'-(4-methoxyphenylazanediyl)dibut-2-enoate (327b) 
  
To a solution of K2CO3 (10.36 g, 75.0 mmol) and 4-anisidine (3.69 g, 30.0 mmol) in 
CH3CN (300 mL) at reflux was added ethyl-4-bromocrotonate (11.9 mL, 66.0 
mmol). The reaction mixture was stirred at reflux for 20 h, cooled to room 
temperature, quenched with saturated aqueous NH4Cl (100 mL), and extracted with 
Et2O (2 x 100 mL). The combined organic layers were washed with brine (2 x 100 
mL), dried (MgSO4) and concentrated in vacuo. Purification of the residue by 
column chromatography (10% EtOAc/hexane→30% EtOAc/hexane) gave the 
diallylamine 327b (7.90 g, 79%) as an oil. Rf = 0.40 (25% EtOAc/hexanes); IR (film) 
2982, 2937, 2904, 2833, 1716 (C=O), 1657, 1515, 1464, 1368, 1273 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 6.95 (2H, dt, J = 15.7, 4.5 Hz, 2 x CH=CHC=O), 6.80 (2H, dm, 
J = 9.1 Hz, ArH), 6.60 (2H, dm, J = 9.1 Hz, ArH), 5.93 (2H, dt, J = 15.7, 1.9 Hz, 2 x 
CHC=O), 4.18 (4H, q, J = 7.1 Hz, 2 x OCH2CH3), 4.01 (4H, dd, J = 4.5, 1.9 Hz, 2 x 
NCH2), 3.74 (3H, s, OCH3), 1.27 (6H, t, J = 7.1 Hz, 2 x OCH2CH3); 13C NMR (62.9 
MHz, CDCl3) δ 166.0 (2 x C), 152.2 (C), 144.3 (2 x CH), 142.0 (C), 122.2 (2 x CH), 
114.8 (2 x CH), 114.2 (2 x CH), 60.4 (2 x CH2), 55.6 (CH3), 52.3 (2 x CH2), 14.1 (2 
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(E)-4-(E)-3-Ethoxycarbonylallyl-4-methoxybenzylaminobut-2-
enoic acid ethyl ester (327c) 
The title compound was prepared according to General Procedure B from 4-
methoxybenzylamine (645 µl, 5.00 mmol) and purified by column chromatography 
(10% Et2O/hexane→30% Et2O/hexane) gave the diallylamine 327c (790 mg, 44%) 
as an oil. Rf = 0.37 (25% EtOAc/hexanes); IR (film) 2981, 2936, 2905, 2834, 2816, 
1729, 1716 (C=O), 1657, 1611, 1512 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.22 (2H, 
d, J = 8.7 Hz, ArH), 6.93 (2H, dt, J = 15.7, 5.8 Hz, 2 x CH=CHC=O), 6.84 (2H, d, J 
= 8.7 Hz, ArH), 6.02 (2H, dt, J = 15.7, 1.6 Hz, 2 x CHC=O), 4.18 (4H, q, J = 7.1 Hz, 
2 x OCH2CH3), 3.78 (3H, s, OCH3), 3.53 (2H, s, CH2Ph), 3.18 (4H, dd, J = 5.8, 1.6 
Hz, 2 x NCH2), 1.28 (6H, t, J = 7.1 Hz, 2 x OCH2CH3); 13C NMR (62.9 MHz, 
CDCl3) δ 166.1 (2 x C), 158.8 (C), 145.6 (2 x CH), 130.1 (C), 129.7 (2 x CH), 122.9 
(2 x CH), 113.7 (2 x CH), 60.2 (2 x CH2), 57.7 (CH2), 55.1 (CH3), 54.3 (2 x CH2), 




amino]but-2-enoic acid ethyl ester (327d) 
The title compound was prepared according to General Procedure A from p-toluene 
sulfonamide (1.71 g, 10.0 mmol) and ethyl 4-bromocrotonate (3.96 mL, 22.0 mmol), 
and purified by column chromatography (20% EtOAc/hexane→50% 
EtOAc/hexane), followed by recrystallisation from CH2Cl2/hexane to give the 
diallylamine 327d (1.04 g, 53%) as a white solid. Rf = 0.14 (25% EtOAc/hexanes); 
m.p. 78-80 oC; IR (CHCl3) 2983, 2925, 1717 (C=O), 1662, 1598, 1447, 1342, 1304, 
1276, 1161, 1096, 1037 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.73 (2H, d, J = 8.3 Hz, 
ArH), 7.35 (2H, d, J = 8.3 Hz, ArH), 6.69 (2H, dt, J = 15.7, 5.9 Hz, 2 x 
CH=CHC=O), 5.90 (2H, dt, J = 15.7, 1.4 Hz, 2 x CHC=O), 4.20 (4H, q, J = 7.1 Hz, 
2 x OCH2CH3), 3.97 (4H, dd, J = 5.9, 1.4 Hz, 2 x NCH2), 2.46 (3H, s, ArCH3), 1.30 
(6H, t, J = 7.1 Hz, 2 x OCH2CH3). 13C NMR (62.9 MHz, CDCl3) δ 165.3 (2 x C), 
143.9 (C), 141.3 (2 x CH), 136.3 (C), 129.8 (2 x CH), 127.1 (2 x CH), 124.4 (2 x 
CH), 60.5 (2 x CH2), 48.0 (2 x CH2), 21.4 (CH3), 14.0 (2 x CH3); HRMS (ES) Exact 
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 (E)-4-Benzyl-(E)-3-ethoxycarbonylallylaminobut-2-enoic acid 
ethyl ester (327e) 
The title compound was prepared according to General Procedure B from 
benzylamine (545 µl, 5.00 mmol) and purified by column chromatography (10% 
Et2O/hexane→30% Et2O/hexane) gave the diallylamine 327e (655 mg, 41%) as an 
oil. Rf = 0.57 (25% EtOAc/hexanes); IR (film) 2981, 2937, 2905, 2805, 1717, 1657 
(C=O), 1454, 1368, 1302, 1270 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.35-7.26 (5H, 
m, ArH), 6.97 (2H, dt, J = 15.7, 5.8 Hz, 2 x CH=CHC=O), 6.06 (2H, dt, J = 15.7, 1.7 
Hz, 2 x CHC=O), 4.21 (4H, q, J = 7.1 Hz, 2 x OCH2CH3), 3.63 (2H, s, CH2Ph), 3.24 
(4H, dd, J = 5.8, 1.7 Hz, 2 x NCH2), 1.31 (6H, t, J = 7.1 Hz, 2 x OCH2CH3); 13C 
NMR (62.9 MHz, CDCl3) δ 166.0 (2 x C), 145.4 (2 x CH), 138.2 (C), 128.5 (2 x 
CH), 128.3 (2 x CH), 127.2 (CH), 123.0 (2 x CH), 60.3 (2 x CH2), 58.3 (CH2), 54.4 
(2 x CH2), 14.1 (2 x CH3); HRMS (ES) Exact mass calcd for C19H26NO4 [M+H]+: 
332.1856, found: 332.1856.   
 
(E)-4-(4-Methoxyphenylamino)but-2-enoic acid ethyl ester (330) 
 
To a solution of 4-anisidine (1.23 g, 10.0 mmol) in CH2Cl2 (50 ml) was added 
triethylamine (6.97 mL, 50.0 mmol), followed by methyl-4-bromo-crotonate (1.17 
mL, 10.0 mmol). The reaction was stirred at room temperature for 20 h before it was 
quenched with saturated aqueous NH4Cl (20 mL) and extracted with CH2Cl2 (2 x 20 
mL). The combined organic layers were washed with brine (2 x 20 mL), dried 
(MgSO4) and concentrated in vacuo. The crude product was purified by column 
chromatography (10% EtOAc/hexane→30% EtOAc/hexane) to give mono-
allylamine 330 (0.58 g, 55%) as an oil. Rf = 0.26 (25% EtOAc/hexanes); IR (film) 
2951, 2835, 1718 (C=O), 1684, 1512, 1437, 1362, 1245, 1168, 1172 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 7.05 (1H, dt, J = 15.7, 4.7 Hz, CH=CHC=O), 6.79 (2H, d, J = 
8.8 Hz, ArH), 6.57 (2H, d, J = 8.8 Hz, ArH), 6.06 (1H, dt, J = 15.7, 2.0 Hz, 
CHC=O), 3.90 (2H, dd, J = 4.7, 2.0 Hz, NCH2), 3.76 (3H, s, OCH3), 3.74 (3H, s, 
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enoic acid ethyl ester (331) 
  
To a solution of K2CO3 (248.8 mg, 1.80 mmol) and (E)-4-(4-
methoxyphenylamino)but-2-enoic acid ethyl ester (330) (315.5 mg, 1.50 mmol) in 
CH3CN (5 mL) at reflux was added (E)-3-methyl-4-(toluene-4-sulfonyloxy)but-2-
enoic acid ethyl ester (334) (248.8 mg, 1.8 mmol) in CH3CN (2.5 mL) via cannula. 
The reaction mixture was allowed to stir at reflux for 20 h before it was quenched 
with saturated aqueous NH4Cl (5 mL) and extracted with diethyl ether (2 x 5 mL). 
The combined organic layers were washed with brine (2 x 5 mL), dried (MgSO4) and 
concentrated in vacuo. Purification of the residue by column chromatography (10% 
EtOAc/hexane→30% EtOAc/hexane) gave cyclisation precursor 331 as an orange 
solid (350.1 mg, 67%). Rf = 0.26 (25% EtOAc/hexanes); m.p. 75-77 oC; IR (CHCl3) 
2954, 2890, 1973, 1722 (C=O), 1666, 1598, 1446, 1401, 1367, 1172 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 6.94 (1H, dt, J = 15.7, 4.4 Hz, CH=CHCO2CH3), 6.78 (2H, d, J 
= 9.2 Hz, ArH), 6.53 (1H, d, J = 9.2 Hz, ArH), 5.90 (1H, dt, J = 15.7, 1.9 Hz, 
CHCO2CH3), 5.77 (1H, q, J = 1.4 Hz, CHCO2CH2CH3), 4.12 (2H, q, J = 7.1 Hz 
CH2CH3), 4.02 (1H, dd, J = 4.4, 1.9 Hz, C=CHCH2N), 3.83 (2H, br s, 
C=C(CH3)CH2N), 3.72 (3H, s, OCH3), 3.70 (1H, s, CO2CH3), 2.13 (3H, d, J = 1.4 
Hz, C=CCH3), 1.24 (3H, t, J = 7.1 Hz, CH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 
166.6 (C), 166.5 (C), 154.4 (C), 152.1 (C), 144.4 (CH), 142.1 (C), 121.9 (CH), 114.8 
(3 x CH), 113.7 (2 x CH), 59.7 (CH2), 58.9 (CH2), 55.7 (CH3), 51.9 (CH2), 51.5 
(CH3), 16.5 (CH3), 14.2 (CH3); HRMS (ES) Exact mass calcd for C19H26NO5 
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(E)-3-Methyl-4-(toluene-4-sulfonyloxy)but-2-enoic acid ethyl ester (332) 
 
To a solution of (E)-4-Hydroxy-3-methylbut-2-enoic acid ethyl ester (334) (1.44 g, 
10.0 mmol) and Et3N (2.09 mL, 15.0 mmol) in CH2Cl2 (200 mL) at 0 oC was added 
tosyl chloride (2.29 g, 12.0 mmol), followed by 4-dimethylaminopyridine (0.12 g, 
1.00 mmol). The reaction mixture was allowed to warm to room temperature and 
stirred for 20 h. The reaction mixture was then quenched with saturated aqueous 
NH4Cl (50 mL) and extracted with CH2Cl2 (2 x 50 mL). The combined organic 
layers were washed with brine (2 x 50 mL), dried (MgSO4) and concentrated in 
vacuo. Purification of the crude mixture by column chromatography (10% 
EtOAc/hexane→30% EtOAc/hexane) gave 332 as a colourless oil (2.44 g, 81%). Rf 
= 0.67 (25% EtOAc/hexanes); IR (film) 2982, 2930, 1923, 1717, 1666, 1598, 1446, 
1400, 1367, 1172 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.77 (2H, d, J = 8.5 Hz, ArH), 
7.33 (2H, d, J = 8.5 Hz, ArH), 5.84 (1H, m, C=CH), 4.45 (2H, m, OCH2), 4.12 (2H, 
q, J = 7.1 Hz, CH2CH3), 2.42 (3H, s, ArCH3), 2.03 (3H, m, C=CCH3), 1.24 (3H, t, J 
= 7.1 Hz, CH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 165.5 (C), 148.5 (C), 145.0 (C), 
132.4 (C), 129.8 (2 x CH), 127.7 (2 x CH), 117.5 (CH), 72.3 (CH2), 59.8 (CH2), 21.4 
(CH3), 15.1 (CH3), 13.9 (CH3). 
 
(E)-4-Hydroxy-3-methylbut-2-enoic acid ethyl ester73 (334) 
 
CeCl3 (7.80 g, 21.0 mmol) was added in one portion to a stirred solution of ethyl-3-
methyl-4-oxocrotonate (2.84 g, 20.0 mmol) in EtOH (315 mL) at 0 oC. After 10 
mins, NaBH4 (0.90 g, 24.0 mmol) was added in small portions over 5 mins. The 
mixture was allowed to warm to room temperature and stir for 17 h, before it was 
quenched with saturated aqueous NH4Cl (100 mL). The EtOH was removed in vacuo 
and the remaining residue was extracted with CH2Cl2 (2 x 100 mL). The combined 
organic layers were washed with brine (2 x 50 mL), dried (MgSO4) and concentrated 
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without further purification and displayed spectral data consistent with those 
described previously.73 
 
General Procedure C: Preparation of Phosphonium Ylides 
 
A solution of the appropriate 2-bromoketone (20.0 mmol) in toluene (15 mL) was 
added dropwise over 10 min to a solution of triphenylphosphine (5.25 g, 20.0 mmol) 
in toluene (15 mL). The reaction mixture was stirred at room temperature for 18 h, 
and the resulting phosphonium salt was filtered and oven-dried. The phosphonium 
salt was obtained in quantitative yield, and was used without further purification. 
Na2CO3 (3.18 g, 30.0 mmol) was added to a suspension of the phosphonium salt 
(20.0 mmol) in H2O (60 mL) and CH2Cl2 (60 mL). The mixture was stirred at room 
temperature for 18 h and then transferred to a separating funnel. The organic layer 
was separated and the aqueous layer was extracted with CH2Cl2 (3 x 20 mL). The 
combined organic layers were dried (MgSO4) and concentrated in vacuo to leave the 
ylide, which was used without further purification. 
 
 (Phenylacylidene)triphenylphosphorane (368a).74 The title compound 
was prepared according to General Procedure A from 2-
bromoacetophenone (3.98 g, 20.0 mmol) and the resultant ylide (6.11 g, 80%) 
displayed spectral data consistent with those described previously.74 
 
 1-(4-Chlorophenyl)-2-(triphenylphosphanylidene)ethanone 
(368b).75 The title compound was prepared according to General 
Procedure A from 2-bromo-4′-chloroacetophenone (4.67 g, 20.0 mmol) and the 
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General Procedure D: Wittig Reactions 
 
To a solution of phthaldialdehyde (670 mg, 5.00 mmol) in CHCl3 (60 mL) was added 
the appropriate ylide (12.5 mmol). The mixture was stirred at room temperature for 
16 h and concentrated in vacuo. Purification of the residue by column 
chromatography afforded the cyclization precursor.  
 
General Procedure E: Heck Reactions 
 
To a suspension of Pd(OAc)2 (90 mg, 0.40 mmol), n-Bu4NCl (1.14 g, 5.00 mmol), 
K2CO3 (3.45 g, 25.0 mmol), and LiCl (212 mg, 5.00 mmol) in DMF (25 mL) was 
added 1,2-dibromo-4,5-difluorobenzene (1.36 g, 5.00 mmol) and the appropriate 
alkyl acrylate (25.0 mmol). The mixture was stirred at 100 °C for 18 h, cooled to 
room temperature, diluted with Et2O (25 mL), and washed with H2O (50 mL). The 
aqueous layer was extracted with Et2O (2 x 50 mL), and the combined organic layers 
were washed with brine (2 x 100 mL), dried (MgSO4), and concentrated in vacuo. 
Purification of the residue by column chromatography gave the cyclization precursor. 
 
 (E)-3-[2-{(E)-2-Ethoxycarbonylvinyl}phenyl]acrylic acid ethyl 
ester (341a).76 The title compound was prepared according to 
General Procedure D from ethyl (triphenylphosphoranylidene)acetate (4.35 g, 12.5 
mmol) and purified by column chromatography (10% EtOAc/hexane→20% 
EtOAc/hexane) followed by recrystallization from CH2Cl2/hexane to give 341a as a 
white solid (1.15 g, 84%), which displayed spectral data consistent with those 
described previously.76 Rf = 0.50 (25% EtOAc/hexanes); m.p. 73-75 °C; IR (CHCl3) 
3063, 2986, 2942, 2906, 1710 (C=O), 1702 (C=O), 1477, 1363, 1309, 1184 cm-1; 
1H NMR (360 MHz, CDCl3) δ 8.03 (2H, d, J = 15.8 Hz, 2 x CH=CHC=O), 7.58-7.56 
(2H, m, ArH), 7.41-7.38 (2H, m, ArH), 6.35 (2H, d, J = 15.8 Hz, 2 x CHC=O), 4.28 
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(62.9 MHz, CDCl3) δ 166.4 (2 x C), 141.2 (2 x CH), 134.3 (2 x C), 129.9 (2 x CH), 
127.6 (2 x CH), 121.9 (2 x CH), 60.7 (2 x CH2), 14.3 (2 x CH3); HRMS (EI) Exact 
mass calcd for C16H18O4 [M]+: 274.1200, found: 274.1200. 
 
 (E)-3-[2-{(E)-2-Methoxycarbonylvinyl}phenyl]acrylic acid 
methyl ester (341b).77 The title compound was prepared according 
to General Procedure D from methyl (triphenylphosphoranylidene)acetate (4.18 g, 
12.5 mmol) and purified by column chromatography (10% EtOAc/hexane→30% 
EtOAc/hexane) followed by recrystallization from EtOAc/hexane to give 341b as a 
white solid (1.08 g, 83%), which displayed spectral data consistent with those 
described previously.77 Rf = 0.37 (25% EtOAc/hexanes); m.p. 63-65 °C; IR (CHCl3) 
2951, 1718 (C=O), 1635, 1596, 1435, 1314, 1277, 1249, 1216, 1195 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 8.03 (2H, d, J = 15.8 Hz, 2 x CH=CHC=O), 7.58-7.55 (2H, m, 
ArH), 7.41-7.38 (2H, m, ArH), 6.35 (2H, d, J = 15.8 Hz, 2 x CHC=O), 3.83 (6H, 2 x 
OCH3); 13C NMR (62.9 MHz, CDCl3) δ 166.8 (2 x C), 141.4 (2 x CH), 134.2 (2 x C), 
130.0 (2 x CH), 127.6 (2 x CH), 121.4 (2 x CH), 51.8 (2 x CH3); HRMS (ES) Exact 
mass calcd for C14H18NO4 [M+NH4]+: 264.1230, found: 264.1228.   
 
(2E,7E)-Nona-2,7-dienedioic acid dibenzyl ester (344) 
 
To a solution of benzyl (triphenylphosphoranylidene)acetate (1.43 g, 3.5 mmol) in 
THF (8 mL) was added glutaric dialdehyde solution (50% solution in water, 181 uL, 
1.0 mmol), followed by MgSO4 (c.a. 1.2 g) and the reaction mixture was stirred for 
48 h. After filtration, and concentration in vacuo, the resulting solid was purified by 
column chromatography (10% EtOAc/hexane) to give the bis-α,β-unsaturated ester 
344 (220 mg, 60%) as a colourless oil. Rf = 0.51 (25% EtOAc/hexanes); IR (film) 
3033, 2938, 1712 (C=O), 1652, 1455, 1316, 1289, 1264, 1169, 1146 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 7.41-7.32 (10H, m, ArH), 7.01 (2H, dt, J = 15.6, 6.9 Hz, 2 x 
CH=CHCO), 5.91 (2H, dm, J = 15.6 Hz, 2 x CHC=O), 5.20 (4H, s, 2 x CH2Ph), 2.25 
(4H, qd, J = 7.4, 1.5 Hz, 2 x CH=CHCH2), 1.69-1.61 (2H, m, CH=CHCH2CH2); 13C 
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CH), 128.1 (6 x CH), 121.5 (4 x CH), 66.0 (2 x CH2), 31.3 (2 x CH2), 26.1 (CH2); 
HRMS (ES) Exact mass calcd for C23H25O4 [M+H]+: 365.1747, found: 365.1754. 
 
 (E)-3-[2-{(E)-2-Ethoxycarbonylvinyl}-4,5-
difluorophenyl]acrylic acid ethyl ester (346a). The title 
compound was prepared according to General Procedure E from ethyl acrylate (2.72 
mL, 25.0 mmol) and purified by column chromatography (10% 
EtOAc/hexane→30% EtOAc/hexane) to give 346a as a pale yellow solid (0.91 g, 
59%). Rf = 0.55 (25% EtOAc/hexanes); m.p. 112-114 °C; IR (CHCl3) 3050, 2990, 
1705 (C=O), 1505, 1305, 1266, 1169, 1096, 973, 909 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 7.92 (2H, d, J = 15.8 Hz, 2 x CH=CHC=O), 7.38 (2H, app t, JH-F = 9.4 Hz, 
ArH), 6.29 (2H, d, J = 15.8 Hz, 2 x CHC=O), 4.29 (4H, q, J = 7.1 Hz, 2 x CH2CH3), 
1.35 (6H, t, J = 7.1 Hz, 2 x CH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 165.9 (2 x C), 
151.1 (2 x C, dd, JC-F = 255.4, 15.1 Hz), 138.9 (2 x CH), 131.4 (2 x C, t, JC-F = 4.8 
Hz), 122.8 (2 x CH), 116.2 (2 x CH, dd, JC-F = 11.3, 8.0 Hz), 60.9 (2 x CH2), 14.2 (2 




difluorophenyl]acrylic acid tert-butyl ester (346b). The title 
compound was prepared according to General Procedure E from tert-butyl acrylate 
(3.66 mL, 25.0 mmol) and purified by column chromatography (5% 
EtOAc/hexane→10% EtOAc/hexane) to give 346b as a white solid (1.34 g, 73%). Rf 
= 0.67 (25% EtOAc/hexanes); m.p. 104-106 °C; IR (CHCl3) 2980, 1710 (C=O), 
1635, 1502, 1368, 1297, 1259, 1152, 849 cm-1; 1H NMR (250 MHz, CDCl3) δ 8.02 
(2H, d, J = 15.8 Hz, 2 x CH=CHC=O), 6.41 (2H, d, J = 15.8 Hz, CHC=O), 7.55 
(2H, app t, JH-F = 9.5 Hz, ArH), 1.74 (18H, s, 2 x C(CH3)3); 13C NMR (62.9 MHz, 
CDCl3) δ 165.1 (2 x C), 150.9 (2 x C, dd, JC-F = 254.8, 15.1 Hz), 138.0 (2 x CH), 
131.5 (2 x C, t, JC-F = 4.8 Hz), 124.5 (2 x CH), 116.0 (2 x CH, dd, JC-F = 11.2, 8.0 
Hz), 81.1 (2 x C), 28.1 (6 x CH3); HRMS (ES) Exact mass calcd for C20H24F2O4Na 
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(2E,7E)-5,5-Bis-benzyloxycarbonyl-nona-2,7-dienedioic acid diethyl ester (350) 
 
To a solution of NaH (0.88 g, 22.0 mmol, 2.2 eq) in THF (40 mL) was added 
dibenzyl malonate (4.45 mL, 10.0 mmol), dropwise over 5 min at 0 oC. The reaction 
mixture was stirred at 0 oC for 15 minutes before it was allowed to warm to room 
temperature. Ethyl 4-bromocrotonate (3.97 mL, 22.0 mmol, 2.2 eq) was then added 
and the reaction was allowed to stir at room temperature for 17 h. The reaction 
mixture was then quenced with saturated aqueous NH4Cl (50 mL) and extracted with 
EtOAc (2 x 50 mL). The combined organic layers were washed with brine (2 x 30 
mL), dried (MgSO4), and concentrated in vacuo. Purification of the residue by 
column chromatography (5% EtOAc/hexane→15% EtOAc/hexane) gave bis-α,β-
unsaturated ester 350 (4.53 g, 89%). Rf = 0.47 (25% EtOAc/hexanes); IR (film) 
3034, 2981, 1722 (C=O), 1656, 1497, 1456, 1368, 1315, 1271, 1174 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 7.34-7.32 (6H, m, ArH), 7.28-7.24 (4H, m, ArH), 6.73 (2H, dt, 
J = 15.5, 7.8 Hz, 2 x CH=CHC=O), 5.81 (2H, dt, J = 15.5, 1.3 Hz, 2 x CHC=O), 
5.13 (4H, s, 2 x CH2Ph), 4.17 (4H, q, J = 7.1 Hz, 2 x OCH2CH3), 3.81 (2H, dd, J = 
7.8, 1.3 Hz, 2 x CH=CHCH2), 1.29 (6H, t, J = 7.1 Hz, 2 x OCH2CH3); 13C NMR 
(62.9 MHz, CDCl3) δ 169.3 (2 x C), 165.5 (2 x C), 141.2 (2 x CH), 134.8 (2 x C), 
128.5 (4 x CH), 128.5 (2 x CH), 128.3 (4 x CH), 125.7 (2 x CH), 67.6 (2 x CH2), 
60.4 (2 x CH2), 56.9 (C), 35.5 (2 x CH2), 14.1 (2 x CH3); HRMS (ES) Exact mass 
calcd for C29H33O8 [M+H]+: 509.2170, found: 509.2173. 
 
(E)-3-(2-Formylphenyl)acrylic acid ethyl ester (357) 
 
To a solution of Pd(OAc)2 (112 mg, 1.00 mmol) and P(o-tol)3 (304 mg, 1.0 mmol) in 
Et3N (40 mL) at 80 oC was added 2-bromobenzaldehyde (0.85 mL, 5.00 mmol), 
followed by ethyl acrylate (0.54 mL, 5.00 mmol). The reaction mixture was stirred at 
80 oC for 18 h, before the addition of 1 M HCl (50 mL), and extraction with CH2Cl2 
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dried (MgSO4) and concentrated in vacuo. Purification of the residue by column 
chromatography (5% EtOAc/hexane→20% EtOAc/hexane) gave 357 as a yellow oil 
(644 mg, 63%). Rf = 0.39 (25% EtOAc/hexanes); IR (film) 2981, 2939, 1713 (C=O), 
1635, 1595, 1569, 1367, 1318, 1286, 1182 cm-1; 1H NMR (360 MHz, CDCl3) δ 
10.31 (1H, s, CHO), 8.52 (1H, d, J = 15.9 Hz, CH=CHC=O), 7.90-7.87 (1H, m, 
ArH), 7.65-7.54 (3H, m, ArH), 6.38 (1H, d, J = 15.9 Hz, CHC=O), 4.30 (2H, q, J = 
7.1 Hz, OCH2CH3), 1.36 (3H, t, J = 7.1 Hz, OCH2CH3); 13C NMR (62.9 MHz, 
CDCl3) δ 191.7 (CH), 166.1 (C), 140.8 (CH), 136.6 (C), 133.9 (CH), 132.1 (CH), 
129.8 (CH), 127.9 (CH), 123.2 (CH), 60.7 (CH2), 14.2 (CH3); HRMS (ES) Exact 
mass calcd for C12H13O3 [M+H]+: 205.0859, found: 205.0860.  
 
(E)-3-[2-((E)-3-Oxobut-1-enyl)phenyl]acrylic acid ethyl ester (358) 
 
To a solution of (E)-3-(2-Formylphenyl)acrylic acid ethyl ester (357) (459.0 mg, 
2.25 mmol) in CHCl3 (25 mL) was added (acetylmethylene)triphenylphosphorane 
(860 mg, 2.70 mmol). The reaction mixture was stirred at room temperature for 20 h, 
before the solvent was removed in vacuo. The resulting residue was purified by 
column chromatography (10% EtOAc/hexane) to give 358 as a yellow oil (401 mg, 
73%). Rf = 0.19 (25% EtOAc/hexanes); IR (film) 2981, 2929, 1713 (C=O), 1673, 
1634, 1609, 1315, 1284, 1258, 1179 cm-1; 1H NMR (360 MHz, CDCl3) δ 8.03 (1H, 
d, J = 15.8 Hz, HC=CHCO2CH2CH3), 7.87 (1H, d, J = 16.1 Hz, HC=CHCOCH3), 
7.60-7.57 (2H, m, ArH), 7.43-7.40 (2H, m, ArH), 6.62 (1H, d, J = 16.1 Hz, 
CHCOCH3), 6.36 (1H, d, J = 15.8 Hz, CHCO2CH2CH3), 4.29 (2H, q, J = 7.1 Hz, 
OCH2CH3), 2.41 (3H, s, CH3C=O), 1.38 (3H, t, J = 7.1 Hz, OCH2CH3); 13C NMR 
(62.9 MHz, CDCl3) δ 197.8 (C), 166.3 (C), 141.1 (CH), 139.8 (CH), 134.4 (C), 134.2 
(C), 130.3 (CH), 130.1 (CH), 130.0 (CH), 127.7 (CH), 127.6 (CH), 122.0 (CH), 60.7 
(CH3), 27.7 (CH2), 14.2 (CH3); HRMS (ES) Exact mass calcd for C15H17O3 [M+H]+: 
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(E)-3-(2-Formylphenyl)acrylic acid tert-butyl ester (361) 
 
To a solution of phthaldialdehyde (1.00 g, 7.45 mmol) in CHCl3 (90 mL), was added 
(triphenylphosphanylidene)acetic acid tert-butyl ester (5.60 g, 14.9 mmol). The 
reaction mixture was heated to 50 oC and stirred for 16 h, after which it was allowed 
to cool to room temperature and the solvent was removed in vacuo. Purification of 
the residue by column chromatography (10% EtOAc/hexane→30% EtOAc/hexane), 
afforded the mono-adduct product 361 as a yellow oil (672 mg, 39%). Rf = 0.50 
(25% EtOAc/hexanes); IR (film) 2978, 1708 (C=O), 1633, 1595, 1568, 1482, 1392, 
1368, 1324, 1289 cm-1; 1H NMR (360 MHz, CDCl3) δ 10.33 (1H, s, CHO), 8.42 
(1H, d, J = 15.9 Hz, CH=CHC=O), 7.88 (1H, dd, J = 7.4, 1.4 Hz, ArH), 7.65-7.58 
(3H, m, ArH), 6.32 (1H, d, J = 15.9 Hz, CHC=O), 1.55 (3H, s, C(CH3)3); 13C NMR 
(62.9 MHz, CDCl3) δ 192.1 (CH), 164.9 (C), 141.9 (CH), 136.7 (C), 136.2 (C), 133.5 
(CH), 132.1 (CH), 129.3 (CH), 128.9 (CH), 128.2 (CH), 43.6 (C), 26.4 (3 x CH3); 
HRMS (ES) Exact mass calcd for C14H17O3 [M+H]+: 232.1149, found: 232.1152.  
 
(E)-3-[2-((E)-3-Oxobut-1-enyl)phenyl]acrylic acid tert-butyl ester (362) 
  
To a solution of (E)-3-(2-formylphenyl)acrylic acid tert-butyl ester (361) (671 mg, 
2.89 mmol) in THF (30 mL) was added (acetylmethylene)triphenylphosphorane 
(1.38 g, 4.34 mmol). The reaction mixture was heated to reflux and stirred for 16 h, 
after which it was allowed to cool to room temperature, and the solvent was removed 
in vacuo. The resulting residue was purified by column chromatography to afford 
cyclisation precursor 362 (406 mg, 52%) as a yellow oil, which solidified on 
standing. Rf = 0.50 (25% EtOAc/hexanes); m.p. 70-72 oC; IR (film) 2978, 2931, 
1707 (C=O), 1673, 1634, 1609, 1477, 1367, 1322, 1255 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 7.95 (1H, d, J = 15.8 Hz, CH=CHCO2C(CH3)3, 7.88 (1H, d, J = 16.1 Hz, 
CH=CHCOCH3), 7.59-7.57 (2H, m, ArH), 7.41-7.39 (2H, m, ArH), 6.62 (1H, d, J = 
16.1 Hz CHCOCH3), 6.30 (1H, d, J = 15.8 Hz, CHCO2C(CH3)3), 2.42 (3H, s, 
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(C), 140.1 (CH), 140.0 (CH), 134.6 (C), 134.1 (C), 130.4 (CH), 130.2 (CH), 129.8 
(CH), 127.6 (CH), 127.5 (CH), 123.9 (CH), 80.9 (C), 28.2 (4 x CH3); HRMS (ES) 




To a solution of K2CO3 (1.38 g, 10.0 mmol) in DMF (10 mL) was added 
salicaldehyde (0.73 mL, 10.0 mmol), followed by ethyl 4-bromocrotonate (1.80 mL, 
10.0 mmol). The reaction mixture was stirred at room temperature for 20 h, before it 
was quenched with saturated aqueous NH4Cl (5 mL) and extracted with Et2O (2 x 5 
mL). The combined organic layers were washed with brine (2 x 20 mL), dried 
(MgSO4) and concentrated in vacuo. Purification of the crude mixture by column 
chromatography (5% EtOAc/hexane→20% EtOAc/hexane) gave 364 as a yellow oil 
(1.31 g, 56%), which displayed spectral data consistent with those described 
previously.78 IR (film) 2982, 1720 (C=O), 1688 (C=O), 1075, 1483, 1459, 1304, 
1289, 1240, 1182 cm-1; 1H NMR (360 MHz, CDCl3) δ 10.53 (1H, d, J = 0.7 Hz, 
CHO), 7.84 (1H, dd, J = 7.7, 1.8 Hz, ArH), 7.53 (1H, ddd, J = 8.4, 7.3, 1.9 Hz, 
ArH), 7.13-7.031 (2H, m, ArH and CH=CHCO2Et) 6.94 (1H, d, J = 8.3 Hz, ArH), 
6.21 (1H, td, J = 15.8, 2.0, 2.0 Hz, CHCO2Et), 4.82 (2H, dd, J = 4.1, 2.1 Hz, OCH2), 
4.21 (2H, q, J = 7.1 Hz, CH2CH3), 1.29 (3H, t, J = 7.1 Hz, CH2CH3); 13C NMR (201 
MHz, CDCl3) δ 189.2 (CH), 189.2 (C), 165.7 (C), 160.1 (C), 141.1 (CH), 135.8 
(CH), 128.7 (CH), 122.4 (CH), 121.3 (CH), 112.5 (CH), 67.0 (CH2), 60.6 (CH2), 
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(E)-4-[2-((E)-3-Oxobut-1-enyl)phenoxy]but-2-enoic acid ethyl ester (365) 
 
To a solution of 2-((E)-4-ethoxypenta-2,4-dienyloxy)benzaldehyde (364) (750 mg, 
3.20 mmol) in CHCl3 (50 mL) was added acetylmethylene)triphenylphosphorane 
(1.12 g, 3.52 mmol). The reaction mixture was stirred at room temperature for 20 h, 
after which the solvent was removed in vacuo. Purification of the residue by column 
chromatography (40% Et2O/hexane→80% Et2O/hexane) gave 365 as a yellow solid 
(1.31 g, 56%). Rf = 0.43 (50% EtOAc/hexanes); m.p. 54-56 oC; IR (film) 2982, 1719 
(C=O), 1667, 1618, 1599, 1487, 1458, 1361, 1304, 1261 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 7.93 (1H, d, J = 16.5 Hz, CH=CHCOCH3), 7.58 (1H, dd, J = 7.6, 1.5 Hz, 
ArH), 7.35 (1H, ddd, J = 8.4, 7.6, 1.5 Hz, ArH), 7.11 (1H, dt, J = 15.8, 4.2 Hz, 
CH=CHCO2CH2CH3), 7.01 (1H, t, J = 7.6 Hz, ArH), 6.87 (1H, app d, J = 8.4 Hz, 
ArH), 6.75 (1H, d, J = 16.5 Hz, CHCOCH3), 6.18 (1H, dt, J = 15.8, 2.0 Hz, 
CHCO2CH2CH3), 4.81 (2H, dd, J = 4.2, 2.0 Hz, OCH2CH=CH), 4.23 (2H, q, J = 7.1 
Hz, OCH2CH3), 2.41 (3H, s, CH3C=O), 1.31 (3H, t, J = 7.1 Hz, OCH2CH3); 13C 
NMR (62.9 MHz, CDCl3) δ 198.8 (C), 165.8 (C), 156.5 (C), 141.8 (CH), 138.1 
(CH), 131.7 (CH), 128.3 (CH), 128.0 (CH), 123.8 (C), 122.4 (CH), 121.5 (CH), 
112.3 (CH), 66.9 (CH2), 60.6 (CH2), 27.2 (CH3), 14.2 (CH3); HRMS (ES) Exact 
mass calcd for C16H19O4 [M+H]+: 275.1278, found: 275.1278.  
 
 (E)-4-[2-{(E)-3-Oxobut-1-enyl}phenyl]but-3-en-2-one (367).77 
The title compound was prepared according to General Procedure D 
from (acetylmethylene)triphenylphosphorane (3.98 g, 12.5 mmol) and purified by 
column chromatography (10% EtOAc/hexane→30% EtOAc/hexane) to give 367 as 
an off-white solid (846 mg, 79%), which displayed spectral data consistent with 
those described previously.77 Rf = 0.18 (25% EtOAc/hexanes); m.p. 89-91 °C; IR 
(CHCl3) 3038, 1675 (C=O), 1653, 1621, 1595, 1474, 1363, 1255, 1217, 1201 cm-1; 
1H NMR (360 MHz, CDCl3) δ 7.84 (2H, d, J = 16.0 Hz, 2 x CH=CHC=O), 7.57 (2H, 
d, J = 5.8, 3.4 Hz, ArH), 7.40 (2H, dd, J = 5.8, 3.4 Hz, ArH), 6.61 (2H, d, J = 16.0 
Hz, 2 x CHC=O), 2.38 (6H, s, 2 x CH3C=O); 13C NMR (62.9 MHz, CDCl3) δ 197.6 
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CH), 27.9 (2 x CH3); HRMS (ES) Exact mass calcd for C14H18NO2 [M+NH4]+: 
232.1332, found: 232.1330.   
 
 (E)-3-[2-{(E)-3-Oxo-3-phenylpropenyl}phenyl]-1-
phenylpropenone (369a).77 The title compound was prepared 
according to General Procedure D, but heated to reflux from 
(phenylacylidene)triphenylphosphorane (4.75 g, 12.5 mmol) and purified by column 
chromatography (10% EtOAc/hexane→20% EtOAc/hexane) followed by 
recrystallization from CH2Cl2/hexane to give 369a as a pale yellow solid (832 mg, 
57%), which displayed spectral data consistent with those described previously.77 Rf 
= 0.35 (25% EtOAc/hexanes); m.p. 125-127 °C; IR (CHCl3) 3061, 3026, 1661 
(C=O), 1604 (C=O), 1475, 1447, 1331, 1301, 1215, 1016 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 8.20 (2H, d, J = 15.6 Hz, 2 x CH=CHC=O), 8.06-8.03 (4H, m, ArH), 7.72 
(2H, dd, J = 5.7, 3.4 Hz, ArH), 7.62-7.57 (2H, m, ArH), 7.53-7.46 (6H, m, ArH), 
7.44 (2H, d, J = 15.6 Hz, 2 x CHC=O); 13C NMR (62.9 MHz, CDCl3) δ 190.0 (2 x 
C), 141.6 (2 x CH), 137.8 (2 x C), 135.3 (2 x C), 132.9 (2 x CH), 130.1 (2 x CH), 
128.7 (4 x CH), 128.6 (4 x CH), 128.1 (2 x CH), 126.0 (2 x CH); HRMS (ES) Exact 
mass calcd for C24H19O2 [M+H]+: 339.1380, found: 339.1385.   
 
 (E)-1-(4-Chlorophenyl)-3-{2-[(E)-3-(4-chlorophenyl)-3-
oxopropenyl]phenyl}propenone (369b). The title compound 
was prepared according to General Procedure D, but heated to reflux from 1-(4-
chlorophenyl)-2-(triphenylphosphanylidene)ethanone (5.18 g, 12.5 mmol) and 
purified by column chromatography (1% MeOH/CHCl3→5% MeOH/CHCl3) 
followed by recrystallization from CH2Cl2/hexane to give 369b as a pale yellow solid 
(895 mg, 44%). Rf = 0.45 (25% EtOAc/hexanes); m.p. 155-157 °C; IR (CHCl3) 
3061, 1662 (C=O), 1604, 1590, 1487, 1400, 1327, 1301, 1215, 1176 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 8.20 (2H, d, J = 15.5 Hz, 2 x CH=CHC=O), 8.02-7.98 (4H, m, 
ArH), 7.72 (2H, dd, J = 5.7, 3.5 Hz, ArH), 7.51-7.48 (6H, m, ArH), 7.40 (2H, d, J = 
15.5 Hz, 2 x CHC=O); 13C NMR (62.9 MHz, CDCl3) δ 188.6 (2 x C), 142.1 (2 x 
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129.0 (4 x CH), 128.3 (2 x CH), 125.5 (2 x CH); HRMS (EI) Exact mass calcd for 




To a solution of phthaldialdehyde (268 mg, 2.00 mmol) in THF (5 mL) at 60 °C was 
added a solution of (acetylmethylene)triphenylphosphorane (637 mg, 2.00 mmol) in 
THF (10 mL) dropwise via cannula over 30 min, and the mixture was stirred at 60 °C 
for 18 h. (Phenacylidene)triphenylphosphorane (761 mg, 4.00 mmol) was added and 
the resulting mixture was stirred at reflux for a further 18 h before being 
concentrated in vacuo. Purification of the residue by column chromatography (10% 
EtOAc/hexane→30% EtOAc/hexane) gave cyclization precursor 371 as an orange 
oil (248 mg, 45%), which displayed spectral data consistent with those described 
previously.77 Rf = 0.27 (25% EtOAc/hexanes); IR (film) 3062, 2924, 2853, 1667 
(C=O), 1605 (C=O), 1333, 1300, 1287, 1256, 1217 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 8.16 (1H, d, J = 15.5 Hz, CH=CHCOPh), 8.06-8.03 (2H, m, ArH), 7.93 
(1H, d, J = 16.1 Hz, CH=CHCOCH3), 7.73-7.70 (1H, m, ArH), 7.64-7.59 (2H, m, 
ArH), 7.55-7.50 (2H, m, ArH), 7.48-7.44 (2H, m, ArH), 7.45 (1H, d, J = 15.5 Hz, 
CHCOPh), 6.64 (1H, d, J = 16.1 Hz, CHCOCH3), 2.41 (3H, s, CH3C=O); 13C NMR 
(62.9 MHz, CDCl3) δ 197.9 (C), 189.8 (C), 141.2 (CH), 139.9 (CH), 137.8 (C), 134.9 
(C), 134.7 (C), 133.0 (CH), 130.5 (CH), 130.2 (CH), 130.1 (CH), 128.6 (2 x CH), 
128.5 (2 x CH), 127.8 (CH), 127.7 (CH), 125.7 (CH), 27.5 (CH3); HRMS (ES) Exact 
mass calcd for C19H17O2 [M+H]+: 277.1223, found: 277.1226. 
 
(E)-4-[(E)-4-Oxo-4-phenylbut-2-enyloxy]-1-phenylbut-2-en-1-one (374)  
 
To a suspension of silica gel-supported NaIO471 (2.00 g) in CH2Cl2 (5 mL) was 
added 1,4-anhydroerythritol (82 µL, 1.00 mmol) and the mixture was stirred at room 
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was then added in one portion and the mixture was stirred for a further 16 h, before it 
was filtered through a sintered glass funnel, using  CH2Cl2 (3 x 10 mL) as eluent. 
The filtrate was concentrated in vacuo and the residue was purified by column 
chromatography (5% EtOAc/hexane→40% EtOAc/hexane) to give the diallyl ether 
374 (192 mg, 63%) as a yellow oil. Rf = 0.26 (25% EtOAc/hexanes); IR (film) 2922, 
1673 (C=O), 1625, 1596, 1484, 1328, 1285, 1212, 1130, 691 cm-1; 1H NMR (360 
MHz, CDCl3) δ 8.00-7.97 (4H, m, ArH), 7.61-7.56 (2H, m, ArH), 7.51-7.46 (4H, m, 
ArH), 7.25 (2H, dt, J = 15.5, 1.9 Hz, 2 x CH=CHC=O), 7.09 (2H, dt, J = 15.5, 4.0 
Hz, 2 x CHC=O), 4.38 (4H, dd, J = 4.0, 1.9 Hz, 2 x OCH2); 13C NMR (62.9 MHz, 
CDCl3) δ 190.1 (2 x C), 143.7 (2 x CH), 137.5 (2 x C), 133.0 (2 x CH), 128.6 (8 x 




2.4.3 Racemic Reductive Michael Cyclisations 
 
General Procedure F: Racemic Reductive Michael Cyclisations with 
Cu(OAc)2·H2O, rac-Binap and TMDS 
 
A solution of Cu(OAc)2·H2O (4.0 mg, 0.02 mmol) and rac-Binap (12.5 mg, 0.02 
mmol) in THF (0.4 mL) was stirred for 15 min before TMDS (71 µL, 0.40 mmol) 
was added. The initially blue solution was stirred until it became yellow (ca. 5 min), 
after which a solution of the substrate (0.40 mmol) in THF (0.4 + 0.2 mL rinse) was 
then added rapidly via cannula. The reaction mixture was stirred at room temperature 
for 18 h. The reaction was quenched by the addition of 1 M HCl (1 mL), and the 
mixture was extracted with CH2Cl2 (3 x 1 mL) and the combined organic layers were 
dried (MgSO4) and concentrated in vacuo. Purification of the residue by column 










Cu(OAc)2·H2O (5 mol %)
rac-Binap (5 mol %)
TMDS (1.0 equiv),THF, rt
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General Procedure G: Racemic Reductive Michael Cyclisations with 
Cu(OAc)2·H2O, dppf and TMDS 
 
A solution of Cu(OAc)2·H2O (4.0 mg, 0.02 mmol) and dppf (11.1 mg, 0.02 mmol) in 
THF (0.4 mL) was stirred for 15 min before TMDS (71 µL, 0.40 mmol) was added. 
The solution was stirred until for 5 min, after which a solution of the substrate (0.40 
mmol) in THF (0.4 + 0.2 mL rinse) was then added rapidly via cannula. The reaction 
mixture was stirred at room temperature for 18 h. The reaction was quenched by the 
addition of 1 M HCl (1 mL), and the mixture was extracted with CH2Cl2 (3 x 1 mL) 
and the combined organic layers were dried (MgSO4) and concentrated in vacuo. 




methoxyphenyl)piperidine-4-carboxylic acid methyl ester 
(335a) 
The title compound was prepared using a slight modification of the quantities 
described in General Procedure F from 327a (159 mg, 0.50 mmol), Cu(OAc)2·H2O 
(5.0 mg, 0.025 mmol), rac-Binap (15.6 mg, 0.025 mmol) and TMDS (88 µL, 0.50 
mmol) and purified by column chromatography (10% EtOAc/hexane→20% 
EtOAc/hexane) to give the substituted piperidine as an oil (35 mg, 22 %). Rf = 0.57 
(50% EtOAc/hexanes); IR (film) 2980, 2955, 2937, 2906, 1731 (C=O), 1512, 1294, 
1248, 1178, 1037 cm-1; 1H NMR (360 MHz, CDCl3) δ 6.88 (2H, d, J = 9.1 Hz, ArH), 
6.82 (2H, d, J = 9.2 Hz, ArH), 3.77 (1H, s, OCH3), 3.71 (3H, s, CO2CH3), 3.69 (3H, 
s, CO2CH3), 3.48-3.35 (2H, m, NCH2CH and NCH2CH2), 2.88-3.63 (5H, m, 
NCH2CH, NCH2CH NCH2CH2, CHCO2CH3 and CH2C=O), 2.33 (1H, ddd, J = 16.1, 
2.6 Hz, CH2C=O), 2.05-1.90 (2H, m, NCH2CH2); 13C NMR (62.9 MHz, CDCl3) δ 
174.0 (C), 173.2 (C), 153.8 (C), 146.2 (C), 119.1 (2 x CH), 114.3 (2 x CH), 55.5 









Cu(OAc)2·H2O (5 mol %)
dppf (5 mol %)
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4-carboxylic acid ethyl ester (335b) 
The title compound was prepared using a slight modification of the quantities 
described in General Procedure G, from 327b (173 mg, 0.50 mmol), Cu(OAc)2·H2O 
(5.0 mg, 0.025 mmol), dppf (13.8 mg, 0.025 mmol) and TMDS (88 µL, 0.50 mmol) 
and purified by column chromatography (10% EtOAc/hexane→20% EtOAc/hexane) 
to give the substituted piperidine as an oil (63 mg, 36%). Rf = 0.32 (25% 
EtOAc/hexanes); IR (film) 2980, 2955, 2937, 2906, 1731 (C=O), 1512, 1294, 1248, 
1178, 1037 cm-1; 1H NMR (360 MHz, CDCl3) δ 6.88 (2H, d, J = 9.2 Hz, ArH), 6.82 
(2H, d, J = 9.2 Hz, ArH), 4.17 (2H, q, J = 7.1 Hz, CH2CH3), 4.15 (2H, q, J = 7.1 Hz, 
CH2CH3), 3.77 (3H, s, CH3), 3.46 (1H, ddd, J = 12.2, 4.4, 1.4 Hz, NCH2CH), 3.39 
(1H, dtd, J = 11.3, 4.4, 1.2 Hz, NCH2CH2), 2.86 (1H, dd, J = 12.2, 2.6 Hz, 
NCH2CH), 2.85-2.62 (4H, m, NCH2CH2, CHC=O, CH2C=O, and NCH2CH), 2.31 
(1H, ddd, J = 15.9, 3.4, 1.1 Hz, CH2C=O), 2.01-1.88 (2H, m, NCH2CH2), 1.28 (3H, 
t, J = 7.1 Hz, CH2CH3), 1.27 (3H, t, J = 7.1 Hz, CH2CH3); 13C NMR (62.9 MHz, 
CDCl3) δ 173.6 (C), 172.9 (C), 153.8 (C), 146.4 (C), 119.1 (2 x CH), 114.3 (2 x CH), 
60.4 (2 x CH2), 55.5 (CH3), 55.3 (CH2), 49.7 (CH2), 43.6 (CH), 33.3 (CH2), 32.9 
(CH), 24.4 (CH2), 14.2 (2 x CH3); HRMS (ES) Exact mass calcd for C19H27NO5 




acid ethyl ester (cis-335c) and Trans-
Ethoxycarbonylmethyl-1-(4-methoxybenzyl)piperidine-4-carboxylic acid ethyl 
ester (trans-335c) 
General Procedure G was followed using 327c (145 mg, 0.40 mmol). Purification by 
column chromatography (10% EtOAc/hexane→50% EtOAc/hexane) gave a 2:1 
mixture of inseparable diastereomers as an oil (69 mg, 48%). Rf = 0.28 (25% 
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1179, 1035 cm-1; 1H NMR (360 MHz, CDCl3) (mixture of diastereomers – not fully 
assigned) δ 7.13 (2H, dd, J = 8.6, 2.4, ArH), 6.78-6.74 (m, ArH), 4.083-3.964 (m), 
3.71 (3H, s, OCH3 major), 3.71 (3H, s, OCH3 minor), 3.408-3.258 (m), 2.84 (1H, dd, 
J = 11.1, 2.0 Hz, NCH2CH major), 2.78-2.75 (m), 2.69-2.63 (m), 2.52-2.46 (m), 
2.36-2.20 (m) 2.11-2.00 (m), 1.87 (1H, td, J = 10.9, 3.2 Hz), 1.79-1.67 (m), 1.19-1.09 
(m, CH2CH3); 13C NMR (62.9 MHz, CDCl3) (mixture of diastereomers – not fully 
assigned) δ 174.5 (C), 173.8 (C), 172.8 (C), 171.9 (C), 158.6 (C), 158.5 (C), 130.1 (2 
x CH), 130.0 (2 x C), 129.9 (2 CH), 113.4 (2 x CH), 113.4 (2 CH), 62.1 (CH2), 62.0 
(CH2), 60.3 (CH2), 60.3 (CH2), 60.2 (CH2), 60.1 (CH2), 57.6 (2 x CH2), 55.1 (2 x 
CH3), 52.4 (CH2), 52.2 (CH2), 46.8 (CH), 37.1 (CH2), 34.6 (CH), 33.0 (CH), 31.9 
(CH2), 28.6 (CH2), 22.2 (CH2), 14.1 (CH3), 14.0 (CH3); HRMS (ES) Exact mass 
calcd for C20H30NO5 [M+H]+: 364.2118, found: 364.2117. 
 
1-Benzyl-3-ethoxycarbonylmethylpiperidine-4-carboxylic acid ethyl ester (trans-
335d) and 1-Benzyl-3-ethoxycarbonylmethylpiperidine-4-carboxylic acid ethyl 
ester (cis-335d) 
 
General procedure G was followed using 327d (126 mg, 0.40 mmol). Purification by 
column chromatography (10% EtOAc/hexane→40% EtOAc/hexane) gave the 
piperidine trans-335d as an oil (18 mg, 14%), followed by the piperidine cis-335d as 
an oil (29 mg, 22%).  
 
Data for trans-335d: Rf = 0.4 (25% EtOAc/hexanes); IR (film) 2979, 1965, 2803, 
1732 (C=O), 1495, 1454, 1376, 1258, 1175, 1032 cm-1; 1H NMR (360 MHz, CDCl3) 
δ 7.25 (4H, app d, J = 4.5 Hz, ArH), 7.25-7.20 (1H, m, ArH), 4.13 (2H, q, J = 7.1 
Hz, CH2CH3), 4.09 (2H, q, J = 7.1 Hz, CH2CH3), 3.52 (1H, d, J = 13.3 Hz, 
NCH2Ph), 3.41 (1H, d, J = 13.3 Hz, NCH2Ph), 2.81-2.74 (2H, m), 2.62-2.53 (2H, 
m), 2.29-2.24 (1H, m), 2.19-2.07 (2H, m), 1.92-1.73 (3H, m) 1.25 (3H, t, J = 7.1 Hz, 
CH2CH3), 1.20 (3H, t, J = 7.1 Hz, CH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 173.9 
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60.3 (CH2), 60.2 (CH2), 56.5 (CH2), 52.7 (CH2), 43.8 (CH), 33.2 (CH), 32.0 (CH2), 
22.4 (CH2), 14.2 (2 x CH3); HRMS (ES) Exact mass calcd for C19H28NO4 [M+H]+: 
334.2013, found: 334.2014. 
Data for cis-335d: Rf = 0.35 (25% EtOAc/hexanes); IR (film) 2936, 2806, 2359, 
2341, 1733 (C=O), 1495, 1455, 1374, 1275, 1182 cm-1; 1H NMR (360 MHz, CDCl3) 
δ 7.31 (4H, app d, J = 4.4 Hz, ArH), 7.26-7.21 (1H, m, ArH), 4.14 (2H, q, J = 7.1 
Hz, CH2CH3), 4.07 (2H, q, J = 7.1 Hz, CH2CH3), 3.53 (1H, d, J = 13.2 Hz, 
NCH2Ph), 3.46 (1H, d, J = 13.2 Hz, NCH2Ph), 2.93 (1H, dd, J = 10.9, 2.9 Hz, 
NCH2CH), 2.85 (1H, dt, J = 11.2, 2.9 Hz, NCH2CH2), 2.48-2.36 (2H, m), 2.20-2.01 
(2H, m),  2.03-1.97 (1H, m), 1.87-1.80 (3H m), 1.26 (3H, t, J = 7.1 Hz, CH2CH3), 
1.19 (3H, t, J = 7.1 Hz, CH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 174.5 (C), 171.9 
(C), 138.2 (C), 128.9 (2 x CH), 128.2 (2 x CH), 127.0 (CH), 62.8 (CH2), 60.4 (CH2), 
60.3 (CH2), 57.8 (CH2), 52.5 (CH2), 46.8 (CH), 37.2 (CH2), 34.7 (CH), 28.7 (CH2), 
14.2 (CH3), 14.1 (CH3); HRMS (ES) Exact mass calcd for C19H28NO4 [M+H]+: 
334.2013, found: 334.2010. 
 
Cis-1-Ethoxycarbonylmethylindan-2-carboxylic acid ethyl ester 
(351a) 
The title compound was prepared according to General Procedure F, but heated to 50 
oC from 341a (104 mg, 0.40 mmol) and purified by column chromatography (5% 
EtOAc/hexane) to give an 8:1 inseparable mixture of diastereomers as a colourless 
oil (63 mg, 57%). Rf = 0.57 (25% EtOAc/hexanes); IR (film) 2981, 2938, 1734 
(C=O), 1478, 1374, 1308, 1295, 1254, 1214, 1178 cm-1; 1H NMR (360 MHz, CDCl3) 
(major diastereomer) δ 7.24-7.16 (4H, m, ArH), 4.16 (2H, q, J = 7.1 Hz, CH2CH3), 
4.15 (2H, q, J = 7.1 Hz, CH2CH3), 3.97 (1H, app q, J = 7.7 Hz, CHCH2C=O), 3.50 
(1H, app q, J = 8.1 Hz, CH2CHC=O), 3.32 (1H, dd, J = 15.9, 8.4 Hz, CH2CHC=O), 
3.06 (1H, dd, J = 15.9, 8.0 Hz, CH2CHC=O), 2.64 (1H, dd, J = 16.1, 7.1 Hz, 
CHCH2C=O), 2.53 (1H, dd, J = 16.1, 8.0 Hz, CHCH2C=O), 1.29 (3H, t, J = 7.1 Hz, 
CH2CH3), 1.26 (3H, t, J = 7.1 Hz, CH2CH3); 13C NMR (62.9 MHz, CDCl3) (major 
diastereomer) δ 173.4 (C), 172.1 (C), 143.9 (C), 141.3 (C), 127.3 (CH), 126.7 (CH), 
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34.0 (CH2), 14.2 (2 x CH3); HRMS (ES) Exact mass calcd for C16H21O4 [M+H]+: 
277.1434, found: 277.1435. 
 
Cis-1-Methoxycarbonylmethylindan-2-carboxylic acid methyl 
ester (351b) 
The title compound was prepared according to General Procedure F, but heated to 50 
oC from 341b (98 mg, 0.40 mmol) and purified by column chromatography (5% 
EtOAc/hexane) to give a 5:1 inseparable mixture of diastereomers as a colourless oil 
(47 mg, 48%). Rf = 0.33 (25% EtOAc/hexanes); IR (film) 2951, 1736 (C=O), 1479, 
1436, 1366, 1294, 1254, 1219, 1195, 1169 cm-1; 1H NMR (360 MHz, CDCl3, major) 
δ 7.26-7.16 (4H, m, ArH), 3.97 (1H, app q, J = 7.7 Hz, CHCH2C=O), 3.70 (3H, s, 
CH3), 3.69 (3H, s, CH3), 3.53 (1H, app q, J = 8.1 Hz, CH2CHC=O), 3.33 (1H, dd, J 
= 15.9, 8.1 Hz, CH2CHC=O), 3.01 (1H, dd, J = 15.9, 8.1 Hz, CH2CHC=O), 2.63 
(1H, dd, J = 16.2, 7.7 Hz, CHCH2C=O), 2.53 (1H, dd, J = 16.2, 7.7 Hz, 
CHCH2C=O); 13C NMR (62.9 MHz, CDCl3) δ 173.8 (C), 172.6 (C), 143.8 (C), 141.2 
(C), 127.4 (CH) 126.8 (CH), 124.6 (CH), 123.8 (CH), 51.6 (CH3), 51.5 (CH3), 47.5 
(CH), 43.1 (CH), 36.0 (CH2), 34.0 (CH2); HRMS (ES) Exact mass calcd for 
C14H17O4 [M+H]+: 249.1121, found: 249.1122. 
 
Cis-1-Ethoxycarbonylmethyl-5,6-difluoroindan-2-carboxylic 
acid ethyl ester (353a) 
The title compound was prepared according to General Procedure F, but using half of 
all quantities from 347a (62 mg, 0.20 mmol) and purified by column 
chromatography (2.5% EtOAc/hexane→5% EtOAc/hexane) to give the indane 353a 
as a colourless oil (30 mg, 48%). Rf = 0.57 (25% EtOAc/hexanes); IR (film) 2984, 
1733 (C=O), 1498, 1375, 1338, 1291, 1257, 1181, 1095, 1034 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.00 (1H, app t, JH-F = 7.2 Hz, ArH), 6.98 (1H, app t, JH-F = 7.2 Hz, 
ArH) 4.20-4.11 (4H, m, 2 x CH2CH3), 3.92-3.85 (1H, m, CHCH2C=O), 3.51 (1H, 
app q, J = 8.1 Hz CH2CHC=O), 3.25 (1H, dd, J = 16.1, 7.9 Hz, CH2CHC=O), 2.99 
(1H, dd, J = 16.1, 8.0 Hz, CH2CHC=O), 2.60 (1H, dd, J = 16.3, 6.7 Hz, 
CHCH2C=O), 2.47 (1H, dd, J = 16.3, 8.5 Hz, CHCH2C=O), 1.27 (3H, t, J = 7.1, 
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171.7 (C), 149.9 (C, dd, JC-F = 241.4, 8.4 Hz), 149.5 (C, dd, JC-F = 243.8, 11.2 Hz), 
139.8 (C, dd, JC-F = 5.8, 3.1 Hz), 137.3 (C, dd, JC-F = 6.4, 3.2 Hz), 113.0, (2 x CH, t, 
JC-F = 17.7 Hz), 60.8 (CH2), 60.7 (CH2), 48.2 (CH), 42.6 (CH), 35.8 (CH2), 33.5 
(CH2), 14.2 (2 x CH3); HRMS (ES) Exact mass calcd for C16H22F2NO4 [M+NH4]+: 
330.1511, found: 330.1515. 
 
 Cis-1-tert-Butoxycarbonylmethyl-5,6-difluoroindan-2-
carboxylic acid tert-butyl ester (353b) 
The title compound was prepared according to General Procedure F from 347b (146 
mg, 0.40 mmol) and purified by column chromatography (2.5% 
EtOAc/hexane→10% EtOAc/hexane) to give the indane 353b as a colourless oil (72 
mg, 49%). Rf = 0.67 (25% EtOAc/hexanes); IR (film) 2979, 2933, 1727 (C=O), 
1498, 1368, 1341, 1291, 1257, 1152, 844 cm-1; 1H NMR (250 MHz, CDCl3) δ 7.03-
6.95 (2H, m, ArH), 3.79 (1H, app q, J = 7.7 Hz, CHCH2C=O), 3.39 (1H, app q, J = 
7.8 Hz, CH2CHC=O), 3.15 (1H, dd, J = 16.0, 7.8 Hz, CH2CHC=O), 2.94 (1H, dd, J 
= 16.0, 7.8 Hz, CH2CHC=O), 2.56 (1H, dd, J = 15.8, 5.8 Hz, CHCH2C=O), 2.38 
(1H, dd, J = 15.8, 9.4 Hz, CHCH2C=O), 1.45 (18H, s, 2 x C(CH3)3); 13C NMR (62.9 
MHz, CDCl3) δ 172.1 (C), 171.2 (C), 149.7 (C, dd, JC-F = 243.1, 10.3 Hz), 149.3 (C, 
dd, JC-F = 243.6, 11.8 Hz), 140.2 (C, dd, JC-F = 5.7, 3.0 Hz), 137.5 (C, dd, JC-F = 6.2, 
3.2 Hz), 113.0, (2 x CH, dd, JC-F = 18.2, 4.8 Hz), 81.0 (C), 80.9 (C), 49.3 (CH), 42.8 
(CH), 36.6 (CH2), 33.6 (CH2), 28.0 (6 x CH3); HRMS (ES) Exact mass calcd for 
C20H26F2O4Na [M+Na]+: 391.1691, found: 391.1694. 
 
Cis-1-Carboxymethyl-5,6-difluoroindan-2-carboxylic acid (385) 
 
Trifluoroacetic acid (approximately 1 mL) was added to 353b (38 mg, 0.10 mmol) 
and the mixture was stirred at room temperature for 1 h. The excess trifluoroacetic 
acid was removed in vacuo and the bis-acid was isolated as a yellow solid (> 
quantitative yield) and used without further pruification. mp. 162-164 oC; 1H NMR 
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CHCH2C=O), 3.55 (1H, app q, J =  8.0 Hz, CH2CHC=O), 3.21 (1H, dd, J = 16.0, 
7.8 Hz, CH2CHC=O), 3.03 (1H, dd, J = 16.0, 8.0 Hz, CH2CHC=O), 2.68 (1H, dd, J 
= 16.3, 6.3 Hz, CHCH2C=O), 2.51 (1H, dd, J = 16.3, 8.8 Hz, CHCH2C=O); 13C 
NMR (150.9 MHz, CD3OD) δ 176.3 (C), 175.5 (C), 151.20 (C, dd, JC-F = 244.6, 13.3 
Hz), 150.74 (C, dd, JC-F = 243.8, 13.3 Hz), 142.07 (C, dd, JC-F = 6.3, 3.0 Hz), 139.58 
(C, dd, JC-F = 6.3, 2.9 Hz), 114.23 (CH, d, JC-F = 18.1 Hz), 113.80 (CH, d, JC-F = 18.1 
Hz), 49.6 (CH), 43.9 (CH), 36.6 (CH2), 34.6 (CH2); HRMS (ES) Exact mass calcd 
for C12H11F2O4 [M+H]+: 257.0620, found: 257.0622. 
 
Cis-5,6-Difluoro-1-methoxycarbonylmethylindan-2-carboxylic acid methyl ester 
(355) 
 
Trimethylsilyldiazomethane (2.0 M in Et2O, 75 µl, 0.15 mmol) was added dropwise 
over 1 min to a solution of 385 (19.5 mg, 0.08 mmol) in MeOH (0.1 mL) and toluene 
(0.15 mL), and the mixture was stirred at room temperature for 16 h. The mixture 
was concentrated in vacuo and the residue was purified by column chromatography 
(5% EtOAc/hexane→20% EtOAc/hexane) to give the bis-methyl ester 355 (7 mg, 
32%) as a colourless oil. Rf = 0.37 (25% EtOAc/hexanes); IR (film) 2955, 1736 
(C=O), 1497, 1438, 1336, 1264, 1170, 912, 825, 739 cm-1; 1H NMR (600 MHz, 
CDCl3) δ 7.03-6.97 (2H, m, ArH), 3.90 (1H, app q, J = 7.7 Hz, CHCH2C=O), 3.71 
(3H, s, OCH3), 3.70 (3H, s, OCH3), 3.54 (1H, app q, J = 8.1 Hz, CH2CHC=O), 3.26 
(1H, dd, J = 16.0, 8.2 Hz, CH2CHC=O), 3.01 (1H, dd, J = 16.0, 8.0 Hz, 
CH2CHC=O), 2.60 (1H, dd, J = 16.4, 7.0 Hz, CHCH2C=O), 2.49 (1H, dd, J = 16.4, 
8.1 Hz, CHCH2C=O); 13C NMR (150.9 MHz, CDCl3) δ 173.2 (C), 172.2 (C), 150.0 
(C, dd, JC-F = 246.9, 13.2 Hz), 149.6 (C, dd, JC-F = 245.9, 13.2 Hz), 139.7 (C, dd, JC-
F = 5.8, 3.2 Hz), 137.2 (C, dd, JC-F = 6.2, 3.1 Hz), 113.4-113.1 (m, CH), 112.9-112.7 
(m, CH), 51.8 (2 x CH3), 48.0 (CH), 42.7 (CH), 35.7 (CH2), 33.5 (CH2); HRMS (ES) 
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Cis-2-Acetylindan-1-yl)propan-2-one (cis-375),  trans-2-Acetylindan-1-
yl)propan-2-one (trans-375), and 4-[2-((E)-3-Hydroxybut-1-enyl)phenyl]butan-
2-one (386) 
  
General Procedure F was followed using 367 (86 mg, 0.4 mmol). Purification by 
column chromatography (5% EtOAc/hexane→20% EtOAc/hexane) gave the indane 
cis-375 as a colourless oil (42 mg, 49%), followed by the indane trans-375 as a 
colourless oil (10 mg, 12%), followed by the allylic alcohol 386 as a colourless oil 
(13 mg, 15%). 
 
Data for cis-375: Rf = 0.29 (25% EtOAc/hexanes); IR (film) 2942, 2855, 1712 
(C=O), 1478, 1459, 1420, 1365, 1259, 1206, 1164 cm-1; 1H NMR (360 MHz, CDCl3) 
δ 7.22-7.12 (4H, m, ArH), 4.02 (1H, td, J = 8.0, 5.9 Hz, CHCH2C=O), 3.65 (1H, dt, 
J = 9.4, 7.8 Hz, CH2CHC=O), 3.26 (1H, dd, J = 16.0, 9.5 Hz, CH2CHC=O), 2.92 
(1H, dd, J = 16.0, 7.8 Hz, CH2CHC=O), 2.82 (1H, dd, J = 18.2, 8.0 Hz, 
CHCH2C=O), 2.52 (1H, dd, J = 18.2, 5.9 Hz, CHCH2C=O), 2.22 (3H, s, CH3), 2.08 
(3H, s, CH3); 13C NMR (62.9 MHz, CDCl3) δ 210.4 (C), 207.4 (C), 144.9 (C), 141.2 
(C), 127.2 (CH) 126.9 (CH), 124.6 (CH), 123.8 (CH), 54.7 (CH), 45.0 (CH2), 41.9 
(CH), 33.5 (CH2), 31.0 (CH3) 30.5 (CH3); HRMS (ES) Exact mass calcd for 
C14H17O2 [M+H]+: 217.1223, found: 217.1225. 
 
Data for trans-375: Rf = 0.17 (25% EtOAc/hexanes); IR (film) 2945, 2923, 1711 
(C=O), 1480, 1458, 1422, 1361, 1259, 1162, 1042 cm-1; 1H NMR (360 MHz, CDCl3) 
δ 7.21-7.18 (3H, m, ArH), 7.14-7.11 (1H, m, ArH), 4.01-3.95 (1H, m, CHCH2C=O), 
3.30-3.19 (1H, m, CH2CHC=O), 3.14-3.04 (2H, m, CH2CHC=O and CH2CHC=O), 
2.95 (1H, dd, J = 16.8, 5.9 Hz, CHCH2C=O), 2.67 (1H, dd, J = 16.8, 8.1 Hz, 
CHCH2C=O), 2.28 (3H, s, CH3), 2.21 (3H, s, CH3); 13C NMR (62.9 MHz, CDCl3) δ 
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123.6 (CH), 58.1 (CH), 49.1 (CH2), 42.3 (CH), 34.8 (CH2), 30.3 (CH3) 28.4 (CH3); 
HRMS (ES) Exact mass calcd for C14H17O2 [M+H]+: 217.1223, found: 217.1224. 
 
Data for 386: Rf = 0.12 (25% EtOAc/hexanes); IR (film) 3448 (OH), 2970, 2925, 
1714 (C=O), 1452, 1364, 1161, 1061, 967, 754 cm-1; 1H NMR (360 MHz, CDCl3) δ 
7.45-7.43 (1H, m, ArH), 7.20-7.13 (1H, m, ArH), 6.80 (1H, dd, J = 15.7, 1.1 Hz, 
CH=CHCH(OH)), 6.16 (1H, dd, J = 15.7, 6.3 Hz, CH=CHCH(OH)), 4.52 (1H, pd, J 
= 6.3, 1.1 Hz, CH(OH)), 2.96 (2H, t, J = 7.8 Hz, CH2CH2C=O), 2.70 (2H, t, J = 7.8 
Hz, CH2CH2C=O), 2.14 (3H, s, CH3C=O, 1.84 (1H br s, OH), 1.39 (3H, d, J =  6.3 
Hz, CH(OH)CH3); 13C NMR (62.9 MHz, CDCl3) δ 208.0 (C), 138.3 (C), 135.8 
(CH), 135.5 (C), 129.3 (CH), 127.8 (CH), 126.6 (CH), 126.5 (CH), 126.3 (CH), 68.9 
(CH), 44.5 (CH2), 30.1 (CH3), 27.1 (CH2), 23.5 (CH3); HRMS (ES) Exact mass calcd 
for C14H22NO2 [M+NH4]+: 236.1645, found: 236.1649. 
 
Trans-2-Benzoylindan-1-yl]-1-phenylethanone (trans-377a)79 and Cis-2-
Benzoylindan-1-yl]-1-phenylethanone (cis-377a) 
 
A solution of CuF(PPh3)3.2MeOH (20 mg, 0.02 mmol), dppf (11.1 mg, 0.02 mmol) 
and 369a (135 mg, 0.4 mmol) in toluene (1.5 mL) was stirred for 30 min at room 
temperature, after which a solution of PMHS (24 µL, 0.4 mmol) in toluene (0.4 mL) 
was added rapidly via cannula. The reaction mixture was stirred at room temperature 
for 24 h before the addition of a solution of more CuF(PPh3)3.2MeOH (20 mg, 0.02 
mmol), dppf (11.1 mg, 0.02 mmol), and PMHS (24 µL, 0.4 mmol) in toluene (0.5 
mL) was added rapidly via cannula. The reaction was quenched by the addition of 1 
M HCl (5 mL), and the mixture was extracted with CH2Cl2 (3 x 5 mL) and the 
combined organic layers were dried (MgSO4) and concentrated in vacuo. Purification 
of the residue by column chromatography (5% EtOAc/hexane→20% EtOAc/hexane) 
gave the indane trans-377a as a white solid (43 mg, 32%) that displayed spectral 
data consistent with those reported previously,79 followed by the indane cis-377a (4 
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Data for trans-377a: Rf = 0.50 (25% EtOAc/hexanes); IR (film) 2981, 2938, 1734 
(C=O), 1478, 1374, 1308, 1295, 1254, 1214, 1178 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 7.99-7.93 (4H, m, ArH), 7.58-7.53 (2H, m, ArH), 7.48-7.42 (4H, m, ArH), 7.24-
7.19 (4H, m, ArH), 4.44 (1H, app q, J = 6.8 Hz, CHCH2C=O), 4.15 (1H, dt, J = 9.2, 
7.0 Hz, CH2CHC=O), 3.53 (1H, dd, J = 16.7, 5.9 Hz, CHCH2C=O), 3.45 (1H, dd, J 
= 16.0, 9.2 Hz, CH2CHC=O), 3.27 (1H, dd, J = 16.7, 7.7 Hz, CHCH2C=O), 3.12 
(1H, dd, J = 16.0, 7.4 Hz, CH2CHCOPh); 13C NMR (62.9 MHz, CDCl3) δ 200.7 (C), 
198.8 (C), 144.9 (C), 140.7 (C), 136.9 (C), 136.6 (C), 133.1 (CH), 133.0 (CH), 128.6 
(4 x CH), 128.5 (2 x CH), 128.1 (2 x CH), 127.1 (CH), 127.0 (CH), 124.4 (CH), 
123.9 (CH), 52.6 (CH), 43.9 (CH2), 43.1 (CH), 36.9 (CH2); HRMS (ES) Exact mass 
calcd for C24H21O2 [M+H]+: 341.1536, found: 341.1538. 
 
Data for cis-377a: Rf = 0.55 (25% EtOAc/hexanes); IR (film) 2925, 1725, 1682 
(C=O), 1596, 1448, 1365, 1222, 1152, 749, 690 cm-1; 1H NMR (500 MHz, CDCl3) δ 
8.03 (2H, d, J = 7.3 Hz, ArH), 7.74 (2H, d, J = 7.3 Hz, ArH), 7.59 (1H, t, J = 7.4 
Hz, ArH), 7.49 (3H, t, J = 7.8 Hz, ArH), 7.36 (2H, t, J = 7.8 Hz, ArH), 7.29 (1H, d, 
J = 7.4 Hz, ArH), 7.24 (1H, d, J = 7.4 Hz, ArH), 7.20 (1H, t, J = 7.4 Hz, ArH), 7.15 
(1H, t, J = 7.4 Hz, ArH), 4.61 (1H, dt, J = 9.3, 7.9 Hz, CH2CHC=O), 4.38 (1H, app 
q, J = 7.2 Hz, CHCH2C=O), 3.65 (1H, dd, J = 16.0, 9.4 Hz, CH2CHC=O), 3.16 (1H, 
dd, J = 17.8, 7.9 Hz, CHCH2C=O), 3.11 (1H, dd, J = 17.8, 6.5 Hz, CHCH2C=O), 
3.07 (1H, dd, J = 16.0, 7.7 Hz, CH2CHC=O); 13C NMR (151 MHz, CDCl3) δ 200.8 
(C), 198.5 (C), 145.0 (C), 141.3 (C), 137.0 (C), 137.0 (C), 133.3 (CH), 132.9 (CH), 
128.8 (3 x CH), 128.4 (2 x CH), 127.9 (3 x CH), 127.2 (CH), 126.8 (CH), 124.7 
(CH), 124.5 (CH), 50.4 (CH), 43.4 (CH2), 40.1 (CH2), 34.0 (CH); HRMS (ES) Exact 
mass calcd for C24H21O2 [M+H]+: 341.1536, found: 341.1539. 
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Trans-2-(4-Chlorobenzoyl)indan-1-yl]-1-(4-chlorophenyl)ethanone (trans-377b) 
and Cis-2-(4-Chlorobenzoyl)indan-1-yl]-1-(4-chlorophenyl)ethanone (cis-377b) 
 
A solution of CuF(PPh3)3·2MeOH (20 mg, 0.02 mmol), rac-Binap (12.4 mg, 0.02 
mmol) and 369b (163 mg, 0.40 mmol) in toluene (1.5 mL) was stirred for 30 min at 
room temperature, after which a solution of PMHS (24 µL, 0.40 mmol) in toluene 
(0.4 mL) was added rapidly via cannula. The reaction mixture was stirred at room 
temperature for 24 h before a solution of more CuF(PPh3)3·2MeOH (20 mg, 0.02 
mmol), rac-Binap (12.4 mg, 0.02 mmol), and PMHS (24 µL, 0.40 mmol) in toluene 
(0.5 mL) was added rapidly via cannula. After stirring for a further 24 h at room 
temperature the reaction was quenched carefully by the addition of 1 M HCl (5 mL), 
the mixture was extracted with CH2Cl2 (3 x 5 mL) and the combined organic layers 
were dried (MgSO4) and concentrated in vacuo. Purification of the residue by 
column chromatography (2.5% EtOAc/hexane→10% EtOAc/hexane) gave the 
indane trans-377b as a white solid (63 mg, 40%), followed by the indane cis-377b (3 
mg, 2%) as a yellow oil. 
 
Data for trans-377b: m.p. 130-132 °C; Rf = 0.55 (25% EtOAc/hexanes); IR (film) 
2925, 1680 (C=O), 1589, 1570, 1401, 1220, 1092, 1012, 817, 750 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 7.93 (2H, d, J = 8.5 Hz, ArH), 7.88 (2H, d, J = 8.5 Hz, ArH),  
7.45 (2H, d, J = 8.5 Hz, ArH), 7.42 (2H, d, J = 8.5 Hz, ArH), 7.28-7.21 (4H, m, 
ArH), 4.43-4.39 (1H, m, CHCH2C=O), 4.08 (1H, dt, J = 9.2, 7.1 Hz, CH2CHC=O), 
3.53 (1H, dd, J = 16.7, 5.5 Hz, CHCH2C=O), 3.44 (1H, dd, J = 16.0, 9.2 Hz, 
CH2CHC=O), 3.21 (1H, dd, J = 16.7, 8.2 Hz, CHCH2C=O), 3.09 (1H, dd, J = 16.0, 
7.4 Hz, CH2CHC=O); 13C NMR (62.9 MHz, CDCl3) δ 199.4 (C), 197.6 (C), 144.4 
(C), 140.4 (C), 139.7 (C), 139.4 (C), 135.0 (C), 134.8 (C), 129.9 (2 x CH), 129.5 (2 x 
CH), 128.9 (4 x CH), 127.3 (CH), 127.1 (CH), 124.4 (CH), 123.7 (CH), 52.5 (CH), 
43.8 (CH2), 43.0 (CH), 36.9 (CH2); HRMS (ES) Exact mass calcd for 
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Data for cis-377b: Rf = 0.87 (25% EtOAc/hexanes); IR (film) 2925, 2802, 1682 
(C=O), 1589, 1263, 1092, 913, 834, 743, 516 cm-1; H NMR (600 MHz, CDCl3) 7.93 
(2H, d, J = 8.6 Hz, ArH), 7.68 (2H, d, J = 8.6 Hz, ArH), 7.45 (2H, d, J = 8.6 Hz, 
ArH), 7.35 (2H, d, J = 8.6 Hz, ArH), 7.30-7.27 (1H, m, ArH), 7.23-7.21 (2H, m, 
ArH), 7.19-7.16 (1H, m, ArH), 4.55 (1H, app q, J = 8.6 Hz, CH2CHC=O), 4.34 (1H, 
app q, J = 7.3 Hz, CHCH2C=O), 3.59 (1H, dd, J = 16.0, 9.3 Hz, CH2CHC=O), 3.20 
(1H, dd, J = 17.7, 7.3 Hz, CHCH2C=O), 3.10-3.06 (2H, m, CHCH2C=O and 
CH2CHC=O); 13C NMR (75.5 MHz, CDCl3) δ 199.913 (C), 197.2 (C), 144.7 (C), 
141.2 (C), 139.8 (C), 139.5 (C), 135.4 (C), 135.2 (C), 129.7 (2 x CH), 129.3 (2 x 
CH), 129.1 (2 x CH), 128.8 (2 x CH), 127.4 (CH), 126.9 (CH), 124.7 (CH), 124.2 
(CH), 49.9 (CH), 43.4 (CH), 40.2 (CH2), 34.2 (CH2); HRMS (ES) Exact mass calcd 




A solution of CuF(PPh3)3·2MeOH (5 mg, 0.005 mmol), rac-Binap (3.1 mg, 0.005 
mmol) and 374 (61.2 mg, 0.20 mmol) in toluene (0.5 mL) was stirred for 30 min at 
room temperature, after which a solution of PMHS (6 µL, 0.10 mmol) in toluene (0.2 
mL) was added rapidly via cannula. The reaction mixture was stirred at room 
temperature for 24 h before a solution of more CuF(PPh3)3·2MeOH (5 mg, 0.005 
mmol), rac-Binap (3.4 mg, 0.005 mmol), and PMHS (6 µL, 0.10 mmol) in toluene 
(0.3 mL) was added rapidly via cannula. After stirring at room temperature for a 
further 24 h, the reaction was quenched carefully by the addition of 1 M HCl (2 mL), 
the mixture was extracted with CH2Cl2 (3 x 2 mL), and the combined organic layers 
were dried (MgSO4) and concentrated in vacuo. Purification of the residue by 
column chromatography (5% EtOAc/hexane→50% EtOAc/hexane) gave the 
tetrahydropyran 378 (23 mg, 36%) as a pale yellow oil, which displayed spectral data 
consistent with those described previously.80 Rf = 0.26 (25% EtOAc/hexanes); IR 
(film) 2923, 2852, 1678 (C=O), 1596, 1448, 1280, 1213, 1138, 959, 700 cm-1; 
1H NMR (360 MHz, CDCl3) δ 7.99 (4H, dd, J = 13.5, 7.3 Hz, ArH), 7.62-7.43 (6H, 
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and CHC=O), 3.36 (1H, t, J = 10.8 Hz, OCH2CH), 3.14 (1H, dd, J = 15.5, 3.6 Hz, 
CH2C=O), 2.90-2.80 (1H, m, OCH2CH), 2.63 (1H, dd, J = 15.5, 9.3 Hz, CH2C=O), 
1.92 (1H, ddd, J = 13.5, 6.0, 2.6 Hz, OCH2CH2), 1.82-1.70 (1H, m, OCH2CH2); 13C 
NMR (62.9 MHz, CDCl3) δ 201.6 (C), 198.7 (C), 136.4 (C), 136.1 (C), 133.4 (CH), 
133.2 (CH), 128.8 (2 x CH), 128.6 (2 x CH), 128.3 (2 x CH), 128.3 (2 x CH), 70.8 
(CH2), 67.3 (CH2), 47.1 (CH), 39.8 (CH2), 33.8 (CH), 30.3 (CH2); LRMS (ES) 639 
([2M+Na]+, 100), 331 ([M+Na]+, 78). 
 
Trans-2-Benzoylindan-1-yl]propan-2-one (trans-379) and Cis-2-benzoylindan-1-
yl]propan-2-one (cis-379) 
 
A solution of CuF(PPh3)3·2MeOH (20 mg, 0.02 mmol), rac-Binap (12.4 mg, 0.02 
mmol) and 371 (110 mg, 0.40 mmol) in toluene (1.0 mL) was stirred for 30 min at 
room temperature, after which a solution of PMHS (24 µL, 0.40 mmol) in toluene 
(0.6 mL) was added rapidly via cannula. The reaction mixture was stirred at room 
temperature for 24 h before the reaction was quenched by the addition of 1 M HCl (5 
mL), the mixture was extracted with CH2Cl2 (3 x 5 mL) and the combined organic 
layers were dried (MgSO4) and concentrated in vacuo. Purification of the residue by 
column chromatography (5% EtOAc/hexane→20% EtOAc/hexane) gave the indane 
cis-379 (10 mg, 9%) as a yellow oil, followed by the indane trans-379 (24 mg, 22%) 
as a yellow oil. 
  
Data for trans-379 (isolated as a 5:1 mixture of inseparable regioisomers): Rf = 0.31 
(25% EtOAc/hexanes); IR (film) 2920, 1712 (C=O), 1681 (C=O), 1448, 1361, 1230, 
1161, 750, 721, 699 cm-1; 1H NMR (500 MHz, CDCl3) (major regioisomer) δ 8.00 
(2H, dd, J = 8.3, 1.2 Hz, ArH), 7.59 (1H, tt, J = 7.4, 1.0 Hz, ArH), 7.50 (2H, t, J = 
7.7 Hz, ArH), 4.28 (1H, app q, J = 6.8 Hz, CHCH2COCH3), 4.06 (1H, dt, J = 9.0, 
7.5 Hz, CH2CHCOPh), 3.41 (1H, dd, J = 16.0, 9.3 Hz, CH2CHCOPh), 3.08 (1H, dd, 
J = 16.0, 7.9 Hz, CH2CHCOPh), 2.99 (1H, dd, J = 16.2, 6.0 Hz, CHCH2COCH3), 
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of the minor regioisomer were observed at δ 4.16 (1H, dt, J = 8.4, 6.0 Hz, 
CHCH2COPh or CH2CHCOCH3), 3.49 (1H, dd, J = 17.3, 5.2 Hz, CHCH2COPh or 
CH2CHCOCH3) 3.14 (1H, dd, J = 14.6, 6.5 Hz, CHCH2COPh or CH2CHCOCH3), 
2.32 (3H, s, CH3); 13C NMR (75.5 MHz, CDCl3) (major regioisomer) δ 207.7 (C), 
200.7 (C), 144.5 (C), 140.6 (C), 136.6 (C), 133.1 (CH), 128.7 (2 x CH), 128.5 (2 x 
CH), 127.1 (CH), 127.0 (CH), 124.3 (CH), 123.6 (CH), 52.5 (CH), 48.7 (CH2), 42.6 
(CH), 36.9 (CH2), 30.2 (CH3); HRMS (ES) Exact mass calcd for C19H22NO2 
[M+NH4]+: 296.1645, found: 296.1646. 
 
Data for cis-379 (isolated as an 8:1 mixture of inseparable regioisomers): Rf = 0.45 
(25% EtOAc/hexanes); IR (film) 2925, 1708 (C=O), 1679 (C=O), 1596, 1448, 1364, 
1251, 1228, 1162, 751 cm-1; 1H NMR (600 MHz, CDCl3) (Major regioisomer) δ 8.03 
(2H, dd, J = 8.4, 1.2 Hz, ArH), 7.62-7.58 (1H, m, ArH), 7.50 (2H, t, J = 8.4, 1.2 Hz, 
ArH), 7.27-7.16 (4H, m, ArH), 4.51 (1H, dt, J = 9.5, 7.8 Hz, CH2CHCOPh), 4.17 
(1H, app q, J = 7.4 Hz, CHCH2COCH3), 3.56 (1H, dd, J = 15.9, 9.5 Hz, 
CH2CHCOPh), 3.01 (1H, dd, J = 15.9, 7.7 Hz, CH2CHCOPh), 2.64 (1H, dd, J = 
17.8, 6.7 Hz, CHCH2COCH3), 2.59 (1H, dd, J = 17.8, 7.6 Hz, CHCH2COCH3), 1.95 
(3H, s, CH3); Diagnostic peaks of the minor regioisomer were observed at δ 4.27 
(1H, app q, J = 6.9 Hz, CHCH2COPh), 3.77 (1H, dt, J = 9.1, 7.8 Hz, 
CH2CHCOCH3), 3.36 (1H, dd, J = 18.0, 7.6 Hz, CHCH2COPh), 3.35 (1H, dd, J = 
15.8, 9.3 Hz, CH2CHCOCH3), 3.09 (1H, dd, J = 18.0, 6.1 Hz, CHCH2COPh), 2.99 
(1H, dd, J = 15.8, 7.7 Hz, CH2CHCOCH3), 2.26 (3H, s, CH3); 13C NMR (75.5 MHz, 
CDCl3) (major regioisomer) δ 207.1 (C), 200.9 (C), 145.0 (C), 141.3 (C), 137.0 (C), 
133.4 (CH), 128.8 (2x CH), 128.3 (2 x CH), 127.2 (CH), 126.8 (CH), 124.7 (CH), 
124.2 (CH), 50.0 (CH), 44.9 (CH2), 43.1 (CH), 33.9 (CH2), 30.7 (CH3); HRMS (ES) 
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2.4.4 Enantioselective Reductive Michael Cyclisations 
 
General Procedure H: Enantioselective Reductive Michael Cyclisations with 
Cu(OAc)2·H2O and TMDS 
 
A solution of Cu(OAc)2·H2O (4.0 mg, 0.02 mmol) and the appropriate chiral ligand 
(0.02 mmol) in THF (0.4 mL) was stirred for 15 min before TMDS (71 µL, 0.40 
mmol) was added. The initially blue solution was stirred until it became yellow (ca. 
5 min), after which a solution of the substrate (0.40 mmol) in THF (0.4 + 0.2 mL 
rinse) was then added rapidly via cannula. The mixture was stirred at room 
temperature for 18 h, quenched carefully with 1 M HCl (1 mL), diluted with H2O (15 
mL) and then extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were 
dried (MgSO4) and concentrated in vacuo, and purification of the residue by column 
chromatography (EtOAc/hexane) afforded the cyclized product. 
 
Cis-3-Ethoxycarbonylmethyl-1-(4-methoxyphenyl)piperidine-
4-carboxylic acid ethyl ester (335a).  
The title compound was prepared using a slight modification of the quantities 
described in General Procedure H from 327a (104 mg, 0.30 mmol), Cu(OAc)2·H2O 
(3.0 mg, 0.015 mmol), TMDS (55 µL, 0.30 mmol) and (S)-DM-Segphos (10.8 mg, 
0.015 mmol) to the enantioenriched product (43 mg, 41%). Rf = 0.32 (25% 
EtOAc/hexanes); [α]  –88.5 (c. 0.66, CH2Cl2); Enantiomeric excess was 
determined by HPLC with a Chiralpak AD-H column (90:10 hexane:isopropanol, 0.8 
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Cis-3-Meoxycarbonylmethyl-1-(4-methoxyphenyl)piperidine-
4-carboxylic acid methyl ester (335b)  
The title compound was prepared using a slight modification of the quantities 
described in General Procedure H from 327b (159 mg, 0.50 mmol), Cu(OAc)2·H2O 
(5.0 mg, 0.025 mmol), TMDS (88 µL, 0.50 mmol) and (R)-MeO-biphep (14.6 mg, 
0.025 mmol) to give the enantioenriched product (52.2 mg, 33%). Enantiomeric 
excess was determined by HPLC with a Chiralpak OD-H column (99:1 
hexanes:isopropanol, 0.8 mL/min, 254 nm, 25 °C); tr (major) = 13.9 min, tr (minor) = 
15.9 min; 93% ee; [α]  +37.3 (c. 0.04, CH2Cl2). 
 
Cis-1-Ethoxycarbonylmethylindan-2-carboxylic acid ethyl ester 
(351a).  
The title compound was prepared according to General Procedure H from 341a (110 
mg, 0.40 mmol) and (S)-Segphos (12.2 mg, 0.02 mmol) and purified by column 
chromatography (5% EtOAc/hexane) to give the enantioenriched product as a 12:1 
inseparable mixture of diastereomers (63 mg, 57%). [α]  +27.0 (c. 0.74, CH2Cl2); 
Enantiomeric excess of the major diastereomer was determined by HPLC with a 
Chiralpak OD-H column (99.5:0.5 hexane:isopropanol, 0.5 mL/min, 225 nm, 0 °C); 
tr (major) = 17.0 min, tr (minor) = 18.1 min; 94% ee.  
 
Cis-Methoxycarbonylmethylindan-2-carboxylic acid methyl 
ester (351b).  
The title compound was prepared according to General Procedure H from 341b (98 
mg, 0.40 mmol) and (S)-Segphos (12.2 mg, 0.02 mmol) and purified by column 
chromatography (5% EtOAc/hexane) to give the enantioenriched product as a 6:1 
inseparable mixture of diastereomers (41 mg, 41%). [α]  +25.3 (c. 0.32, CH2Cl2); 
Enantiomeric excess of the major diastereomer was determined by HPLC with a 
Chiralpak AD-H column (99.5:0.5 hexane:isopropanol, 0.5 mL/min, 210 nm, 0 °C); 
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Cis-1-Ethoxycarbonylmethyl-5,6-difluoroindan-2-carboxylic 
acid ethyl ester (353a).  
The title compound was prepared according to General Procedure 
H, but using half of all quantities from 347a (62 mg, 0.20 mmol) and (S)-Segphos 
(6.1 mg, 0.01 mmol) and purified by column chromatography (2.5% 
EtOAc/hexane→5% EtOAc/hexane) to give the enentioenriched product (33 mg, 
53%). [α]  +37.3 (c. 1.13, CH2Cl2); Enantiomeric excess was determined by HPLC 
with a Chiralpak AD-H column (99:1 hexane:isopropanol, 0.8 mL/min, 210 nm, 25 
°C); tr (minor) = 10.7 min, tr (major) = 11.5 min; 92% ee. 
 
Cis-1-tert-Butoxycarbonylmethyl-5,6-difluoroindan-2-
carboxylic acid tert-butyl ester (353b).  
The title compound was prepared according to General Procedure H, but using half 
of all quantities, from 347b (73 mg, 0.20 mmol) and (R)-Binap (6.2 mg, 0.01 mmol) 
and purified by column chromatography (2.5% EtOAc/hexane→10% 
EtOAc/hexane) to give the enantioenriched product (39 mg, 54%). [α]  –46.7 (c. 
1.97, CH2Cl2); Enantiomeric excess was determined from 353b. 
 
Cis-5,6-Difluoro-1-methoxycarbonylmethylindan-2-carboxylic acid methyl ester 
(355) 
 
TFA (1 mL) was added to 353b (25 mg, 0.07 mmol) and the resulting solution was 
stirred at room temperature for 1 h. The reaction was concentrated in vacuo and the 
resulting bis-acid was dissolved in a mixture of MeOH (0.1 mL) and toluene (0.2 
mL). Trimethylsilyldiazomethane (2.0 M in Et2O, 70 µL, 0.14 mmol) was added 
dropwise over 1 min and the mixture was stirred at room temperature for 16 h. The 
reaction was concentrated in vacuo and the residue was purified by column 
chromatography (5% EtOAc/hexane→20% EtOAc/hexane) to give the 
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Enantiomeric excess was determined by HPLC with a Chiralpak AD-H column (99:1 
hexane:isopropanol, 0.8 mL/min, 230 nm, 25 °C); tr (major) = 16.6 min, tr (minor) = 
21.6 min; 90% ee. 
 
Cis-2-Acetylindan-1-yl)propan-2-one (cis-375).  
The title compound was prepared according to General Procedure H 
from 367 (86 mg, 0.4 mmol) and (S)-Segphos (12.2 mg, 0.02 mmol) and purified by 
column chromatography (5% EtOAc/hexane→20% EtOAc/hexane) to give the 
enantioenriched product (36 mg, 41%). [α]  +17.8 (c. 1.35, CH2Cl2); Enantiomeric 
excess was determined by HPLC with a Chiralpak AD-H column (99:1 
hexane:isopropanol, 0.8 mL/min, 225 nm, 25 °C); tr (minor) = 19.2 min, tr (major) = 




A solution of CuF(PPh3)3·2MeOH (20 mg, 0.02 mmol), Taniaphos ligand (R,R)-L21 
(13.7 mg, 0.02 mmol) and 369a (135 mg, 0.40 mmol) in toluene (1.5 mL) was stirred 
for 30 min at room temperature, after which the mixture was cooled to 0 °C. A 
solution of PMHS (24 µL, 0.40 mmol) in toluene (0.4 mL) was added rapidly via 
cannula. The reaction mixture was stirred at 0 °C for 24 h before a solution of more 
CuF(PPh3)3·2MeOH (20 mg, 0.02 mmol), (R,R)-L21 (13.7 mg, 0.02 mmol), and 
PMHS (24 µL, 0.40 mmol) in toluene (0.5 mL) was added rapidly via cannula. After 
stirring at 0 °C for a further 24 h, the reaction was quenched carefully by the addition 
of 1 M HCl (5 mL), the mixture was extracted with CH2Cl2 (3 x 5 mL) and the 
combined organic layers were dried (MgSO4) and concentrated in vacuo. Purification 
of the residue by column chromatography (5% EtOAc/hexane→20% EtOAc/hexane) 
gave the enantioenriched product 377a (62 mg, 46%). [α]  –33.3 (c. 2.38, CH2Cl2); 
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(90:10 hexane:isopropanol, 0.8 mL/min, 280 nm, 25 °C); tr (minor) = 36.7 min, tr 




A solution of CuF(PPh3)3·2MeOH (5 mg, 0.005 mmol), Taniaphos ligand (R,R)-L21 
(3.4 mg, 0.005 mmol) and 369b (41 mg, 0.10 mmol) in toluene (0.5 mL) was stirred 
for 30 min at room temperature, after which the mixture was cooled to –20 °C and a 
solution of PMHS (6 µL, 0.10 mmol) in toluene (0.2 mL) was added rapidly via 
cannula. The reaction mixture was stirred at –20 °C for 24 h before a solution of 
more CuF(PPh3)3·2MeOH (5 mg, 0.005 mmol), (R,R)-L21 (3.4 mg, 0.005 mmol), 
and PMHS (6 µL, 0.10 mmol) in toluene (0.3 mL) was added rapidly via cannula. 
After stirring at –20 °C for a further 24 h, the reaction was quenched carefully by the 
addition of 1 M HCl (2 mL), the mixture was extracted with CH2Cl2 (3 x 2 mL), and 
the combined organic layers were dried (MgSO4) and concentrated in vacuo. 
Purification of the residue by column chromatography (2.5% EtOAc/hexane→10% 
EtOAc/hexane) gave the enantioenriched product 377b (17 mg, 41%) as a white 
solid. Recrystallization of 376b from CH2Cl2/hexane gave colorless crystals that 
were suitable for X-ray crystallography. [α]  –109.5 (c. 0.73, CH2Cl2); 
Enantiomeric excess was determined by HPLC with a Chiralpak AD-H column 
(80:20 hexane:isopropanol, 0.8 mL/min, 230 nm, 25 °C); tr (major) = 41.3 min, tr 
(minor) = 56.0 min; 90% ee. 
 
CuF(PPh3)3·2MeOH
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2-[(3S,4R)-4-Benzoyltetrahydropyran-3-yl]-1-phenylethanone80 (378) 
 
A solution of CuF(PPh3)3·2MeOH (5 mg, 0.005 mmol), Taniaphos ligand (R,R)-L21 
(3.4 mg, 0.005 mmol) and 374 (30.6 mg, 0.10 mmol) in toluene (0.5 mL) was stirred 
for 30 min at room temperature, after which the mixture was cooled to –20 °C and a 
solution of PMHS (6 µL, 0.10 mmol) in toluene (0.2 mL) was added rapidly via 
cannula. The reaction mixture was stirred at –20 °C for 24 h before a solution of 
more CuF(PPh3)3·2MeOH (5 mg, 0.005 mmol), (R,R)-L21 (3.4 mg, 0.005 mmol), 
and PMHS (6 µL, 0.10 mmol) in toluene (0.3 mL) was added rapidly via cannula. 
After stirring at –20 °C for a further 24 h, the reaction was quenched carefully by the 
addition of 1 M HCl (2 mL), the mixture was extracted with CH2Cl2 (3 x 2 mL), and 
the combined organic layers were dried (MgSO4) and concentrated in vacuo. 
Purification of the residue by column chromatography (5% EtOAc/hexane→50% 
EtOAc/hexane) gave the enantioenriched product 378 (17 mg, 54%). [α]  –9.8 (c. 
0.41, CH2Cl2); Enantiomeric excess was determined by HPLC with a Chiralpak OD-
H column (90:10 hexane:isopropanol, 0.8 mL/min, 254 nm, 25 °C); tr (major) = 20.5 
min, tr (minor) = 23.8 min; 52% ee. 
 
1-[(1S,2R)-2-Benzoylindan-1-yl]propan-2-one (trans-379) and 1-[(1R,2R)-2-
benzoylindan-1-yl]propan-2-one (cis-379) 
 
A solution of CuF(PPh3)3·2MeOH (20 mg, 0.02 mmol), Taniaphos ligand (R,R)-L21 
(13.7 mg, 0.02 mmol) and 371 (111 mg, 0.40 mmol) in toluene (1 mL) was stirred 
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in toluene (0.6 mL) was added rapidly via cannula. The mixture was stirred at room 
temperature for 24 h, quenched carefully with 1 M HCl (5 mL), and the mixture was 
extracted with CH2Cl2 (3 x 5 mL). The combined organic layers were dried (MgSO4) 
and concentrated in vacuo. Purification of the residue by column chromatography 
(5% EtOAc/hexane→20% EtOAc/hexane) gave the indane cis-379 (13 mg, 12%) as 
a yellow oil, followed by the indane trans-379 (33 mg, 30%) as a yellow oil. 
 
Data for trans-379 (isolated as a 5:1 mixture of inseparable regioisomers): [α]  –
95.0 (c. 1.01, CH2Cl2); Enantiomeric excess of the major regioisomer was 
determined by HPLC with a Chiralpak AD-H column (90:10 hexane:isopropanol, 0.8 
mL/min, 225 nm, 25 °C); tr (minor) = 24.3 min, tr (major) = 25.8 min; 80% ee. 
 
Data for cis-379 (isolated as an 8:1 mixture of inseparable regioisomers): [α]  –
50.0 (c. 0.36, CH2Cl2); Enantiomeric excess of the major regioisomer was 
determined by HPLC with a Chiralpak AD-H column (95:05 hexane:isopropanol, 0.8 
mL/min, 254 nm, 25 °C); tr (major) = 13.6 min, tr (minor) = 19.7 min; 67% ee. 
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